ID,Study,Reference,Grouping,Analyte,t0,tend,t Unit,AUC Avg,AUC AvgUnit,AUC AvgType,AUC Var,AUC VarUnit,AUC VarType,AUC Type,Cmax Avg,Cmax AvgUnit,Cmax AvgType,Cmax Var,Cmax VarUnit,Cmax VarType,Cmax Type,CL Avg,CL AvgUnit,CL AvgType,CL Var,CL VarUnit,CL VarType,CL Type,Comment
61,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 1 Normal,Buspirone,0,inf,h,2.89,ng*h/mL,arith. mean,3.4,ng*h/mL,arith. SD,AUC_inf,1.01,ng/mL,arith. mean,0.87,ng/mL,arith. SD,Cmax,,,,,,,,
62,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 1 Renal mild,Buspirone,0,inf,h,6.63,ng*h/mL,arith. mean,4.59,ng*h/mL,arith. SD,AUC_inf,2.48,ng/mL,arith. mean,2.12,ng/mL,arith. SD,Cmax,,,,,,,,
63,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 1 Renal moderate,Buspirone,0,inf,h,4.64,ng*h/mL,arith. mean,3.7,ng*h/mL,arith. SD,AUC_inf,1.81,ng/mL,arith. mean,1.17,ng/mL,arith. SD,Cmax,,,,,,,,
64,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 1 Renal severe,Buspirone,0,inf,h,4.09,ng*h/mL,arith. mean,3.35,ng*h/mL,arith. SD,AUC_inf,1.83,ng/mL,arith. mean,1.26,ng/mL,arith. SD,Cmax,,,,,,,,
65,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 1 Hepatic compensated,Buspirone,0,inf,h,15.4,ng*h/mL,arith. mean,12.5,ng*h/mL,arith. SD,AUC_inf,4.61,ng/mL,arith. mean,3.64,ng/mL,arith. SD,Cmax,,,,,,,,
66,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 1 Hepatic decompensated,Buspirone,0,inf,h,70.2,ng*h/mL,arith. mean,65.3,ng*h/mL,arith. SD,AUC_inf,11.7,ng/mL,arith. mean,8.66,ng/mL,arith. SD,Cmax,,,,,,,,
67,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 5 Normal,Buspirone,96,108,h,1.9,ng*h/mL,arith. mean,2.63,ng*h/mL,arith. SD,AUC_tau,0.96,ng/mL,arith. mean,1.13,ng/mL,arith. SD,Cmax,,,,,,,,
68,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 5 Renal mild,Buspirone,96,108,h,9.18,ng*h/mL,arith. mean,6.22,ng*h/mL,arith. SD,AUC_tau,3.42,ng/mL,arith. mean,2.09,ng/mL,arith. SD,Cmax,,,,,,,,
69,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 5 Renal moderate,Buspirone,96,108,h,6.58,ng*h/mL,arith. mean,6.53,ng*h/mL,arith. SD,AUC_tau,4.26,ng/mL,arith. mean,4.64,ng/mL,arith. SD,Cmax,,,,,,,,
70,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 5 Renal severe,Buspirone,96,108,h,10,ng*h/mL,arith. mean,10.8,ng*h/mL,arith. SD,AUC_tau,4.74,ng/mL,arith. mean,5.72,ng/mL,arith. SD,Cmax,,,,,,,,
71,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 5 Hepatic compensated,Buspirone,96,108,h,27.6,ng*h/mL,arith. mean,44.7,ng*h/mL,arith. SD,AUC_tau,13.46,ng/mL,arith. mean,23.89,ng/mL,arith. SD,Cmax,,,,,,,,
72,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 5 Hepatic decompensated,Buspirone,96,108,h,54,ng*h/mL,arith. mean,33.5,ng*h/mL,arith. SD,AUC_tau,13.1,ng/mL,arith. mean,9.8,ng/mL,arith. SD,Cmax,,,,,,,,
73,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 10 Normal,Buspirone,96,108,h,2.91,ng*h/mL,arith. mean,3.37,ng*h/mL,arith. SD,AUC_tau,1.08,ng/mL,arith. mean,0.8,ng/mL,arith. SD,Cmax,,,,,,,,
74,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 10 Renal mild,Buspirone,216,228,h,13.6,ng*h/mL,arith. mean,15.1,ng*h/mL,arith. SD,AUC_tau,5.38,ng/mL,arith. mean,5.4,ng/mL,arith. SD,Cmax,,,,,,,,
75,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 10 Renal moderate,Buspirone,216,228,h,9.58,ng*h/mL,arith. mean,11.6,ng*h/mL,arith. SD,AUC_tau,4.03,ng/mL,arith. mean,3.97,ng/mL,arith. SD,Cmax,,,,,,,,
76,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 10 Renal severe,Buspirone,216,228,h,11.1,ng*h/mL,arith. mean,10.1,ng*h/mL,arith. SD,AUC_tau,4.61,ng/mL,arith. mean,3.52,ng/mL,arith. SD,Cmax,,,,,,,,
77,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 10 Hepatic compensated,Buspirone,216,228,h,24.8,ng*h/mL,arith. mean,33.5,ng*h/mL,arith. SD,AUC_tau,9.78,ng/mL,arith. mean,15.7,ng/mL,arith. SD,Cmax,,,,,,,,
78,Barbhaiya 1993,https://www.ncbi.nlm.nih.gov/pubmed/7911763,Day 10 Hepatic decompensated,Buspirone,216,228,h,54.5,ng*h/mL,arith. mean,36.2,ng*h/mL,arith. SD,AUC_tau,13,ng/mL,arith. mean,8.51,ng/mL,arith. SD,Cmax,,,,,,,,
123,Dockens 2006,https://www.ncbi.nlm.nih.gov/pubmed/17050795,Day 5,Buspirone,144,156,h,0.69,ng*h/mL,geo. mean,80,%,geo. CV,AUC_tau,0.25,ng/mL,geo. mean,93,%,geo. CV,Cmax,,,,,,,,
124,Dockens 2006,https://www.ncbi.nlm.nih.gov/pubmed/17050795,Day 10,Buspirone,264,276,h,1,ng*h/mL,geo. mean,73,%,geo. CV,AUC_tau,0.44,ng/mL,geo. mean,83,%,geo. CV,Cmax,,,,,,,,
125,Dockens 2006,https://www.ncbi.nlm.nih.gov/pubmed/17050795,Day 15,Buspirone,384,396,h,2.3,ng*h/mL,geo. mean,73,%,geo. CV,AUC_tau,1.1,ng/mL,geo. mean,79,%,geo. CV,Cmax,,,,,,,,
126,Dockens 2006,https://www.ncbi.nlm.nih.gov/pubmed/17050795,Day 20,Buspirone,504,516,h,3.4,ng*h/mL,geo. mean,64,%,geo. CV,AUC_tau,1.3,ng/mL,geo. mean,63,%,geo. CV,Cmax,,,,,,,,
127,Dockens 2006,https://www.ncbi.nlm.nih.gov/pubmed/17050795,Day 25,Buspirone,624,636,h,4.7,ng*h/mL,geo. mean,82,%,geo. CV,AUC_tau,2,ng/mL,geo. mean,101,%,geo. CV,Cmax,,,,,,,,
134,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Autistic children,Buspirone,0,inf,h,,,,,,,,1141.3,pg/mL,arith. mean,748,pg/mL,arith. SD,Cmax,87.8,L/h/kg,arith. mean,44.8,L/h/kg,arith. SD,CL/F,
168,Gammans 1986,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Intravenous 1mg (n=8),Buspirone,0,inf,h,9.25,ng*h/mL,arith. mean,5.42,ng*h/mL,arith. SEM,AUC_inf,,,,,,,,,,,,,,,
169,Gammans 1986,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Oral 20 mg (n=8),Buspirone,0,inf,h,6.31,ng*h/mL,arith. mean,6.31,ng*h/mL,arith. SEM,AUC_inf,2.47,ng/mL,arith. mean,2.11,ng/mL,arith. SEM,Cmax,,,,,,,,
165,Gammans 1985,https://www.ncbi.nlm.nih.gov/pubmed/2860931,10 mg,Buspirone,0,inf,h,2.7,ng*h/mL,arith. mean,1.4,ng*h/mL,arith. SD,AUC_inf,0.88,ng/mL,arith. mean,0.4,ng/mL,arith. SEM,Cmax,,,,,,,,means taken from Gammans 1986 Table III
166,Gammans 1985,https://www.ncbi.nlm.nih.gov/pubmed/2860931,20 mg,Buspirone,0,inf,h,4.69,ng*h/mL,arith. mean,2.4,ng*h/mL,arith. SD,AUC_inf,1.66,ng/mL,arith. mean,1,ng/mL,arith. SEM,Cmax,,,,,,,,means taken from Gammans 1986 Table III
167,Gammans 1985,https://www.ncbi.nlm.nih.gov/pubmed/2860931,40 mg,Buspirone,0,inf,h,9.43,ng*h/mL,arith. mean,4.9,ng*h/mL,arith. SD,AUC_inf,3.22,ng/mL,arith. mean,2,ng/mL,arith. SEM,Cmax,,,,,,,,means taken from Gammans 1986 Table III
230,Hanley 2013,https://www.ncbi.nlm.nih.gov/pubmed/22943633,Control (Perpetrator Placebo),Buspirone,0,inf,h,3.11,ng*h/mL,arith. mean,0.52,ng*h/mL,arith. SEM,AUC_inf,1.14,ng/mL,arith. mean,0.24,ng/mL,arith. SEM,Cmax,78,L/min,arith. mean,20,L/min,arith. SEM,CL/F,
231,Hanley 2013,https://www.ncbi.nlm.nih.gov/pubmed/22943633,with Perpetrator (GFJ),Buspirone,15,inf,h,6.15,ng*h/mL,arith. mean,0.92,ng*h/mL,arith. SEM,AUC_inf,1.53,ng/mL,arith. mean,0.2,ng/mL,arith. SEM,Cmax,33,L/min,arith. mean,7,L/min,arith. SEM,CL/F,
317,Kivistö 1997,https://www.ncbi.nlm.nih.gov/pubmed/9333111,Control (Perpetrator Placebo),Buspirone,0,inf,h,3.3,ng*h/mL,arith. mean,3.9,ng*h/mL,arith. SD,AUC_inf,1,ng/mL,arith. mean,0.99,ng/mL,arith. SD,Cmax,,,,,,,,
318,Kivistö 1997,https://www.ncbi.nlm.nih.gov/pubmed/9333111,with Perpetrator (Erythromycin),Buspirone,79,inf,h,19.5,ng*h/mL,arith. mean,13.6,ng*h/mL,arith. SD,AUC_inf,5,ng/mL,arith. mean,2.3,ng/mL,arith. SD,Cmax,,,,,,,,
320,Kivistö 1997,https://www.ncbi.nlm.nih.gov/pubmed/9333111,with Perpetrator (Itraconazole),Buspirone,79,inf,h,63.2,ng*h/mL,arith. mean,29.5,ng*h/mL,arith. SD,AUC_inf,13.4,ng/mL,arith. mean,3.9,ng/mL,arith. SD,Cmax,,,,,,,,
326,Lamberg 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9923581,Control (Perpetrator Placebo),Buspirone,0,inf,h,4.81,ng*h/mL,arith. mean,2.75,ng*h/mL,arith. SD,AUC_inf,1.87,ng/mL,arith. mean,1.17,ng/mL,arith. SD,Cmax,,,,,,,,
327,Lamberg 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9923581,with Perpetrator (Fluvoxamine),Buspirone,114,inf,h,11.3,ng*h/mL,arith. mean,8.54,ng*h/mL,arith. SD,AUC_inf,3.76,ng/mL,arith. mean,2.51,ng/mL,arith. SD,Cmax,,,,,,,,
328,Lamberg 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9578186,Control (Perpetrator Placebo),Buspirone,0,inf,h,22,ng*h/mL,arith. mean,15.1,ng*h/mL,arith. SD,AUC_inf,6.6,ng/mL,arith. mean,3.7,ng/mL,arith. SD,Cmax,,,,,,,,
329,Lamberg 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9578186,with Perpetrator (Rifampicin),Buspirone,113,inf,h,1.64,ng*h/mL,arith. mean,1.64,ng*h/mL,arith. SD,AUC_inf,0.84,ng/mL,arith. mean,0.23,ng/mL,arith. SD,Cmax,,,,,,,,
330,Lamberg 1998c,https://www.ncbi.nlm.nih.gov/pubmed/9663178,Control (Perpetrator Placebo),Buspirone,0,inf,h,6.9,ng*h/mL,arith. mean,2.5,ng*h/mL,arith. SD,AUC_inf,2.6,ng/mL,arith. mean,1,ng/mL,arith. SD,Cmax,,,,,,,,
331,Lamberg 1998c,https://www.ncbi.nlm.nih.gov/pubmed/9663178,with Perpetrator (Verapamil),Buspirone,30,inf,h,24.3,ng*h/mL,arith. mean,19.2,ng*h/mL,arith. SD,AUC_inf,8.8,ng/mL,arith. mean,7.9,ng/mL,arith. SD,Cmax,,,,,,,,
333,Lamberg 1998c,https://www.ncbi.nlm.nih.gov/pubmed/9663178,with Perpetrator (Diltiazem),Buspirone,30,inf,h,36.8,ng*h/mL,arith. mean,15.2,ng*h/mL,arith. SD,AUC_inf,10.3,ng/mL,arith. mean,3.5,ng/mL,arith. SD,Cmax,,,,,,,,
335,Lamberg 1999,https://www.ncbi.nlm.nih.gov/pubmed/10227067,Control (Perpetrator Placebo),Buspirone,0,inf,h,6.7,ng*h/mL,arith. mean,3.2,ng*h/mL,arith. SD,AUC_inf,2.4,ng/mL,arith. mean,1.1,ng/mL,arith. SD,Cmax,,,,,,,,
339,Lilja 1998,https://www.ncbi.nlm.nih.gov/pubmed/9871430,Control (Perpetrator Placebo),Buspirone,0,inf,h,4.32,ng*h/mL,arith. mean,1.4,ng*h/mL,arith. SEM,AUC_inf,1.96,ng/mL,arith. mean,0.74,ng/mL,arith. SEM,Cmax,,,,,,,,
340,Lilja 1998,https://www.ncbi.nlm.nih.gov/pubmed/9871430,with Perpetrator (GFJ),Buspirone,50,inf,h,39.8,ng*h/mL,arith. mean,9.6,ng*h/mL,arith. SEM,AUC_inf,8.4,ng/mL,arith. mean,0.74,ng/mL,arith. SEM,Cmax,,,,,,,,
135,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 1,Buspirone,0,inf,h,,,,,,,,414,pg/mL,individual,,,,Cmax,190.1,L/h/kg,individual,,,,CL/F,
136,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 2,Buspirone,0,inf,h,,,,,,,,840.7,pg/mL,individual,,,,Cmax,49.4,L/h/kg,individual,,,,CL/F,
137,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 3,Buspirone,0,inf,h,,,,,,,,1149.9,pg/mL,individual,,,,Cmax,63.7,L/h/kg,individual,,,,CL/F,
138,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 5,Buspirone,0,inf,h,,,,,,,,926.3,pg/mL,individual,,,,Cmax,72.9,L/h/kg,individual,,,,CL/F,
139,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 7,Buspirone,0,inf,h,,,,,,,,423,pg/mL,individual,,,,Cmax,155.4,L/h/kg,individual,,,,CL/F,
140,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 8,Buspirone,0,inf,h,,,,,,,,1281.2,pg/mL,individual,,,,Cmax,77.6,L/h/kg,individual,,,,CL/F,
141,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 9,Buspirone,0,inf,h,,,,,,,,773.9,pg/mL,individual,,,,Cmax,75,L/h/kg,individual,,,,CL/F,
142,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 10,Buspirone,0,inf,h,,,,,,,,3001.3,pg/mL,individual,,,,Cmax,48.1,L/h/kg,individual,,,,CL/F,
143,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 12,Buspirone,0,inf,h,,,,,,,,1461.7,pg/mL,individual,,,,Cmax,122.8,L/h/kg,individual,,,,CL/F,
144,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 13,Buspirone,0,inf,h,,,,,,,,901.1,pg/mL,individual,,,,Cmax,81.7,L/h/kg,individual,,,,CL/F,
145,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 14,Buspirone,0,inf,h,,,,,,,,530,pg/mL,individual,,,,Cmax,132.3,L/h/kg,individual,,,,CL/F,
146,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 15,Buspirone,0,inf,h,,,,,,,,786.2,pg/mL,individual,,,,Cmax,72.1,L/h/kg,individual,,,,CL/F,
147,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 16,Buspirone,0,inf,h,,,,,,,,877.2,pg/mL,individual,,,,Cmax,144.5,L/h/kg,individual,,,,CL/F,
148,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 17,Buspirone,0,inf,h,,,,,,,,764.2,pg/mL,individual,,,,Cmax,57.6,L/h/kg,individual,,,,CL/F,
149,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 18,Buspirone,0,inf,h,,,,,,,,1829.2,pg/mL,individual,,,,Cmax,28.9,L/h/kg,individual,,,,CL/F,
150,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 19,Buspirone,0,inf,h,,,,,,,,2603.1,pg/mL,individual,,,,Cmax,60.4,L/h/kg,individual,,,,CL/F,
151,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 20,Buspirone,0,inf,h,,,,,,,,1260.3,pg/mL,individual,,,,Cmax,71.6,L/h/kg,individual,,,,CL/F,
152,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 21,Buspirone,0,inf,h,,,,,,,,494.9,pg/mL,individual,,,,Cmax,88,L/h/kg,individual,,,,CL/F,
153,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 23,Buspirone,0,inf,h,,,,,,,,2227.2,pg/mL,individual,,,,Cmax,23.6,L/h/kg,individual,,,,CL/F,
154,Edwards 2006,https://www.ncbi.nlm.nih.gov/pubmed/16638734,Subject 24,Buspirone,0,inf,h,,,,,,,,280.5,pg/mL,individual,,,,Cmax,140.6,L/h/kg,individual,,,,CL/F,
79,Barone 1993,https://www.ncbi.nlm.nih.gov/pubmed/8388198,day 1 fasted,Itraconazole,0,inf,h,2094,ng*h/mL,arith. mean,905,ng*h/mL,arith. SD,AUC_inf,140,ng/mL,arith. mean,65,ng/mL,arith. SD,Cmax,,,,,,,CL/F,
80,Barone 1993,https://www.ncbi.nlm.nih.gov/pubmed/8388198,day 1 fasted,Hydroxy-Itraconazole,0,inf,h,5194,ng*h/mL,arith. mean,2489,ng*h/mL,arith. SD,AUC_inf,287,ng/mL,arith. mean,101,ng/mL,arith. SD,Cmax,,,,,,,,
81,Barone 1993,https://www.ncbi.nlm.nih.gov/pubmed/8388198,day 1 fed,Itraconazole,0,inf,h,3415,ng*h/mL,arith. mean,1153,ng*h/mL,arith. SD,AUC_inf,239,ng/mL,arith. mean,85,ng/mL,arith. SD,Cmax,,,,,,,,
82,Barone 1993,https://www.ncbi.nlm.nih.gov/pubmed/8388198,day 1 fed,Hydroxy-Itraconazole,0,inf,h,7952,ng*h/mL,arith. mean,2648,ng*h/mL,arith. SD,AUC_inf,397,ng/mL,arith. mean,103,ng/mL,arith. SD,Cmax,,,,,,,,
83,Barone 1993,https://www.ncbi.nlm.nih.gov/pubmed/8388198,day 15 fed,Itraconazole,432,444,h,22.6,µg*h/mL,arith. mean,5.4,µg*h/mL,arith. SD,AUC_tau,2282,ng/mL,arith. mean,514,ng/mL,arith. SD,Cmax,,,,,,,,
84,Barone 1993,https://www.ncbi.nlm.nih.gov/pubmed/8388198,day 15 fed,Hydroxy-Itraconazole,432,444,h,38.6,µg*h/mL,arith. mean,8.5,µg*h/mL,arith. SD,AUC_tau,3488,ng/mL,arith. mean,742,ng/mL,arith. SD,Cmax,,,,,,,,
85,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 1 fasted,Itraconazole,0,24,h,4519.9,ng*h/mL,arith. mean,160.2,µg*h/mL,arith. SD,AUC_tend,545.7,ng/mL,arith. mean,22,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
86,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 1 fasted,Hydroxy-Itraconazole,0,24,h,9554.5,ng*h/mL,arith. mean,199.8,µg*h/mL,arith. SD,AUC_tend,622.1,ng/mL,arith. mean,15.2,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
87,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 15 fasted,Itraconazole,336,360,h,29287.7,ng*h/mL,arith. mean,841.2,µg*h/mL,arith. SD,AUC_tau,1965.3,ng/mL,arith. mean,54.5,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
88,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 15 fasted,Hydroxy-Itraconazole,336,360,h,45143.9,ng*h/mL,arith. mean,1061.6,µg*h/mL,arith. SD,AUC_tau,2053.2,ng/mL,arith. mean,48.6,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
89,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 1 fed,Itraconazole,0,24,h,3161.7,ng*h/mL,arith. mean,160.2,µg*h/mL,arith. SD,AUC_tend,306.9,ng/mL,arith. mean,22,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
90,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 1 fed,Hydroxy-Itraconazole,0,24,h,6904.3,ng*h/mL,arith. mean,199.8,µg*h/mL,arith. SD,AUC_tend,424.3,ng/mL,arith. mean,15.2,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
91,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 15 fed,Itraconazole,336,360,h,22738.4,ng*h/mL,arith. mean,841.2,µg*h/mL,arith. SD,AUC_tau,1429.8,ng/mL,arith. mean,54.5,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
92,Barone 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9545149,day 15 fed,Hydroxy-Itraconazole,336,360,h,38717.6,ng*h/mL,arith. mean,1061.6,µg*h/mL,arith. SD,AUC_tau,1776.2,ng/mL,arith. mean,48.6,ng/mL,arith. SD,Cmax,,,,,,,,ANOVA
1,Acocella 1972a,https://doi.org/10.1007/BF00561755,day 1,Rifampicin,0,12,h,,,,,,,,13.4,µg/mL,arith. mean,1.5,µg/mL,arith. SEM,Cmax,,,,,,,,
2,Acocella 1972a,https://doi.org/10.1007/BF00561755,day 7,Rifampicin,144,156,h,,,,,,,,8.9,µg/mL,arith. mean,2.8,µg/mL,arith. SEM,Cmax,,,,,,,,
355,Nitti 1977,https://www.ncbi.nlm.nih.gov/pubmed/832508,300 mg,Rifampicin,0,12,h,17.642,µg*h/mL,arith. mean,6.76,µg*h/mL,arith. SEM,AUC_tend,,,,,,,,,,,,,,,
356,Nitti 1977,https://www.ncbi.nlm.nih.gov/pubmed/832508,450 mg,Rifampicin,0,12,h,50.48,µg*h/mL,arith. mean,12.47,µg*h/mL,arith. SEM,AUC_tend,,,,,,,,,,,,,,,
357,Nitti 1977,https://www.ncbi.nlm.nih.gov/pubmed/832508,600 mg,Rifampicin,0,12,h,64.12,µg*h/mL,arith. mean,5.8,µg*h/mL,arith. SEM,AUC_tend,,,,,,,,,,,,,,,
100,Blume 1989,https://doi.org/10.1002/pauz.19900190516,450 mg REFERENZ,Rifampicin,0,inf,h,34,mg*h/L,arith. mean,36,%,arith. CV,AUC_inf,5.8,mg/L,arith. mean,40,%,arith. CV,Cmax,,,,,,,,
101,Blume 1989,https://doi.org/10.1002/pauz.19900190516,600 mg REFERENZ,Rifampicin,0,inf,h,48.9,mg*h/L,arith. mean,39,%,arith. CV,AUC_inf,10,mg/L,arith. mean,40,%,arith. CV,Cmax,,,,,,,,
93,Barone 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9661037,Solution,Itraconazole,0,inf,h,5838,ng*h/mL,arith. mean,,,,AUC_inf,306.4,ng/mL,arith. mean,,,,Cmax,,,,,,,,
94,Barone 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9661037,Solution,Hydroxy-Itraconazole,0,inf,h,15025.5,ng*h/mL,arith. mean,,,,AUC_inf,527,ng/mL,arith. mean,,,,Cmax,,,,,,,,
95,Barone 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9661037,F05 Capsule,Itraconazole,0,inf,h,4475.8,ng*h/mL,arith. mean,,,,AUC_inf,314.7,ng/mL,arith. mean,,,,Cmax,,,,,,,,
96,Barone 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9661037,F05 Capsule,Hydroxy-Itraconazole,0,inf,h,10937.8,ng*h/mL,arith. mean,,,,AUC_inf,501,ng/mL,arith. mean,,,,Cmax,,,,,,,,
97,Barone 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9661037,F12 Capsule,Itraconazole,0,inf,h,4441.3,ng*h/mL,arith. mean,,,,AUC_inf,301.9,ng/mL,arith. mean,,,,Cmax,,,,,,,,
98,Barone 1998b,https://www.ncbi.nlm.nih.gov/pubmed/9661037,F12 Capsule,Hydroxy-Itraconazole,0,inf,h,11148.1,ng*h/mL,arith. mean,,,,AUC_inf,504.3,ng/mL,arith. mean,,,,Cmax,,,,,,,,
232,Hardin 1988,https://www.ncbi.nlm.nih.gov/pubmed/2848442,A 100 mg OD (day 1),Itraconazole,0,inf,h,1320,ng*h/mL,arith. mean,651,ng*h/mL,arith. SD,AUC_inf,110,ng/mL,arith. mean,57.5,ng/mL,arith. SD,Cmax,1.511,L/h/kg,arith. mean,0.863,L/h/kg,arith. SD,CL/F,
234,Hardin 1988,https://www.ncbi.nlm.nih.gov/pubmed/2848442,A 100 mg OD (day 15),Itraconazole,360,384,h,5330,ng*h/mL,arith. mean,1470,ng*h/mL,arith. SD,AUC_tau,412,ng/mL,arith. mean,79.5,ng/mL,arith. SD,Cmax,0.308,L/h/kg,arith. mean,0.073,L/h/kg,arith. SD,CL/F,
235,Hardin 1988,https://www.ncbi.nlm.nih.gov/pubmed/2848442,B 200 mg OD (day 1),Itraconazole,0,inf,h,4160,ng*h/mL,arith. mean,1949,ng*h/mL,arith. SD,AUC_inf,272,ng/mL,arith. mean,81.2,ng/mL,arith. SD,Cmax,0.937,L/h/kg,arith. mean,0.587,L/h/kg,arith. SD,CL/F,
237,Hardin 1988,https://www.ncbi.nlm.nih.gov/pubmed/2848442,B 200 mg OD (day 15),Itraconazole,360,384,h,15400,ng*h/mL,arith. mean,6880,ng*h/mL,arith. SD,AUC_tau,1070,ng/mL,arith. mean,499,ng/mL,arith. SD,Cmax,0.233,L/h/kg,arith. mean,0.087,L/h/kg,arith. SD,CL/F,
472,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,ITZ day 1,Itraconazole,0,inf,h,2862,nmol*h/L,arith. mean,2158,nmol*h/L,arith. SD,AUC_inf,362,nmol/L,arith. mean,148,nmol/L,arith. SD,Cmax,,,,,,,,
473,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,ITZ day 7,Itraconazole,144,168,h,7240,nmol*h/L,arith. mean,3177,nmol*h/L,arith. SD,AUC_tau,1152,nmol/L,arith. mean,203,nmol/L,arith. SD,Cmax,,,,,,,,
474,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,OH-ITZ day 1,Hydroxy-Itraconazole,0,inf,h,4237,nmol*h/L,arith. mean,2175,nmol*h/L,arith. SD,AUC_inf,358,nmol/L,arith. mean,118,nmol/L,arith. SD,Cmax,,,,,,,,
475,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,OH-ITZ day 7,Hydroxy-Itraconazole,144,168,h,9811,nmol*h/L,arith. mean,5263,nmol*h/L,arith. SD,AUC_tau,608,nmol/L,arith. mean,206,nmol/L,arith. SD,Cmax,,,,,,,,
476,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,keto-ITZ day 1,Keto-Itraconazole,0,inf,h,322,nmol*h/L,arith. mean,96,nmol*h/L,arith. SD,AUC_inf,39,nmol/L,arith. mean,11,nmol/L,arith. SD,Cmax,,,,,,,,
477,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,keto-ITZ day 7,Keto-Itraconazole,144,168,h,308,nmol*h/L,arith. mean,81,nmol*h/L,arith. SD,AUC_tau,23,nmol/L,arith. mean,9,nmol/L,arith. SD,Cmax,,,,,,,,
478,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,ND-OH-ITZ day 1,N-desalkyl-Itraconazole,0,inf,h,389,nmol*h/L,arith. mean,150,nmol*h/L,arith. SD,AUC_inf,15,nmol/L,arith. mean,7,nmol/L,arith. SD,Cmax,,,,,,,,
479,Templeton 2008,https://www.ncbi.nlm.nih.gov/pubmed/17495874,ND-OH-ITZ day 7,N-desalkyl-Itraconazole,144,168,h,394,nmol*h/L,arith. mean,133,nmol*h/L,arith. SD,AUC_tau,22,nmol/L,arith. mean,3,nmol/L,arith. SD,Cmax,,,,,,,,
480,Van de Velde 1996,https://www.ncbi.nlm.nih.gov/pubmed/8726601,Fasting ITZ,Itraconazole,0,inf,h,3716,ng*h/mL,arith. mean,2711,ng*h/mL,arith. SD,AUC_inf,349,ng/mL,arith. mean,239,ng/mL,arith. SD,Cmax,,,,,,,,
481,Van de Velde 1996,https://www.ncbi.nlm.nih.gov/pubmed/8726601,Fasting OH-ITZ,Hydroxy-Itraconazole,0,inf,h,8007,ng*h/mL,arith. mean,5185,ng*h/mL,arith. SD,AUC_inf,424,ng/mL,arith. mean,147,ng/mL,arith. SD,Cmax,,,,,,,,
482,Van de Velde 1996,https://www.ncbi.nlm.nih.gov/pubmed/8726601,Fed ITZ,Itraconazole,0,inf,h,2861,ng*h/mL,arith. mean,1914,ng*h/mL,arith. SD,AUC_inf,147,ng/mL,arith. mean,74,ng/mL,arith. SD,Cmax,,,,,,,,
483,Van de Velde 1996,https://www.ncbi.nlm.nih.gov/pubmed/8726601,Fed OH-ITZ,Hydroxy-Itraconazole,0,inf,h,6132,ng*h/mL,arith. mean,4448,ng*h/mL,arith. SD,AUC_inf,250,ng/mL,arith. mean,76,ng/mL,arith. SD,Cmax,,,,,,,,
484,Van Peer 1989,https://www.ncbi.nlm.nih.gov/pubmed/2544431,"100 mg Solution, fasting",Itraconazole,0,inf,h,1920,ng*h/mL,arith. mean,679,ng*h/mL,arith. SD,AUC_inf,223,ng/mL,arith. mean,84,ng/mL,arith. SD,Cmax,,,,,,,,
485,Van Peer 1989,https://www.ncbi.nlm.nih.gov/pubmed/2544431,"100 mg Capsules, fasting",Itraconazole,0,inf,h,722,ng*h/mL,arith. mean,289,ng*h/mL,arith. SD,AUC_inf,38.4,ng/mL,arith. mean,19.9,ng/mL,arith. SD,Cmax,,,,,,,,
486,Van Peer 1989,https://www.ncbi.nlm.nih.gov/pubmed/2544431,"100 mg Capsules, with food",Itraconazole,0,inf,h,1900,ng*h/mL,arith. mean,838,ng*h/mL,arith. SD,AUC_inf,132,ng/mL,arith. mean,67,ng/mL,arith. SD,Cmax,,,,,,,,
488,Van Peer 1989,https://www.ncbi.nlm.nih.gov/pubmed/2544431,"50 mg Capsules, with food",Itraconazole,0,inf,h,567,ng*h/mL,arith. mean,264,ng*h/mL,arith. SD,AUC_inf,44.5,ng/mL,arith. mean,16.4,ng/mL,arith. SD,Cmax,,,,,,,,
489,Van Peer 1989,https://www.ncbi.nlm.nih.gov/pubmed/2544431,"200 mg Capsules, with food",Itraconazole,0,inf,h,5210,ng*h/mL,arith. mean,2120,ng*h/mL,arith. SD,AUC_inf,289,ng/mL,arith. mean,100,ng/mL,arith. SD,Cmax,,,,,,,,
490,Heykants 1989,https://www.ncbi.nlm.nih.gov/pubmed/2561187,iv 100 mg SD,Itraconazole,0,inf,h,4.6,µg*h/mL,arith. mean,1.09,µg*h/mL,arith. SD,AUC_inf,664,ng/mL,arith. mean,234,ng/mL,arith. SD,Cmax,,,,,,,,
491,Heykants 1989,https://www.ncbi.nlm.nih.gov/pubmed/2561187,po 100 mg SD fed,Itraconazole,0,inf,h,2.48,µg*h/mL,arith. mean,0.74,µg*h/mL,arith. SD,AUC_inf,127,ng/mL,arith. mean,37,ng/mL,arith. SD,Cmax,,,,,,,,
492,Heykants 1989,https://www.ncbi.nlm.nih.gov/pubmed/2561187,po 100 mg SD (metabolite screening),Itraconazole,0,inf,h,2.01,µg*h/mL,arith. mean,1.08,µg*h/mL,arith. SD,AUC_inf,149,ng/mL,arith. mean,112,ng/mL,arith. SD,Cmax,,,,,,,,
493,Heykants 1989,https://www.ncbi.nlm.nih.gov/pubmed/2561187,po 100 mg SD (metabolite screening),Hydroxy-Itraconazole,0,inf,h,4.67,µg*h/mL,arith. mean,1.97,µg*h/mL,arith. SD,AUC_inf,255,ng/mL,arith. mean,74,ng/mL,arith. SD,Cmax,,,,,,,,
494,Heykants 1989,https://www.ncbi.nlm.nih.gov/pubmed/2561187,po 100 mg MD OD,Itraconazole,672,696,h,8.17,µg*h/mL,arith. mean,5.23,µg*h/mL,arith. SD,AUC_tau,621,ng/mL,arith. mean,337,ng/mL,arith. SD,Cmax,,,,,,,,
496,Miura 2010,https://www.ncbi.nlm.nih.gov/pubmed/20595406,po 100 mg MD Japanese,Itraconazole,216,240,h,7908,ng*h/mL,arith. mean,2542,ng*h/mL,arith. SD,AUC_tau,653,ng/mL,arith. mean,269,ng/mL,arith. SD,Cmax,,,,,,,,
497,Miura 2010,https://www.ncbi.nlm.nih.gov/pubmed/20595406,po 100 mg MD Japanese,Hydroxy-Itraconazole,216,240,h,15795,ng*h/mL,arith. mean,5286,ng*h/mL,arith. SD,AUC_tau,1059,ng/mL,arith. mean,598,ng/mL,arith. SD,Cmax,,,,,,,,
498,Gubbins 2004,https://www.ncbi.nlm.nih.gov/pubmed/15098799,po 200 mg solution with water,Itraconazole,0,inf,h,7.07,mg*h/L,arith. mean,1.77,mg*h/mL,arith. SD,AUC_inf,589.9,ng/mL,arith. mean,244.2,ng/mL,arith. SD,Cmax,0.43,L/h/kg,arith. mean,0.17,L/h/kg,arith. SD,CL/F,
499,Gubbins 2004,https://www.ncbi.nlm.nih.gov/pubmed/15098799,po 200 mg solution with water,Hydroxy-Itraconazole,0,inf,h,16.5,mg*h/L,arith. mean,5,mg*h/mL,arith. SD,AUC_inf,766.1,ng/mL,arith. mean,218.4,ng/mL,arith. SD,Cmax,,,,,,,,
500,Gubbins 2004,https://www.ncbi.nlm.nih.gov/pubmed/15098799,po 200 mg solution with GFJ,Itraconazole,0,inf,h,8.45,mg*h/L,arith. mean,2.91,mg*h/mL,arith. SD,AUC_inf,580.6,ng/mL,arith. mean,252.8,ng/mL,arith. SD,Cmax,0.37,L/h/kg,arith. mean,0.16,L/h/kg,arith. SD,CL/F,
501,Gubbins 2004,https://www.ncbi.nlm.nih.gov/pubmed/15098799,po 200 mg solution with GFJ,Hydroxy-Itraconazole,0,inf,h,17.9,mg*h/L,arith. mean,6.7,mg*h/mL,arith. SD,AUC_inf,690.7,ng/mL,arith. mean,248.3,ng/mL,arith. SD,Cmax,,,,,,,,
502,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution female with water,Itraconazole,0,inf,h,6.7,mg*h/L,arith. mean,1.8,mg*h/mL,arith. SD,AUC_inf,545.5,ng/mL,arith. mean,212.5,ng/mL,arith. SD,Cmax,0.53,L/h/kg,arith. mean,0.19,L/h/kg,arith. SD,CL/F,
503,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution female with water,Hydroxy-Itraconazole,0,inf,h,16.7,mg*h/L,arith. mean,6.3,mg*h/mL,arith. SD,AUC_inf,799.3,ng/mL,arith. mean,281.9,ng/mL,arith. SD,Cmax,,,,,,,,
504,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution male with water,Itraconazole,0,inf,h,7.4,mg*h/L,arith. mean,1.8,mg*h/mL,arith. SD,AUC_inf,634.2,ng/mL,arith. mean,276.3,ng/mL,arith. SD,Cmax,0.43,L/h/kg,arith. mean,0.19,L/h/kg,arith. SD,CL/F,
505,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution male with water,Hydroxy-Itraconazole,0,inf,h,16.4,mg*h/L,arith. mean,3.6,mg*h/mL,arith. SD,AUC_inf,732.8,ng/mL,arith. mean,137.1,ng/mL,arith. SD,Cmax,,,,,,,,
506,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution female with GFJ,Itraconazole,0,inf,h,8.7,mg*h/L,arith. mean,3.6,mg*h/mL,arith. SD,AUC_inf,577.2,ng/mL,arith. mean,256.6,ng/mL,arith. SD,Cmax,0.34,L/h/kg,arith. mean,0.08,L/h/kg,arith. SD,CL/F,
507,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution female with GFJ,Hydroxy-Itraconazole,0,inf,h,19.3,mg*h/L,arith. mean,8.8,mg*h/mL,arith. SD,AUC_inf,748.3,ng/mL,arith. mean,317.2,ng/mL,arith. SD,Cmax,,,,,,,,
508,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution male with GFJ,Itraconazole,0,inf,h,8.2,mg*h/L,arith. mean,2.3,mg*h/mL,arith. SD,AUC_inf,584,ng/mL,arith. mean,262.8,ng/mL,arith. SD,Cmax,0.31,L/h/kg,arith. mean,0.09,L/h/kg,arith. SD,CL/F,
509,Gubbins 2007,https://www.ncbi.nlm.nih.gov/pubmed/18172627,po 200 mg solution male with GFJ,Hydroxy-Itraconazole,0,inf,h,16.4,mg*h/L,arith. mean,3.7,mg*h/mL,arith. SD,AUC_inf,633.2,ng/mL,arith. mean,148.9,ng/mL,arith. SD,Cmax,,,,,,,,
510,Uno 2006,https://www.ncbi.nlm.nih.gov/pubmed/16885720,day 1 (Japanese),Itraconazole,0,24,h,932.5,ng*h/mL,arith. mean,378.9,ng*h/mL,arith. SD,AUC_tend,107.1,ng/mL,arith. mean,44.1,ng/mL,arith. SD,Cmax,3.4,L/h,arith. mean,2.1,L/h,arith. SD,CL/F,
511,Uno 2006,https://www.ncbi.nlm.nih.gov/pubmed/16885720,day 1 (Japanese),Hydroxy-Itraconazole,0,24,h,2610.7,ng*h/mL,arith. mean,1129,ng*h/mL,arith. SD,AUC_tend,230.2,ng/mL,arith. mean,87.3,ng/mL,arith. SD,Cmax,,,,,,,,
512,Uno 2006,https://www.ncbi.nlm.nih.gov/pubmed/16885720,day 6 (Japanese),Itraconazole,120,144,h,3485.5,ng*h/mL,arith. mean,1159.6,ng*h/mL,arith. SD,AUC_tau,287.7,ng/mL,arith. mean,82.9,ng/mL,arith. SD,Cmax,0.7,L/h,arith. mean,0.3,L/h,arith. SD,CL/F,
513,Uno 2006,https://www.ncbi.nlm.nih.gov/pubmed/16885720,day 6 (Japanese),Hydroxy-Itraconazole,120,144,h,7664.7,ng*h/mL,arith. mean,1961.5,ng*h/mL,arith. SD,AUC_tau,523.7,ng/mL,arith. mean,158.1,ng/mL,arith. SD,Cmax,,,,,,,,
514,Bae 2011,https://www.ncbi.nlm.nih.gov/pubmed/20400647,po 200 mg capsule with water (Korean),Itraconazole,0,inf,h,2290,ng*h/mL,arith. mean,1430,ng*h/mL,arith. SD,AUC_inf,248,ng/mL,arith. mean,137,ng/mL,arith. SD,Cmax,,,,,,,,
515,Bae 2011,https://www.ncbi.nlm.nih.gov/pubmed/20400647,po 200 mg capsule with water (Korean),Hydroxy-Itraconazole,0,inf,h,7580,ng*h/mL,arith. mean,5000,ng*h/mL,arith. SD,AUC_inf,519,ng/mL,arith. mean,272,ng/mL,arith. SD,Cmax,,,,,,,,
516,Bae 2011,https://www.ncbi.nlm.nih.gov/pubmed/20400647,po 200 mg capsule with cola (Korean),Itraconazole,0,inf,h,4050,ng*h/mL,arith. mean,2060,ng*h/mL,arith. SD,AUC_inf,478,ng/mL,arith. mean,265,ng/mL,arith. SD,Cmax,,,,,,,,
517,Bae 2011,https://www.ncbi.nlm.nih.gov/pubmed/20400647,po 200 mg capsule with cola (Korean),Hydroxy-Itraconazole,0,inf,h,11900,ng*h/mL,arith. mean,5670,ng*h/mL,arith. SD,AUC_inf,734,ng/mL,arith. mean,354,ng/mL,arith. SD,Cmax,,,,,,,,
518,Bae 2011,https://www.ncbi.nlm.nih.gov/pubmed/20400647,po 200 mg capsule with vit. C (Korean),Itraconazole,0,inf,h,3420,ng*h/mL,arith. mean,1750,ng*h/mL,arith. SD,AUC_inf,387,ng/mL,arith. mean,212,ng/mL,arith. SD,Cmax,,,,,,,,
519,Bae 2011,https://www.ncbi.nlm.nih.gov/pubmed/20400647,po 200 mg capsule with vit. C (Korean),Hydroxy-Itraconazole,0,inf,h,10600,ng*h/mL,arith. mean,5900,ng*h/mL,arith. SD,AUC_inf,748,ng/mL,arith. mean,371,ng/mL,arith. SD,Cmax,,,,,,,,
524,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_A 100 mg,Itraconazole,144,168,h,12713,µg*h/L,arith. mean,2153,µg*h/L,arith. SD,AUC_tau,2902,µg/L,arith. mean,1470,µg/L,arith. SD,Cmax,8.06,L/h,arith. mean,1.52,L/h,arith. SD,CLiv,
525,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_B 200 mg,Itraconazole,144,168,h,39858,µg*h/L,arith. mean,8240,µg*h/L,arith. SD,AUC_tau,4111,µg/L,arith. mean,864,µg/L,arith. SD,Cmax,5.18,L/h,arith. mean,1.04,L/h,arith. SD,CLiv,
526,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_C 300 mg,Itraconazole,144,168,h,44184,µg*h/L,arith. mean,1825,µg*h/L,arith. SD,AUC_tau,4554,µg/L,arith. mean,343,µg/L,arith. SD,Cmax,6.8,L/h,arith. mean,0.27,L/h,arith. SD,CLiv,
527,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_D 200 mg (HPBCD),Itraconazole,144,168,h,31783,µg*h/L,arith. mean,2675,µg*h/L,arith. SD,AUC_tau,3349,µg/L,arith. mean,334,µg/L,arith. SD,Cmax,6.32,L/h,arith. mean,0.5,L/h,arith. SD,CLiv,
532,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_A 100 mg,Hydroxy-Itraconazole,144,168,h,18177,µg*h/L,arith. mean,2236,µg*h/L,arith. SD,AUC_tau,1028,µg/L,arith. mean,310,µg/L,arith. SD,Cmax,5.56,L/h,arith. mean,0.64,L/h,arith. SD,CLiv,
533,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_B 200 mg,Hydroxy-Itraconazole,144,168,h,50407,µg*h/L,arith. mean,7355,µg*h/L,arith. SD,AUC_tau,2339,µg/L,arith. mean,374,µg/L,arith. SD,Cmax,4.03,L/h,arith. mean,0.55,L/h,arith. SD,CLiv,
534,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_C 300 mg,Hydroxy-Itraconazole,144,168,h,67923,µg*h/L,arith. mean,8643,µg*h/L,arith. SD,AUC_tau,3424,µg/L,arith. mean,367,µg/L,arith. SD,Cmax,4.47,L/h,arith. mean,0.17,L/h,arith. SD,CLiv,
535,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_m_D 200 mg (HPBCD),Hydroxy-Itraconazole,144,168,h,48317,µg*h/L,arith. mean,2275,µg*h/L,arith. SD,AUC_tau,2272,µg/L,arith. mean,93,µg/L,arith. SD,Cmax,4.15,L/h,arith. mean,0.19,L/h,arith. SD,CLiv,
520,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,SAD_A 50 mg,Itraconazole,0,inf,h,2506,µg*h/L,arith. mean,296,µg*h/L,arith. SD,AUC_inf,,,,,,,,20.2,L/h,arith. mean,2.3,L/h,arith. SD,CLiv,
522,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,SAD_A 200 mg,Itraconazole,0,inf,h,7498,µg*h/L,arith. mean,2697,µg*h/L,arith. SD,AUC_inf,,,,,,,,14.8,L/h,arith. mean,5,L/h,arith. SD,CLiv,
521,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,SAD_B 100 mg,Itraconazole,0,inf,h,15292,µg*h/L,arith. mean,2869,µg*h/L,arith. SD,AUC_inf,,,,,,,,13.5,L/h,arith. mean,2.7,L/h,arith. SD,CLiv,
523,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,SAD_B 300 mg,Itraconazole,0,inf,h,28146,µg*h/L,arith. mean,1488,µg*h/L,arith. SD,AUC_inf,,,,,,,,10.7,L/h,arith. mean,0.6,L/h,arith. SD,CLiv,
542,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_s_A 100 mg,Itraconazole,0,inf,h,4531,µg*h/L,arith. mean,891,µg*h/L,arith. SD,AUC_inf,,,,,,,,22.8,L/h,arith. mean,4.8,L/h,arith. SD,CLiv,
543,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_s_B 200 mg,Itraconazole,0,inf,h,14815,µg*h/L,arith. mean,4128,µg*h/L,arith. SD,AUC_inf,,,,,,,,14.2,L/h,arith. mean,3.3,L/h,arith. SD,CLiv,
544,Mouton 2006,https://www.ncbi.nlm.nih.gov/pubmed/16982783,MAD_s_C 300 mg,Itraconazole,0,inf,h,24920,µg*h/L,arith. mean,1562,µg*h/L,arith. SD,AUC_inf,,,,,,,,12.1,L/h,arith. mean,0.8,L/h,arith. SD,CLiv,
545,Zhou 1998,https://www.ncbi.nlm.nih.gov/pubmed/9702843,IV 200 mg OD,Itraconazole,0,12,h,6511,ng*h/mL,arith. mean,1864,ng*h/mL,arith. SD,AUC_tend,9141,ng/mL,arith. mean,546,ng/mL,arith. SD,Cmax,,,,,,,,
546,Zhou 1998,https://www.ncbi.nlm.nih.gov/pubmed/9702843,IV 200 mg OD,Hydroxy-Itraconazole,0,12,h,4578,ng*h/mL,arith. mean,1588,ng*h/mL,arith. SD,AUC_tend,464,ng/mL,arith. mean,150,ng/mL,arith. SD,Cmax,,,,,,,,
548,Mahadik 2012,https://www.ncbi.nlm.nih.gov/pubmed/22275128,Reference,Mefenamic acid,0,inf,h,12458.728,ng*h/mL,arith. mean,3004.021,ng*h/mL,arith. SD,AUC_inf,2168.6,ng/mL,arith. mean,208.4,ng/mL,arith. SD,Cmax,,,,,,,,
51,Allonen 1981,https://www.ncbi.nlm.nih.gov/pubmed/6117393,oral,Midazolam,0,inf,h,,,,,,,,154,ng/mL,arith. mean,51,ng/mL,arith. SD,Cmax,,,,,,,,
52,Allonen 1981,https://www.ncbi.nlm.nih.gov/pubmed/6117393,iv,Midazolam,0,inf,h,,,,,,,,,,,,,,,283,mL/min,arith. mean,43,mL/min,arith. SD,CLiv,
112,Chung 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580903,Control (Perpetrator Placebo),Midazolam,0,inf,h,49,ng*h/mL,geom. mean,22-103,ng*h/mL,range,AUC_inf,23,ng/mL,geom. mean,9-41,ng/mL,Range,Cmax,25,mL/min,geom. mean,12-57,mL/min/kg,Range,CL/F,
113,Chung 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580903,with Perpetrator (Rifampicin),Midazolam,166,inf,h,6.1,ng*h/mL,geom. mean,3.4-10,ng*h/mL,range,AUC_inf,3.9,ng/mL,geom. mean,1.7-6.2,ng/mL,Range,Cmax,203,mL/min,geom. mean,125-371,mL/min/kg,Range,CL/F,
114,Chung 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580903,with Perpetrator (Ketoconazole),Midazolam,118,inf,h,466,ng*h/mL,geom. mean,146-1010,ng*h/mL,range,AUC_inf,55,ng/mL,geom. mean,31-100,ng/mL,Range,Cmax,2.7,mL/min,geom. mean,1.2-8.5,mL/min/kg,Range,CL/F,
115,Chung 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580903,Control (Perpetrator Placebo),Simvastatin,0,inf,h,29,ng*h/mL,geom. mean,8-56,ng*h/mL,range,AUC_inf,7.4,ng/mL,geom. mean,3.1-19,ng/mL,Range,Cmax,312,mL/min,geom. mean,151-1478,mL/min/kg,Range,CL/F,
116,Chung 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580903,with Perpetrator (Rifampicin),Simvastatin,190,inf,h,2.6,ng*h/mL,geom. mean,0.8-26,ng*h/mL,range,AUC_inf,1.1,ng/mL,geom. mean,0.3-7.2,ng/mL,Range,Cmax,3536,mL/min,geom. mean,413-10329,mL/min/kg,Range,CL/F,
117,Chung 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580903,with Perpetrator (Ketoconazole),Simvastatin,190,inf,h,364,ng*h/mL,geom. mean,84-1351,ng*h/mL,range,AUC_inf,55,ng/mL,geom. mean,17-218,ng/mL,Range,Cmax,25,mL/min,geom. mean,8.0-147,mL/min/kg,Range,CL/F,
392,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 0 after Perpetrator (Rifampicin),Midazolam,648,816,h,2.64,ng*h/mL,geom. mean,45.3,%,geom. CV,AUC_inf,1.33,ng/mL,geom. mean,45.3,%,geom. CV,Cmax,,,,,,,,
393,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 1 after Perpetrator (Rifampicin),Midazolam,816,984,h,8.2,ng*h/mL,geom. mean,30.9,%,geom. CV,AUC_inf,3.31,ng/mL,geom. mean,44.9,%,geom. CV,Cmax,,,,,,,,
394,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 2 after Perpetrator (Rifampicin),Midazolam,984,1320,h,17.44,ng*h/mL,geom. mean,37.2,%,geom. CV,AUC_inf,6,ng/mL,geom. mean,31.1,%,geom. CV,Cmax,,,,,,,,
395,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 4 after Perpetrator (Rifampicin),Midazolam,1320,inf,h,21.41,ng*h/mL,geom. mean,33.6,%,geom. CV,AUC_inf,8.21,ng/mL,geom. mean,27.5,%,geom. CV,Cmax,,,,,,,,
396,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 0 after Perpetrator (Rifampicin),Digoxin,649,652,h,3.83,ng*h/mL,geom. mean,26.2,%,geom. CV,AUC_tend,2.04,ng/mL,geom. mean,38.2,%,geom. CV,Cmax,,,,,,,,
397,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 1 after Perpetrator (Rifampicin),Digoxin,817,820,h,1.79,ng*h/mL,geom. mean,114.3,%,geom. CV,AUC_tend,0.95,ng/mL,geom. mean,60.7,%,geom. CV,Cmax,,,,,,,,
398,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 2 after Perpetrator (Rifampicin),Digoxin,985,988,h,2.56,ng*h/mL,geom. mean,24.1,%,geom. CV,AUC_tend,1.2,ng/mL,geom. mean,31.8,%,geom. CV,Cmax,,,,,,,,
399,Reitman 2011,https://www.ncbi.nlm.nih.gov/pubmed/21191377,Week 4 after Perpetrator (Rifampicin),Digoxin,1321,1324,h,2.62,ng*h/mL,geom. mean,19.1,%,geom. CV,AUC_tend,1.37,ng/mL,geom. mean,24.1,%,geom. CV,Cmax,,,,,,,,
415,Smith 1981,https://www.ncbi.nlm.nih.gov/pubmed/6116606,iv 5 mg,Midazolam,0,inf,h,190.3,µg*h/L,arith. mean,49.2,µg*h/L,arith. SD,AUC_inf,112.6,µg/L,arith. mean,16.1,µg/L,arith. SD,Cmax,0.383,L/h/kg,arith. mean,0.094,L/h/kg,arith. SD,CLiv,
416,Smith 1981,https://www.ncbi.nlm.nih.gov/pubmed/6116606,oral solution 10 mg,Midazolam,0,inf,h,135.6,µg*h/L,arith. mean,55,µg*h/L,arith. SD,AUC_inf,60,µg/L,arith. mean,13.8,µg/L,arith. SD,Cmax,,,,,,,,
417,Smith 1981,https://www.ncbi.nlm.nih.gov/pubmed/6116606,oral tablet 10 mg,Midazolam,0,inf,h,147,µg*h/L,arith. mean,78.9,µg*h/L,arith. SD,AUC_inf,77.5,µg/L,arith. mean,27.8,µg/L,arith. SD,Cmax,,,,,,,,
418,Stone 2004,https://www.ncbi.nlm.nih.gov/pubmed/4037525,Day 14 of Rifampin alone,Rifampicin,312,336,h,35.25,µg*h/mL,geom. mean,,,,AUC_tau,8.86,µg/mL,geom. mean,,,,Cmax,,,,,,,,
468,Yeates 1996,http://www.ncbi.nlm.nih.gov/pubmed/8880291,Control (Perpetrator Placebo),Midazolam,0,inf,h,248.84,ng*h/mL,arith. mean,24.41,ng*h/mL,arith. SEM,AUC_inf,76.89,ng/mL,arith. mean,9.25,ng/mL,arith. SEM,Cmax,,,,,,,,
469,Yeates 1996,http://www.ncbi.nlm.nih.gov/pubmed/8880291,with Perpetrator (Clarithromycin),Midazolam,97.5,inf,h,888.75,ng*h/mL,arith. mean,94.13,ng*h/mL,arith. SEM,AUC_inf,187.61,ng/mL,arith. mean,29.15,ng/mL,arith. SEM,Cmax,,,,,,,,
470,Zimmermann 1996,https://www.ncbi.nlm.nih.gov/pubmed/8720318,Control (Perpetrator Placebo),Midazolam,0,inf,h,173.77,ng*h/mL,arith. mean,24.66,ng*h/mL,arith. SEM,AUC_inf,67.23,ng/mL,arith. mean,11.39,ng/mL,arith. SEM,Cmax,,,,,,,,
471,Zimmermann 1996,https://www.ncbi.nlm.nih.gov/pubmed/8720318,with Perpetrator (Erythromycin),Midazolam,97.5,inf,h,662.71,ng*h/mL,arith. mean,76.52,ng*h/mL,arith. SEM,AUC_inf,182.29,ng/mL,arith. mean,182.29,ng/mL,arith. SEM,Cmax,,,,,,,,
279,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,28.4,ng*h/mL,arith. mean,4,ng*h/mL,arith. SD,AUC_inf,50.2,ng/mL,arith. mean,11.9,ng/mL,arith. SD,Cmax,8.3,mL/min/kg,arith. Mean,1.6,mL/min/kg,arith. SD,Cliv,
280,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,iv with Perpetrator (Rifampicin),Midazolam,0,128,h,14.8,ng*h/mL,arith. mean,2.7,ng*h/mL,arith. SD,AUC_inf,50.7,ng/mL,arith. mean,17.7,ng/mL,arith. SD,Cmax,16,mL/min/kg,arith. Mean,2.3,mL/min/kg,arith. SD,Cliv,
281,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,iv with Perpetrator (GFJ),Midazolam,0,inf,h,35.5,ng*h/mL,arith. mean,17.4,ng*h/mL,arith. SD,AUC_inf,51.2,ng/mL,arith. mean,35.4,ng/mL,arith. SD,Cmax,7.6,mL/min/kg,arith. Mean,7.6,mL/min/kg,arith. SD,Cliv,
282,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,iv Control (Perpetrator Placebo),Alfentanil,0,inf,h,64.8,ng*h/mL,arith. mean,26.6,ng*h/mL,arith. SD,AUC_inf,90.2,ng/mL,arith. mean,22.2,ng/mL,arith. SD,Cmax,4.39,mL/min/kg,arith. Mean,1.48,mL/min/kg,arith. SD,Cliv,
283,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,iv with Perpetrator (Rifampicin),Alfentanil,0,129,h,24.3,ng*h/mL,arith. mean,6.5,ng*h/mL,arith. SD,AUC_inf,90.5,ng/mL,arith. mean,25.5,ng/mL,arith. SD,Cmax,10.8,mL/min/kg,arith. Mean,2.1,mL/min/kg,arith. SD,Cliv,
284,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,iv with Perpetrator (GFJ),Alfentanil,0,inf,h,68.3,ng*h/mL,arith. mean,19.9,ng*h/mL,arith. SD,AUC_inf,93.7,ng/mL,arith. mean,19.7,ng/mL,arith. SD,Cmax,4.02,mL/min/kg,arith. Mean,1.34,mL/min/kg,arith. SD,Cliv,
285,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #1 Control (Perpetrator Placebo),Midazolam,0,inf,h,20.9,ng*h/mL,arith. mean,4.2,ng*h/mL,arith. SD,AUC_inf,9.1,ng/mL,arith. mean,2.4,ng/mL,arith. SD,Cmax,35.4,mL/min/kg,arith. Mean,13.7,mL/min/kg,arith. SD,CL/F,
286,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #1 with Perpetrator (Rifampicin),Midazolam,0,inf,h,1.1,ng*h/mL,arith. mean,0.5,ng*h/mL,arith. SD,AUC_inf,1,ng/mL,arith. mean,0.6,ng/mL,arith. SD,Cmax,735,mL/min/kg,arith. Mean,424,mL/min/kg,arith. SD,CL/F,
287,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #1 (60 µg/kg) Control (Perpetrator Placebo),Alfentanil,0,inf,h,103,ng*h/mL,arith. mean,30,ng*h/mL,arith. SD,AUC_inf,45,ng/mL,arith. mean,14.5,ng/mL,arith. SD,Cmax,10.6,mL/min/kg,arith. Mean,30,mL/min/kg,arith. SD,CL/F,
288,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #1 (60 µg/kg) with Perpetrator (Rifampicin),Alfentanil,0,inf,h,4.7,ng*h/mL,arith. mean,4.6,ng*h/mL,arith. SD,AUC_inf,5,ng/mL,arith. mean,3.6,ng/mL,arith. SD,Cmax,339,mL/min/kg,arith. Mean,4.6,mL/min/kg,arith. SD,CL/F,
289,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #2 Control (Perpetrator Placebo),Midazolam,0,inf,h,22.8,ng*h/mL,arith. mean,9.2,ng*h/mL,arith. SD,AUC_inf,10.3,ng/mL,arith. mean,4.4,ng/mL,arith. SD,Cmax,34,mL/min/kg,arith. Mean,12.5,mL/min/kg,arith. SD,CL/F,
290,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #2 with Perpetrator (GFJ),Midazolam,0,inf,h,39.5,ng*h/mL,arith. mean,6.4,ng*h/mL,arith. SD,AUC_inf,15.6,ng/mL,arith. mean,4.2,ng/mL,arith. SD,Cmax,17.9,mL/min/kg,arith. Mean,3.3,mL/min/kg,arith. SD,CL/F,
291,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #2 (23 µg/kg) Control (Perpetrator Placebo),Alfentanil,0,inf,h,38,ng*h/mL,arith. mean,13.3,ng*h/mL,arith. SD,AUC_inf,61.3,ng/mL,arith. mean,9.8,ng/mL,arith. SD,Cmax,11.2,mL/min/kg,arith. Mean,3.8,mL/min/kg,arith. SD,CL/F,
292,Kharasch 2004,https://www.ncbi.nlm.nih.gov/pubmed/15536460,po #2 (23 µg/kg) with Perpetrator (GFJ),Alfentanil,0,inf,h,62.5,ng*h/mL,arith. mean,19.3,ng*h/mL,arith. SD,AUC_inf,30.4,ng/mL,arith. mean,6.9,ng/mL,arith. SD,Cmax,6.7,mL/min/kg,arith. Mean,2.5,mL/min/kg,arith. SD,CL/F,
53,Backman 1996,https://www.ncbi.nlm.nih.gov/pubmed/8549036,Control (Perpetrator Placebo),Midazolam,0,inf,h,10.2,µg*min/ml,arith. mean,0.8,µg*min/ml,arith. SEM,AUC_inf,55,ng/mL,arith. mean,4,ng/ml,arith. SEM,Cmax,,,,,,,,
54,Backman 1996,https://www.ncbi.nlm.nih.gov/pubmed/8549036,with Perpetrator (Rifampicin),Midazolam,113,inf,h,0.42,µg*min/ml,arith. mean,0.05,µg*min/ml,arith. SEM,AUC_inf,3.5,ng/mL,arith. mean,0.7,ng/ml,arith. SEM,Cmax,,,,,,,,
109,Burger 2006,https://www.ncbi.nlm.nih.gov/pubmed/17005814,Rifampin alone,Rifampicin,216,240,h,31267.7,ng*h/mL,geom. Mean,46,%,geom. CV,AUC_tau,8057.6,ng/mL,geom. Mean,45,%,geom. CV,Cmax,,,,,,,,
190,Greiner 1999,https://www.ncbi.nlm.nih.gov/pubmed/10411543,po Control (Perpetrator Placebo),Digoxin,0,inf,h,54.8,ng*h/ml,arith. mean,11.6,ng*h/mL,arith. SD,AUC_tend,5.4,ng/ml,arith. mean,1.9,ng/mL,arith. SD,Cmax,159,mL/min,arith. Mean,30,mL/min,arith. SD,,"CL Type: renal Clearance, AUC(0-144h)=38,2+/-12,4"
191,Greiner 1999,https://www.ncbi.nlm.nih.gov/pubmed/10411543,po with Perpetrator (Rifampicin),Digoxin,240,inf,h,38.2,ng*h/ml,arith. mean,12.4,ng*h/mL,arith. SD,AUC_tend,2.6,ng/ml,arith. mean,0.7,ng/mL,arith. SD,Cmax,159,mL/min,arith. Mean,38,mL/min,arith. SD,,"CL Type: renal Clearance, AUC(240-384h)=54,8+/-11,6"
192,Greiner 1999,https://www.ncbi.nlm.nih.gov/pubmed/10411543,iv Control (Perpetrator Placebo),Digoxin,0,inf,h,87.3,ng*h/ml,arith. mean,8.3,ng*h/mL,arith. SD,AUC_tend,24.7,ng/ml,arith. mean,5.2,ng/mL,arith. SD,Cmax,151,mL/min,arith. Mean,25,mL/min,arith. SD,,"CL Type: renal Clearance; AUC(0-144,5h)=87,3+/-8,3; nonrenal clearance = 17+/-17 ml/min; systemic clearance = renal + nonrenal clearance"
193,Greiner 1999,https://www.ncbi.nlm.nih.gov/pubmed/10411543,iv with Perpetrator (Rifampicin),Digoxin,240,inf,h,74.5,ng*h/ml,arith. mean,10.5,ng*h/mL,arith. SD,AUC_tend,20.9,ng/ml,arith. mean,1.8,ng/mL,arith. SD,Cmax,147,mL/min,arith. Mean,18,mL/min,arith. SD,,"CL Type: renal Clearance; AUC(240-384,5h)=74,5+/-10,5; nonrenal clearance = 54+/-29 ml/min; systemic clearance = renal + nonrenal clearance"
423,Templeton 2010,https://www.ncbi.nlm.nih.gov/pubmed/20739919,Control (Perpetrator Placebo),Midazolam,0,inf,h,63,nmol*h/L,arith. mean,39,nmol*h/L,arith. SD,AUC_inf,,,,,,,,122,L/h,arith. Mean,49,L/h,arith. SD,,individual AUC could be extracted from fig. 1b
424,Templeton 2010,https://www.ncbi.nlm.nih.gov/pubmed/20739919,with Perpetrator (Itraconazole @ 50 mg),Midazolam,4,inf,h,114,nmol*h/L,arith. mean,41,nmol*h/L,arith. SD,AUC_inf,,,,,,,,61,L/h,arith. Mean,28,L/h,arith. SD,,individual AUC could be extracted from fig. 1b
425,Templeton 2010,https://www.ncbi.nlm.nih.gov/pubmed/20739919,with Perpetrator (Itraconazole @ 200 mg),Midazolam,4,inf,h,256,nmol*h/L,arith. mean,75,nmol*h/L,arith. SD,AUC_inf,,,,,,,,26,L/h,arith. Mean,9,L/h,arith. SD,,individual AUC could be extracted from fig. 1b
426,Templeton 2010,https://www.ncbi.nlm.nih.gov/pubmed/20739919,with Perpetrator (Itraconazole @ 400 mg),Midazolam,4,inf,h,289,nmol*h/L,arith. mean,57,nmol*h/L,arith. SD,AUC_inf,,,,,,,,22,L/h,arith. Mean,4,L/h,arith. SD,,individual AUC could be extracted from fig. 1b
214,Gurley 2006,https://www.ncbi.nlm.nih.gov/pubmed/16432272,Control pre-Rifampicin (Perpetrator Placebo),Midazolam,0,inf,h,79.6,ng*h/mL,arith. mean,23.2,ng*h/mL,arith. SD,AUC_inf,30.6,ng/mL,arith. mean,14.6,ng/mL,arith. SD,Cmax,110.8,L/h,arith. Mean,33.2,L/h,arith. SD,CL/F,
215,Gurley 2006,https://www.ncbi.nlm.nih.gov/pubmed/16432272,with Perpetrator (Rifampicin),Midazolam,146,inf,h,4.55,ng*h/mL,arith. mean,2.24,ng*h/mL,arith. SD,AUC_inf,3.7,ng/mL,arith. mean,2.6,ng/mL,arith. SD,Cmax,2256,L/h,arith. Mean,1168,L/h,arith. SD,CL/F,
216,Gurley 2006,https://www.ncbi.nlm.nih.gov/pubmed/16432272,Control pre-Clarithromycin (Perpetrator Placebo),Midazolam,0,inf,h,89.6,ng*h/mL,arith. mean,30.6,ng*h/mL,arith. SD,AUC_inf,31.8,ng/mL,arith. mean,11.6,ng/mL,arith. SD,Cmax,99.3,L/h,arith. Mean,25.2,L/h,arith. SD,CL/F,
217,Gurley 2006,https://www.ncbi.nlm.nih.gov/pubmed/16432272,with Perpetrator (Clarithomycin),Midazolam,146,inf,h,752,ng*h/mL,arith. mean,398,ng*h/mL,arith. SD,AUC_inf,120.7,ng/mL,arith. mean,29.3,ng/mL,arith. SD,Cmax,12.8,L/h,arith. Mean,6.5,L/h,arith. SD,CL/F,
218,Gurley 2006,https://www.ncbi.nlm.nih.gov/pubmed/16432272,Control pre-Black cohosh (Perpetrator Placebo),Midazolam,0,inf,h,94.8,ng*h/mL,arith. mean,29.2,ng*h/mL,arith. SD,AUC_inf,34.6,ng/mL,arith. mean,15.5,ng/mL,arith. SD,Cmax,93.3,L/h,arith. Mean,32.6,L/h,arith. SD,CL/F,
219,Gurley 2006,https://www.ncbi.nlm.nih.gov/pubmed/16432272,Control pre-Milk thistle (Perpetrator Placebo),Midazolam,0,inf,h,96.2,ng*h/mL,arith. mean,42.2,ng*h/mL,arith. SD,AUC_inf,37.2,ng/mL,arith. mean,18.1,ng/mL,arith. SD,Cmax,95.3,L/h,arith. Mean,33,L/h,arith. SD,CL/F,
220,Gurley 2008a,https://www.ncbi.nlm.nih.gov/pubmed/17495878,Control pre-Rifampicin (Perpetrator Placebo),Midazolam,0,inf,h,107.1,ng*h/mL,arith. mean,40.7,ng*h/mL,arith. SD,AUC_inf,44.6,ng/mL,arith. mean,15.8,ng/mL,arith. SD,Cmax,92.7,L/h,arith. Mean,33.2,L/h,arith. SD,CL/F,
221,Gurley 2008a,https://www.ncbi.nlm.nih.gov/pubmed/17495878,with Perpetrator (Rifampicin),Midazolam,146,inf,h,6.46,ng*h/mL,arith. mean,3.51,ng*h/mL,arith. SD,AUC_inf,4.8,ng/mL,arith. mean,3.8,ng/mL,arith. SD,Cmax,1649,L/h,arith. Mean,927,L/h,arith. SD,CL/F,
222,Gurley 2008a,https://www.ncbi.nlm.nih.gov/pubmed/17495878,Control pre-Clarithromycin (Perpetrator Placebo),Midazolam,0,inf,h,102.4,ng*h/mL,arith. mean,43.9,ng*h/mL,arith. SD,AUC_inf,52.2,ng/mL,arith. mean,26.7,ng/mL,arith. SD,Cmax,95.7,L/h,arith. Mean,46.1,L/h,arith. SD,CL/F,
223,Gurley 2008a,https://www.ncbi.nlm.nih.gov/pubmed/17495878,with Perpetrator (Clarithomycin),Midazolam,146,inf,h,561.5,ng*h/mL,arith. mean,188.6,ng*h/mL,arith. SD,AUC_inf,113.5,ng/mL,arith. mean,36.2,ng/mL,arith. SD,Cmax,16.3,L/h,arith. Mean,6.2,L/h,arith. SD,CL/F,
224,Gurley 2008a,https://www.ncbi.nlm.nih.gov/pubmed/17495878,Control pre-Goldenseal (Perpetrator Placebo),Midazolam,0,inf,h,107.9,ng*h/mL,arith. mean,43.3,ng*h/mL,arith. SD,AUC_inf,50.6,ng/mL,arith. mean,26.9,ng/mL,arith. SD,Cmax,88.8,L/h,arith. Mean,39.1,L/h,arith. SD,CL/F,
225,Gurley 2008a,https://www.ncbi.nlm.nih.gov/pubmed/17495878,Control pre-Kava kava (Perpetrator Placebo),Midazolam,0,inf,h,107.1,ng*h/mL,arith. mean,41.9,ng*h/mL,arith. SD,AUC_inf,38.6,ng/mL,arith. mean,15.1,ng/mL,arith. SD,Cmax,86.9,L/h,arith. Mean,35.7,L/h,arith. SD,CL/F,
226,Gurley 2008b,https://www.ncbi.nlm.nih.gov/pubmed/18214850,Control (Perpetrator Placebo),Digoxin,0,inf,h,8.1,ng*h/mL,arith. mean,1.9,ng*h/mL,arith. SD,AUC_inf,1.3,ng/mL,arith. mean,0.4,ng/mL,arith. SD,Cmax,,,,,,,,
227,Gurley 2008b,https://www.ncbi.nlm.nih.gov/pubmed/18214850,with Perpetrator (Rifampicin),Digoxin,146,inf,h,6.1,ng*h/mL,arith. mean,1.9,ng*h/mL,arith. SD,AUC_inf,0.8,ng/mL,arith. mean,0.3,ng/mL,arith. SD,Cmax,,,,,,,,
228,Gurley 2008b,https://www.ncbi.nlm.nih.gov/pubmed/18214850,Control (Perpetrator Placebo),Digoxin,0,inf,h,7.3,ng*h/mL,arith. mean,2,ng*h/mL,arith. SD,AUC_inf,1.2,ng/mL,arith. mean,0.3,ng/mL,arith. SD,Cmax,,,,,,,,
229,Gurley 2008b,https://www.ncbi.nlm.nih.gov/pubmed/18214850,with Perpetrator (Clarithomycin),Digoxin,146,inf,h,10.7,ng*h/mL,arith. mean,3.4,ng*h/mL,arith. SD,AUC_inf,2.1,ng/mL,arith. mean,0.9,ng/mL,arith. SD,Cmax,,,,,,,,
261,Hohmann 2015,https://www.ncbi.nlm.nih.gov/pubmed/25588320,iv 0.001 mg,Midazolam,0,inf,h,37.9,pg*h/mL,geo. mean,13.2,%,geo. CV,AUC_inf,39.1,pg/mL,geo. mean,43.7,%,geo. CV,Cmax,439,mL/min,geo. Mean,11.9,%,geo. CV,CLiv,
262,Hohmann 2015,https://www.ncbi.nlm.nih.gov/pubmed/25588320,iv 1 mg,Midazolam,0,inf,h,39000,pg*h/mL,geo. mean,14,%,geo. CV,AUC_inf,37100,pg/mL,geo. mean,61.3,%,geo. CV,Cmax,428,mL/min,geo. Mean,14.9,%,geo. CV,CLiv,
263,Hohmann 2015,https://www.ncbi.nlm.nih.gov/pubmed/25588320,po 0.003 mg,Midazolam,0,inf,h,26.6,pg*h/mL,geo. mean,30.9,%,geo. CV,AUC_inf,11.9,pg/mL,geo. mean,38.2,%,geo. CV,Cmax,1880,mL/min,geo. Mean,32.3,%,geo. CV,CL/F,
264,Hohmann 2015,https://www.ncbi.nlm.nih.gov/pubmed/25588320,po 3 mg,Midazolam,0,inf,h,24400,pg*h/mL,geo. mean,31.3,%,geo. CV,AUC_inf,9990,pg/mL,geo. mean,51,%,geo. CV,Cmax,2050,mL/min,geo. Mean,35.8,%,geo. CV,CL/F,
293,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,40.9,ng*h/mL,arith. mean,7.6,ng*h/mL,arith. SD,AUC_inf,62,ng/mL,arith. Mean,29,ng/mL,arith. SD,Cmax,5.9,mL/min/kg,arith. mean,1.6,mL/min/kg,arith. SD,CLiv,
294,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 5 mg),Midazolam,108,132,h,34,ng*h/mL,arith. mean,6.5,ng*h/mL,arith. SD,AUC_inf,64,ng/mL,arith. Mean,26,ng/mL,arith. SD,Cmax,7.1,mL/min/kg,arith. mean,2.1,mL/min/kg,arith. SD,CLiv,
295,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 10 mg),Midazolam,108,132,h,30.7,ng*h/mL,arith. mean,4.5,ng*h/mL,arith. SD,AUC_inf,66,ng/mL,arith. Mean,19,ng/mL,arith. SD,Cmax,7.6,mL/min/kg,arith. mean,2,mL/min/kg,arith. SD,CLiv,
296,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 25 mg),Midazolam,108,132,h,25.2,ng*h/mL,arith. mean,3.6,ng*h/mL,arith. SD,AUC_inf,52,ng/mL,arith. Mean,23,ng/mL,arith. SD,Cmax,9.3,mL/min/kg,arith. mean,1.8,mL/min/kg,arith. SD,CLiv,
297,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 75 mg),Midazolam,108,132,h,24.1,ng*h/mL,arith. mean,4.5,ng*h/mL,arith. SD,AUC_inf,82,ng/mL,arith. Mean,34,ng/mL,arith. SD,Cmax,9.8,mL/min/kg,arith. mean,1.6,mL/min/kg,arith. SD,CLiv,
298,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv Control (Perpetrator Placebo),Alfentanil,0,inf,h,78,ng*h/mL,arith. mean,30.7,ng*h/mL,arith. SD,AUC_inf,102,ng/mL,arith. Mean,37,ng/mL,arith. SD,Cmax,3.7,mL/min/kg,arith. mean,1.4,mL/min/kg,arith. SD,CLiv,
299,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 5 mg),Alfentanil,109,133,h,61.7,ng*h/mL,arith. mean,19.4,ng*h/mL,arith. SD,AUC_inf,106,ng/mL,arith. Mean,35,ng/mL,arith. SD,Cmax,4.4,mL/min/kg,arith. mean,1.2,mL/min/kg,arith. SD,CLiv,
300,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 10 mg),Alfentanil,109,133,h,55.5,ng*h/mL,arith. mean,16.7,ng*h/mL,arith. SD,AUC_inf,107,ng/mL,arith. Mean,23,ng/mL,arith. SD,Cmax,4.9,mL/min/kg,arith. mean,1.4,mL/min/kg,arith. SD,CLiv,
301,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 25 mg),Alfentanil,109,133,h,44,ng*h/mL,arith. mean,15.9,ng*h/mL,arith. SD,AUC_inf,102,ng/mL,arith. Mean,27,ng/mL,arith. SD,Cmax,6.3,mL/min/kg,arith. mean,1.8,mL/min/kg,arith. SD,CLiv,
302,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,iv with Perpetrator (Rifampicin @ 75 mg),Alfentanil,109,133,h,37,ng*h/mL,arith. mean,37,ng*h/mL,arith. SD,AUC_inf,105,ng/mL,arith. Mean,26,ng/mL,arith. SD,Cmax,7.1,mL/min/kg,arith. mean,1.4,mL/min/kg,arith. SD,CLiv,
303,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po Control (Perpetrator Placebo),Midazolam,0,inf,h,35,ng*h/mL,arith. mean,12.8,ng*h/mL,arith. SD,AUC_inf,15,ng/mL,arith. Mean,5,ng/mL,arith. SD,Cmax,23,mL/min/kg,arith. mean,10,mL/min/kg,arith. SD,CL/F,
304,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 5 mg),Midazolam,132,inf,h,26.8,ng*h/mL,arith. mean,8.4,ng*h/mL,arith. SD,AUC_inf,12,ng/mL,arith. Mean,4,ng/mL,arith. SD,Cmax,28.4,mL/min/kg,arith. mean,10,mL/min/kg,arith. SD,CL/F,
305,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 10 mg),Midazolam,132,inf,h,22.7,ng*h/mL,arith. mean,6.9,ng*h/mL,arith. SD,AUC_inf,14,ng/mL,arith. Mean,6,ng/mL,arith. SD,Cmax,33.4,mL/min/kg,arith. mean,12.8,mL/min/kg,arith. SD,CL/F,
306,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 25 mg),Midazolam,132,inf,h,13.3,ng*h/mL,arith. mean,3.3,ng*h/mL,arith. SD,AUC_inf,7.6,ng/mL,arith. Mean,3,ng/mL,arith. SD,Cmax,56.5,mL/min/kg,arith. mean,19.4,mL/min/kg,arith. SD,CL/F,
307,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 75 mg),Midazolam,132,inf,h,8.1,ng*h/mL,arith. mean,1.9,ng*h/mL,arith. SD,AUC_inf,5.1,ng/mL,arith. Mean,1.9,ng/mL,arith. SD,Cmax,95.5,mL/min/kg,arith. mean,35.8,mL/min/kg,arith. SD,CL/F,
308,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po Control (Perpetrator Placebo),Alfentanil,0,inf,h,146,ng*h/mL,arith. mean,84,ng*h/mL,arith. SD,AUC_inf,51,ng/mL,arith. Mean,21,ng/mL,arith. SD,Cmax,11.1,mL/min/kg,arith. mean,5.7,mL/min/kg,arith. SD,CL/F,
309,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 5 mg),Alfentanil,133,inf,h,101,ng*h/mL,arith. mean,42,ng*h/mL,arith. SD,AUC_inf,44,ng/mL,arith. Mean,15,ng/mL,arith. SD,Cmax,14.8,mL/min/kg,arith. mean,7.2,mL/min/kg,arith. SD,CL/F,
310,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 10 mg),Alfentanil,133,inf,h,81,ng*h/mL,arith. mean,41,ng*h/mL,arith. SD,AUC_inf,44,ng/mL,arith. Mean,17,ng/mL,arith. SD,Cmax,19.7,mL/min/kg,arith. mean,11.6,mL/min/kg,arith. SD,CL/F,
311,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 25 mg),Alfentanil,133,inf,h,43,ng*h/mL,arith. mean,27,ng*h/mL,arith. SD,AUC_inf,25,ng/mL,arith. Mean,12,ng/mL,arith. SD,Cmax,41.9,mL/min/kg,arith. mean,28.7,mL/min/kg,arith. SD,CL/F,
312,Kharasch 2011,https://www.ncbi.nlm.nih.gov/pubmed/21562488,po with Perpetrator (Rifampicin @ 75 mg),Alfentanil,133,inf,h,18,ng*h/mL,arith. mean,13,ng*h/mL,arith. SD,AUC_inf,13,ng/mL,arith. Mean,10,ng/mL,arith. SD,Cmax,91.7,mL/min/kg,arith. mean,44.6,mL/min/kg,arith. SD,CL/F,
421,Szalat 2007,https://www.ncbi.nlm.nih.gov/pubmed/17553741,Control (Perpetrator Placebo),Midazolam,0,inf,h,5367,ng*min/mL,arith. Mean,981,ng*min/mL,arith. SD,AUC_inf,,,,,,,,10.1,mL/min/kg,arith. Mean,2.2,mL/min/kg,arith. SD,CLiv,
422,Szalat 2007,https://www.ncbi.nlm.nih.gov/pubmed/17553741,with Perpetrator (Rifampicin),Midazolam,132,inf,h,3110,ng*min/mL,arith. Mean,420,ng*min/mL,arith. SD,AUC_inf,,,,,,,,16.2,mL/min/kg,arith. Mean,22.9,mL/min/kg,arith. SD,CLiv,
341,Link 2008,https://www.ncbi.nlm.nih.gov/pubmed/18537963,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,125.8,ng*h/mL,median,,,,AUC_inf,151,ng/mL,median,,,,Cmax,15.9,L/h,median,,,,CLiv,
342,Link 2008,https://www.ncbi.nlm.nih.gov/pubmed/18537963,iv with Perpetrator (Rifampicin),Midazolam,144,inf,h,82.4,ng*h/mL,median,,,,AUC_inf,167,ng/mL,median,,,,Cmax,24.4,L/h,median,,,,CLiv,
343,Link 2008,https://www.ncbi.nlm.nih.gov/pubmed/18537963,po Control (Perpetrator Placebo),Midazolam,0,inf,h,102.9,ng*h/mL,median,,,,AUC_inf,63.1,ng/mL,median,,,,Cmax,,,,,,,,
344,Link 2008,https://www.ncbi.nlm.nih.gov/pubmed/18537963,po with Perpetrator (Rifampicin),Midazolam,144,inf,h,1.6,ng*h/mL,median,,,,AUC_inf,2.2,ng/mL,median,,,,Cmax,,,,,,,,
383,Peloquin 1997,https://www.ncbi.nlm.nih.gov/pubmed/9420037,600 mg,Rifampicin,0,inf,h,79.79,µg*h/mL,arith. mean,27.35,µg*h/mL,arith. SD,AUC_inf,13.61,µg/mL,arith. mean,3.96,µg/mL,arith. SD,Cmax,8.3,L/h,arith. mean,2.5,L/h,arith. SD,CL/F,
384,Peloquin 1999,https://www.ncbi.nlm.nih.gov/pubmed/9925057,fast1,Rifampicin,0,inf,h,57.15,µg*h/mL,arith. Mean,23,%,arith. CV,AUC_inf,10.54,µg/mL,arith. mean,30,%,arith. CV,Cmax,,,,,,,,
385,Peloquin 1999,https://www.ncbi.nlm.nih.gov/pubmed/9925057,fast2,Rifampicin,0,inf,h,58.98,µg*h/mL,arith. Mean,27,%,arith. CV,AUC_inf,11.32,µg/mL,arith. mean,27,%,arith. CV,Cmax,,,,,,,,
386,Peloquin 1999,https://www.ncbi.nlm.nih.gov/pubmed/9925057,antacid,Rifampicin,0,inf,h,58.37,µg*h/mL,arith. Mean,32,%,arith. CV,AUC_inf,10.89,µg/mL,arith. mean,48,%,arith. CV,Cmax,,,,,,,,
387,Peloquin 1999,https://www.ncbi.nlm.nih.gov/pubmed/9925057,fed,Rifampicin,0,inf,h,55.2,µg*h/mL,arith. Mean,26,%,arith. CV,AUC_inf,7.27,µg/mL,arith. mean,31,%,arith. CV,Cmax,,,,,,,,
414,Schwagmeier 1998,https://www.ncbi.nlm.nih.gov/pubmed/9764959,iv administration,Midazolam,0,inf,min,15016,ng*min/mL,arith. Mean,3778,ng*min/mL,arith. SD,AUC_inf,118.8,ng/mL,arith. mean,75.7-155.7,ng/mL,Range,Cmax,362.6,mL/min,arith. mean,85.2,mL/min,arith. SD,CLiv,
427,Tham 2006,https://www.ncbi.nlm.nih.gov/pubmed/16628140,Control (Perpetrator Placebo),Midazolam,0,inf,h,0.17,mg*h/L,arith. Mean,0.28,mg*h/L,arith. SD,AUC_inf,0.26,mg/L,arith. mean,0.72,mg/L,arith. SD,Cmax,26.4,L/h,arith. mean,12.27,L/h,arith. SD,CLiv,
428,Tham 2006,https://www.ncbi.nlm.nih.gov/pubmed/16628140,with Perpetrator (Ketoconazole 50 mg),Midazolam,47,inf,h,0.27,mg*h/L,arith. Mean,0.15,mg*h/L,arith. SD,AUC_inf,0.06,mg/L,arith. mean,0.03,mg/L,arith. SD,Cmax,4.49,L/h,arith. mean,1.82,L/h,arith. SD,CLiv,
388,Phimmasone 2001,https://www.ncbi.nlm.nih.gov/pubmed/11753266,Control (Perpetrator Placebo),Midazolam,0,inf,h,3180,ng*min/mL,arith. Mean,840,ng*min/mL,arith. SD,AUC_inf,,,,,,,,4.37,mL/min/kg,arith. Mean,1.29,mL/min/kg,arith. SD,CLiv,
389,Phimmasone 2001,https://www.ncbi.nlm.nih.gov/pubmed/11753266,with Perpetrator (Rifampicin),Midazolam,106,inf,h,1530,ng*min/mL,arith. Mean,290,ng*min/mL,arith. SD,AUC_inf,,,,,,,,8.78,mL/min/kg,arith. Mean,1.6,mL/min/kg,arith. SD,CLiv,
390,Phimmasone 2001,https://www.ncbi.nlm.nih.gov/pubmed/11753266,Control (Perpetrator Placebo),Alfentanil,0,inf,h,6680,ng*min/mL,arith. Mean,3480,ng*min/mL,arith. SD,AUC_inf,,,,,,,,2.84,mL/min/kg,arith. Mean,1.44,mL/min/kg,arith. SD,CLiv,
391,Phimmasone 2001,https://www.ncbi.nlm.nih.gov/pubmed/11753266,with Perpetrator (Rifampicin),Alfentanil,107,inf,h,2890,ng*min/mL,arith. Mean,568,ng*min/mL,arith. SD,AUC_inf,,,,,,,,5.33,mL/min/kg,arith. Mean,0.95,mL/min/kg,arith. SD,CLiv,
400,Saari 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580904,po Control (Perpetrator Placebo),Midazolam,0,inf,h,91,ng*h/mL,arith. Mean,30,ng*h/mL,arith. SD,AUC_inf,24.1,ng/mL,arith. mean,7.2,ng/mL,arith. SD,Cmax,20.1,mL/min/kg,arith. Mean,8.1,mL/min/kg,arith. SD,CL/F,
401,Saari 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580904,po with Perpetrator (Voriconazole),Midazolam,37,inf,h,855,ng*h/mL,arith. Mean,104,ng*h/mL,arith. SD,AUC_tau,86.6,ng/mL,arith. mean,26.2,ng/mL,arith. SD,Cmax,1.9,mL/min/kg,arith. Mean,0.3,mL/min/kg,arith. SD,CL/F,
402,Saari 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580904,po with Perpetrator (Voriconazole),Voriconazole,36,60,h,12201,ng*h/mL,arith. Mean,6044,ng*h/mL,arith. SD,AUC_tend,1441,ng/mL,arith. mean,329,ng/mL,arith. SD,Cmax,,,,,,,,
403,Saari 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580904,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,151,ng*h/mL,arith. Mean,40,ng*h/mL,arith. SD,AUC_inf,,,,,,,,5.9,mL/min/kg,arith. Mean,1.5,mL/min/kg,arith. SD,CLiv,
404,Saari 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580904,iv with Perpetrator (Voriconazole),Midazolam,37,inf,h,534,ng*h/mL,arith. Mean,88,ng*h/mL,arith. SD,AUC_inf,,,,,,,,1.6,mL/min/kg,arith. Mean,0.3,mL/min/kg,arith. SD,CLiv,
405,Saari 2006,https://www.ncbi.nlm.nih.gov/pubmed/16580904,iv with Perpetrator (Voriconazole),Voriconazole,36,60,h,13776,ng*h/mL,arith. Mean,10758,ng*h/mL,arith. SD,AUC_tend,1495,ng/mL,arith. mean,609,ng/mL,arith. SD,Cmax,,,,,,,,
55,Backman 1998,https://www.ncbi.nlm.nih.gov/pubmed/9591931,Phase I (Control (Perpetrator Placebo)),Midazolam,0,inf,h,277,ng*h/ml,arith. Mean,72,ng*h/ml,arith. SEM,AUC_inf,69.5,ng/mL,arith. mean,10.4,ng/ml,arith. SEM,Cmax,,,,,,,,
56,Backman 1998,https://www.ncbi.nlm.nih.gov/pubmed/9591931,Phase IV (during Perpetrator (Rifampicin)),Midazolam,113,185,h,4.4,ng*h/ml,arith. Mean,1,ng*h/ml,arith. SEM,AUC_inf,3.4,ng/mL,arith. mean,0.8,ng/ml,arith. SEM,Cmax,,,,,,,,
57,Backman 1998,https://www.ncbi.nlm.nih.gov/pubmed/9591931,Phase V (4 days after Perpetrator (Rifampicin)),Midazolam,185,inf,h,27.1,ng*h/ml,arith. Mean,5.1,ng*h/ml,arith. SEM,AUC_inf,13.4,ng/mL,arith. mean,3.7,ng/ml,arith. SEM,Cmax,,,,,,,,
58,Backman 1998,https://www.ncbi.nlm.nih.gov/pubmed/9591931,Phase II (during Perpetrator (Itraconazole)),Midazolam,74,170,h,1707,ng*h/ml,arith. Mean,204,ng*h/ml,arith. SEM,AUC_inf,202,ng/mL,arith. mean,30,ng/ml,arith. SEM,Cmax,,,,,,,,
59,Backman 1998,https://www.ncbi.nlm.nih.gov/pubmed/9591931,Phase III (4 days after Perpetrator (Itraconazole)),Midazolam,170,inf,h,695,ng*h/ml,arith. Mean,208,ng*h/ml,arith. SEM,AUC_inf,120,ng/mL,arith. mean,7,ng/ml,arith. SEM,Cmax,,,,,,,,
110,Chouchane 1995,https://www.ncbi.nlm.nih.gov/pubmed/8983939,Rimactan,Rifampicin,0,inf,h,25.57,µg*h/mL,arith. Mean,12.16,µg*h/mL,arith. SD,AUC_inf,6.06,µg/mL,arith. mean,2.95,µg/mL,arith. SD,Cmax,,,,,,,,
111,Chouchane 1995,https://www.ncbi.nlm.nih.gov/pubmed/8983939,Rifampicin Generic,Rifampicin,0,inf,h,26.11,µg*h/mL,arith. Mean,9.1,µg*h/mL,arith. SD,AUC_inf,6.55,µg/mL,arith. mean,2.47,µg/mL,arith. SD,Cmax,,,,,,,,
118,Darwish 2008,https://www.ncbi.nlm.nih.gov/pubmed/18076219,oral,Midazolam,0,inf,h,53.8,ng*h/mL,arith. Mean,19.5,ng*h/mL,arith. SD,AUC_inf,18.7,ng/mL,arith. mean,6.3,ng/mL,arith. SD,Cmax,1717.6,mL/min,arith. mean,529.2,mL/min,arith. SD,CL/F,
119,Darwish 2008,https://www.ncbi.nlm.nih.gov/pubmed/18076219 ,iv,Midazolam,0,inf,h,76.9,ng*h/mL,arith. Mean,16.5,ng*h/mL,arith. SD,AUC_inf,,,,,,,,451.9,mL/min,arith. mean,92.1,mL/min,arith. SD,CLiv,
120,Darwish 2008,https://www.ncbi.nlm.nih.gov/pubmed/18076219 ,oral,Caffeine,0,inf,h,47.3,µg*h/mL,arith. Mean,20.4,µg*h/mL,arith. SD,AUC_inf,5.01,µg/mL,arith. mean,1.16,µg/mL,arith. SD,Cmax,84.3,mL/min,arith. mean,37.2,mL/min,arith. SD,CL/F,CL: n = 23
172,Gorski 1998,https://www.ncbi.nlm.nih.gov/pubmed/9728893,po Control (Perpetrator Placebo),Midazolam,0,inf,h,48,µg*h/L,arith. Mean,21,µg/L/hr,arith. SD,AUC_inf,,,,,,,,103,L/h,arith. mean,53,L/h,arith. SD,CL/F,
173,Gorski 1998,https://www.ncbi.nlm.nih.gov/pubmed/9728893,po with Perpetrator (Clarithromycin),Midazolam,146,inf,h,336,µg*h/L,arith. Mean,140,µg/L/hr,arith. SD,AUC_inf,,,,,,,,15,L/h,arith. mean,8.7,L/h,arith. SD,CL/F,
174,Gorski 1998,https://www.ncbi.nlm.nih.gov/pubmed/9728893,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,127,µg*h/L,arith. Mean,61,µg/L/hr,arith. SD,AUC_inf,,,,,,,,27.8,L/h,arith. mean,9.3,L/h,arith. SD,CLiv,
175,Gorski 1998,https://www.ncbi.nlm.nih.gov/pubmed/9728893,iv with Perpetrator (Clarithromycin),Midazolam,146,inf,h,349,µg*h/L,arith. Mean,119,µg/L/hr,arith. SD,AUC_inf,,,,,,,,10.1,L/h,arith. mean,3.2,L/h,arith. SD,CLiv,
176,Gorski 2003,https://www.ncbi.nlm.nih.gov/pubmed/12966371,po Control (Perpetrator Placebo),Midazolam,0,inf,h,35.8,µg*h/L,arith. Mean,20.8,µg*h/L,arith. SD,AUC_inf,17.9,ng/mL,arith. mean,7.6,ng/mL,arith. SD,Cmax,115.9,L/h,arith. mean,58.6,L/h,arith. SD,CL/F,
177,Gorski 2003,https://www.ncbi.nlm.nih.gov/pubmed/12966371,po with Perpetrator (Rifampicin),Midazolam,132,inf,h,3.7,µg*h/L,arith. Mean,2.8,µg*h/L,arith. SD,AUC_inf,1.8,ng/mL,arith. mean,1.1,ng/mL,arith. SD,Cmax,2691.4,L/h,arith. mean,1996.1,L/h,arith. SD,CL/F,
178,Gorski 2003,https://www.ncbi.nlm.nih.gov/pubmed/12966371,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,117.6,µg*h/L,arith. Mean,41.6,µg*h/L,arith. SD,AUC_inf,,,,,,,,32.8,L/h,arith. mean,12.2,L/h,arith. SD,CLiv,
179,Gorski 2003,https://www.ncbi.nlm.nih.gov/pubmed/12966371,iv with Perpetrator (Rifampicin),Midazolam,132,inf,h,52.8,µg*h/L,arith. Mean,15.7,µg*h/L,arith. SD,AUC_inf,,,,,,,,70.8,L/h,arith. mean,20.1,L/h,arith. SD,CLiv,
180,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"iv - f, 136kg, 36y (obese female)",Midazolam,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
181,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"iv - f, 61kg, 37y (normal female)",Midazolam,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
182,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"iv - m, 70kg, 32y (young male)",Midazolam,0,inf,h,,,,,,,,,,,,,,,534,ml/min,arith. mean,32,ml/min,arith. SD,CLiv,
183,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"iv - m, 80kg, 70y (elderly male)",Midazolam,0,inf,h,,,,,,,,,,,,,,,339,ml/min,arith. mean,43,ml/min,arith. SD,CLiv,
184,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"po - f, 136kg, 36y (obese female)",Midazolam,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
185,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"po - f, 61kg, 37y (normal female)",Midazolam,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
186,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"po - m, 70kg, 32y (young male)",Midazolam,0,inf,h,,,,,,,,69,ng/ml,arith. mean,12,ng/ml,arith. SD,Cmax,,,,,,,,
187,Greenblat 1984,https://www.ncbi.nlm.nih.gov/pubmed/6742481,"po - m, 80kg, 70y (elderly male)",Midazolam,0,inf,h,,,,,,,,85,ng/ml,arith. mean,11,ng/ml,arith. SD,Cmax,,,,,,,,
188,Greenblat 2003,https://www.ncbi.nlm.nih.gov/pubmed/12891222,Control (Perpetrator Placebo),Midazolam,0,inf,h,64.9,ng*h/mL,arith. Mean,7.2,ng*h/mL,arith. SE,AUC_inf,18.8,ng/mL,arith. mean,1.9,ng/mL,arith. SE,Cmax,27.5,mL/min/kg,arith. mean,3.5,mL/min/kg,arith. SEM,CL/F,
189,Greenblat 2003,https://www.ncbi.nlm.nih.gov/pubmed/12891223,with Perpetrator (GFJ),Midazolam,0,inf,h,106.8,ng*h/mL,arith. Mean,12.1,ng*h/mL,arith. SE,AUC_inf,29.1,ng/mL,arith. mean,2.7,ng/mL,arith. SE,Cmax,18.8,mL/min/kg,arith. mean,2.1,mL/min/kg,arith. SEM,CL/F,
275,Kharasch 1997,https://www.ncbi.nlm.nih.gov/pubmed/9232132,Control (Perpetrator Placebo),Midazolam,0,inf,h,,,,,,,,,,,,,,,3.3,mL/min/kg,arith. mean,1,mL/min/kg,arith. SD,CLiv,
276,Kharasch 1997,https://www.ncbi.nlm.nih.gov/pubmed/9232132,with Perpetrator (Rifampicin),Midazolam,120,inf,h,,,,,,,,,,,,,,,8.7,mL/min/kg,arith. mean,1.4,mL/min/kg,arith. SD,CLiv,
277,Kharasch 1997,https://www.ncbi.nlm.nih.gov/pubmed/9232132,Control (Perpetrator Placebo),Alfentanil,0,inf,h,,,,,,,,,,,,,,,5.3,mL/min/kg,arith. mean,2.3,mL/min/kg,arith. SD,CLiv,
278,Kharasch 1997,https://www.ncbi.nlm.nih.gov/pubmed/9232132,with Perpetrator (Rifampicin),Alfentanil,120.5,inf,h,,,,,,,,,,,,,,,14.6,mL/min/kg,arith. mean,3.8,mL/min/kg,arith. SD,CLiv,Significantly different from control (P<0.05). Microconstants were not statistically compared.
374,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 1 (po) Control (Perpetrator Placebo),Midazolam,0,inf,h,78,ng*h/mL,arith. mean,24,ng*h/mL,arith. SD,AUC_inf,28,ng/mL,arith. mean,9,ng/mL,arith. SD,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: ng*mL-1*h-1 (not in list; might be wrong)
375,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 4 (iv) Control (Perpetrator Placebo),Midazolam,0,inf,h,,,,,,,,,,,,,,,8.7,mL/min/kg,arith. mean,2.7,mL/min/kg,arith. SD,CLiv,
376,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 6 (po) Control (Perpetrator Placebo),Midazolam,0,inf,h,87,ng*h/mL,arith. mean,39,ng*h/mL,arith. SD,AUC_inf,35,ng/mL,arith. mean,14,ng/mL,arith. SD,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: ng*mL-1*h-1 (not in list; might be wrong)
377,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 1 (po) with Perpetrator (Itraconazole),Midazolam,2,74,h,267,ng*h/mL,arith. mean,107,ng*h/mL,arith. SD,AUC_inf,49,ng/mL,arith. mean,20,ng/mL,arith. SD,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: ng*mL-1*h-1 (not in list; might be wrong)
378,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 4 (iv) with Perpetrator (Itraconazole),Midazolam,74,122,h,,,,,,,,,,,,,,,2.7,mL/min/kg,arith. mean,1.6,mL/min/kg,arith. SD,CLiv,
379,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 6 (po) with Perpetrator (Itraconazole),Midazolam,122,inf,h,578,ng*h/mL,arith. mean,142,ng*h/mL,arith. SD,AUC_inf,88,ng/mL,arith. mean,15,ng/mL,arith. SD,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: ng*mL-1*h-1 (not in list; might be wrong)
380,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 1 (po) with Perpetrator (Fluconazole),Midazolam,2,74,h,274,ng*h/mL,arith. mean,99,ng*h/mL,arith. SD,AUC_inf,70,ng/mL,arith. mean,28,ng/mL,arith. SD,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: ng*mL-1*h-1 (not in list; might be wrong)
381,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 4 (iv) with Perpetrator (Fluconazole),Midazolam,74,122,h,,,,,,,,,,,,,,,4.3,mL/min/kg,arith. mean,1.6,mL/min/kg,arith. SD,CLiv,
382,Olkkola 1996,https://www.ncbi.nlm.nih.gov/pubmed/8623953,day 6 (po) with Perpetrator (Fluconazole),Midazolam,122,inf,h,313,ng*h/mL,arith. mean,117,ng*h/mL,arith. SD,AUC_inf,61,ng/mL,arith. mean,16,ng/mL,arith. SD,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: ng*mL-1*h-1 (not in list; might be wrong)
369,Olkkola 1994,https://www.ncbi.nlm.nih.gov/pubmed/8181191,po Control (Perpetrator Placebo),Midazolam,0,inf,h,3.9,µg*min/mL,arith. mean,0.6,µg*min/mL,arith. SEM,AUC_inf,22,ng/mL,arith. mean,6,ng/mL,arith. SEM,Cmax,,,,,,,,
370,Olkkola 1994,https://www.ncbi.nlm.nih.gov/pubmed/8181191,po with Perpetrator (Itraconazole),Midazolam,73,inf,h,42,µg*min/mL,arith. mean,6,µg*min/mL,arith. SEM,AUC_inf,75,ng/mL,arith. mean,7,ng/mL,arith. SEM,Cmax,,,,,,,,
371,Olkkola 1994,https://www.ncbi.nlm.nih.gov/pubmed/8181191,po with Perpetrator (Ketoconazole,Midazolam,73,inf,h,62,µg*min/mL,arith. mean,6,µg*min/mL,arith. SEM,AUC_inf,90,ng/mL,arith. mean,7,ng/mL,arith. SEM,Cmax,,,,,,,,
365,Olkkola 1993,https://www.ncbi.nlm.nih.gov/pubmed/8453848,po Control (Perpetrator Placebo),Midazolam,0,inf,h,12,µg*min/mL,arith. mean,1,µg*min/mL,arith. SEM,AUC_inf,70,ng/mL,arith. mean,9,ng/mL,arith. SEM,Cmax,,,,,,,,
366,Olkkola 1993,https://www.ncbi.nlm.nih.gov/pubmed/8453848,po with Perpetrator (Erythromycin),Midazolam,128,inf,h,53,µg*min/mL,arith. mean,7,µg*min/mL,arith. SEM,AUC_inf,189,ng/mL,arith. mean,16,ng/mL,arith. SEM,Cmax,,,,,,,,
367,Olkkola 1993,https://www.ncbi.nlm.nih.gov/pubmed/8453848,iv Control (Perpetrator Placebo),Midazolam,0,inf,h,,,,,,,,,,,,,,,7.8,mL/min/kg,arith. mean,0.6,mL/min/kg,arith. SEM,CLiv,
368,Olkkola 1993,https://www.ncbi.nlm.nih.gov/pubmed/8453848,iv with Perpetrator (Erythromycin),Midazolam,128,inf,h,,,,,,,,,,,,,,,3.6,mL/min/kg,arith. mean,0.3,mL/min/kg,arith. SEM,CLiv,
361,Okudaira 2007,https://www.ncbi.nlm.nih.gov/pubmed/17585116,EM 0 Control (Perpetrator Placebo),Midazolam,0,inf,h,35.8,ng*h/mL,arith. mean,7.8,ng*h/mL,arith. SD,AUC_inf,11,ng/mL,arith. mean,2.6,ng/mL,arith. SD,Cmax,19.3,mL/min/kg,arith. mean,5.5,mL/min/kg,arith. SD,CL/F,
362,Okudaira 2007,https://www.ncbi.nlm.nih.gov/pubmed/17585116,EM 2 with Perpetrator (Erythromycin),Midazolam,25,73,h,83.1,ng*h/mL,arith. mean,37.7,ng*h/mL,arith. SD,AUC_inf,20,ng/mL,arith. mean,5.9,ng/mL,arith. SD,Cmax,9.4,mL/min/kg,arith. mean,4.2,mL/min/kg,arith. SD,CL/F,
363,Okudaira 2007,https://www.ncbi.nlm.nih.gov/pubmed/17585116,EM 4 with Perpetrator (Erythromycin),Midazolam,73,145,h,118.7,ng*h/mL,arith. mean,57,ng*h/mL,arith. SD,AUC_inf,26.4,ng/mL,arith. mean,8.7,ng/mL,arith. SD,Cmax,6.5,mL/min/kg,arith. mean,2.5,mL/min/kg,arith. SD,CL/F,
364,Okudaira 2007,https://www.ncbi.nlm.nih.gov/pubmed/17585116,EM 7 with Perpetrator (Erythromycin),Midazolam,145,inf,h,119.2,ng*h/mL,arith. mean,50.8,ng*h/mL,arith. SD,AUC_inf,25.8,ng/mL,arith. mean,9.9,ng/mL,arith. SD,Cmax,6.6,mL/min/kg,arith. mean,3,mL/min/kg,arith. SD,CL/F,
351,Majumdar 2007,https://www.ncbi.nlm.nih.gov/pubmed/17463213,po Control (Perpetrator Placebo),Midazolam,0,inf,h,75.4,ng*h/mL,arith. mean,8.57,ng*h/mL,arith. SD,AUC_inf,71.6,ng/mL,arith. mean,48.1,ng/mL,arith. SD,Cmax,447.11,mL/min,arith. mean,50.65,mL/min,arith. SD,CLiv,
352,Majumdar 2007,https://www.ncbi.nlm.nih.gov/pubmed/17463213,po with Perpetrator (Aprepitant),Midazolam,1,inf,h,112.4,ng*h/mL,arith. mean,23.66,ng*h/mL,arith. SD,AUC_inf,108.1,ng/mL,arith. mean,113.2,ng/mL,arith. SD,Cmax,307.51,mL/min,arith. mean,58.44,mL/min,arith. SD,CLiv,
30,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 1 (600 mg, 3 h infusion)",Rifampicin,0,inf,h,51,mg*h/mL,individual,,,,AUC_inf,,,,,,,,11.76,mL/h,individual,,,,,CL=dose/AUC
31,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 2 (600 mg, 3 h infusion)",Rifampicin,0,inf,h,59.7,mg*h/mL,individual,,,,AUC_inf,,,,,,,,10.05,mL/h,individual,,,,,CL=dose/AUC
32,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 3 (600 mg, 2 h infusion)",Rifampicin,0,inf,h,49.7,mg*h/mL,individual,,,,AUC_inf,,,,,,,,12.07,mL/h,individual,,,,,CL=dose/AUC
33,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 4 (600 mg, 2 h infusion)",Rifampicin,0,inf,h,16.1,mg*h/mL,individual,,,,AUC_inf,,,,,,,,37.26,mL/h,individual,,,,,CL=dose/AUC
34,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 5 (600 mg, 1 h infusion)",Rifampicin,0,inf,h,79.1,mg*h/mL,individual,,,,AUC_inf,,,,,,,,7.58,mL/h,individual,,,,,CL=dose/AUC
35,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 6 (600 mg, 1 h infusion)",Rifampicin,0,inf,h,60.6,mg*h/mL,individual,,,,AUC_inf,,,,,,,,9.9,mL/h,individual,,,,,CL=dose/AUC
36,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 7 (900 mg, 3 h infusion)",Rifampicin,0,inf,h,59.3,mg*h/mL,individual,,,,AUC_inf,,,,,,,,15.17,mL/h,individual,,,,,CL=dose/AUC
37,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 8 (900 mg, 3 h infusion)",Rifampicin,0,inf,h,72.7,mg*h/mL,individual,,,,AUC_inf,,,,,,,,12.38,mL/h,individual,,,,,CL=dose/AUC
38,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 9 (900 mg, 2 h infusion)",Rifampicin,0,inf,h,105.7,mg*h/mL,individual,,,,AUC_inf,,,,,,,,8.51,mL/h,individual,,,,,CL=dose/AUC
39,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 10 (900 mg, 2 h infusion)",Rifampicin,0,inf,h,79.2,mg*h/mL,individual,,,,AUC_inf,,,,,,,,11.51,mL/h,individual,,,,,CL=dose/AUC
40,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 11 (900 mg, 1 h infusion)",Rifampicin,0,inf,h,93.3,mg*h/mL,individual,,,,AUC_inf,,,,,,,,9.65,mL/h,individual,,,,,CL=dose/AUC
41,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 12 (900 mg, 1 h infusion)",Rifampicin,0,inf,h,145.4,mg*h/mL,individual,,,,AUC_inf,,,,,,,,6.19,mL/h,individual,,,,,CL=dose/AUC
42,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 13 (1200 mg, 3 h infusion)",Rifampicin,0,inf,h,97.8,mg*h/mL,individual,,,,AUC_inf,,,,,,,,12.26,mL/h,individual,,,,,CL=dose/AUC
43,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 14 (1200 mg, 3 h infusion)",Rifampicin,0,inf,h,201.7,mg*h/mL,individual,,,,AUC_inf,,,,,,,,5.95,mL/h,individual,,,,,CL=dose/AUC
44,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 15 (1200 mg, 2 h infusion)",Rifampicin,0,inf,h,90.4,mg*h/mL,individual,,,,AUC_inf,,,,,,,,13.27,mL/h,individual,,,,,CL=dose/AUC
45,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 16 (1200 mg, 2 h infusion)",Rifampicin,0,inf,h,107.3,mg*h/mL,individual,,,,AUC_inf,,,,,,,,11.18,mL/h,individual,,,,,CL=dose/AUC
46,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 17 (1200 mg, 1 h infusion)",Rifampicin,0,inf,h,231.4,mg*h/mL,individual,,,,AUC_inf,,,,,,,,5.18,mL/h,individual,,,,,CL=dose/AUC
47,Acocella 1984,https://www.ncbi.nlm.nih.gov/pubmed/6473487,"Individual 18 (1200 mg, 1 h infusion)",Rifampicin,0,inf,h,267.9,mg*h/mL,individual,,,,AUC_inf,,,,,,,,4.48,mL/h,individual,,,,,CL=dose/AUC
5197,Abdel-Rahman 2007,https://www.ncbi.nlm.nih.gov/pubmed/17517842,6m-2y,Itraconazole,0,24,h,2121,ng*h/mL,arith. Mean,1231,ng*h/mL,arith. SD,AUC_tau,827,ng/mL,arith. mean,859,ng/mL,arith. SD,Cmax_total,1143,mL/h/kg,arith. Mean,513,mL/h/kg,arith. Mean,CL total,
5198,Abdel-Rahman 2007,https://www.ncbi.nlm.nih.gov/pubmed/17517842,2-6y,Itraconazole,0,24,h,9510,ng*h/mL,arith. Mean,11316,ng*h/mL,arith. SD,AUC_tau,1553,ng/mL,arith. mean,918,ng/mL,arith. SD,Cmax_total,529,mL/h/kg,arith. Mean,611,mL/h/kg,arith. Mean,CL total,
5199,Abdel-Rahman 2007,https://www.ncbi.nlm.nih.gov/pubmed/17517842,6-12y,Itraconazole,0,24,h,3765,ng*h/mL,arith. Mean,1711,ng*h/mL,arith. SD,AUC_tau,785,ng/mL,arith. mean,301,ng/mL,arith. SD,Cmax_total,621,mL/h/kg,arith. Mean,340,mL/h/kg,arith. Mean,CL total,
5200,Abdel-Rahman 2007,https://www.ncbi.nlm.nih.gov/pubmed/17517842,12-16y,Itraconazole,0,24,h,2669,ng*h/mL,arith. Mean,1076,ng*h/mL,arith. SD,AUC_tau,806,ng/mL,arith. mean,381,ng/mL,arith. SD,Cmax_total,777,mL/h/kg,arith. Mean,455,mL/h/kg,arith. Mean,CL total,
49,Ahonen 1995,http://www.ncbi.nlm.nih.gov/pubmed/8527290,Control (Perpetrator Placebo),Midazolam,0,inf,h,102,µg*min/mL,arith. mean,10,µg*min/mL,arith. SEM,AUC_inf,34,ng/mL,arith. mean,5,ng/mL,arith. SEM,Cmax,,,,,,,,
50,Ahonen 1995,http://www.ncbi.nlm.nih.gov/pubmed/8527290,with Perpetrator (Itraconazole),Midazolam,74,inf,h,586,µg*min/mL,arith. mean,73,µg*min/mL,arith. SEM,AUC_inf,87,ng/mL,arith. mean,11,ng/mL,arith. SEM,Cmax,,,,,,,,
128,Eap 2004,https://www.ncbi.nlm.nih.gov/pubmed/15114429,0.075 mg Control (Perpetrator Placebo),Midazolam,0,inf,h,0.68,ng*h/mL,arith. mean,0.25,ng*h/mL,arith. SD,AUC_inf,0.31,ng/mL,arith. mean,0.09,ng/mL,arith. SD,Cmax,128,L/h,arith. mean,60,L/h,arith. SD,CL/F,
129,Eap 2004,https://www.ncbi.nlm.nih.gov/pubmed/15114429,0.075 mg with Perpetrator (Rifampicin),Midazolam,90,inf,h,0.3,ng*h/mL,arith. mean,0.11,ng*h/mL,arith. SD,AUC_inf,0.07,ng/mL,arith. mean,0.02,ng/mL,arith. SD,Cmax,1089,L/h,arith. mean,1619,L/h,arith. SD,CL/F,
130,Eap 2004,https://www.ncbi.nlm.nih.gov/pubmed/15114429,0.075 mg with Perpetrator (Ketoconazole),Midazolam,48,inf,h,4.4,ng*h/mL,arith. mean,1.6,ng*h/mL,arith. SD,AUC_inf,1.16,ng/mL,arith. mean,0.21,ng/mL,arith. SD,Cmax,19,L/h,arith. mean,7,L/h,arith. SD,CL/F,
131,Eap 2004,https://www.ncbi.nlm.nih.gov/pubmed/15114429,7.5 mg Control (Perpetrator Placebo),Midazolam,0,inf,h,67,ng*h/mL,arith. mean,30,ng*h/mL,arith. SD,AUC_inf,26,ng/mL,arith. mean,11,ng/mL,arith. SD,Cmax,129,L/h,arith. mean,44,L/h,arith. SD,CL/F,
132,Eap 2004,https://www.ncbi.nlm.nih.gov/pubmed/15114429,7.5 mg with Perpetrator (Rifampicin),Midazolam,114,inf,h,3.5,ng*h/mL,arith. mean,0.2,ng*h/mL,arith. SD,AUC_inf,2.9,ng/mL,arith. mean,0.5,ng/mL,arith. SD,Cmax,2179,L/h,arith. mean,148,L/h,arith. SD,CL/F,
60,Baneyx 2014,https://www.ncbi.nlm.nih.gov/pubmed/24530864,Day 4 - 600 mg po MD,Rifampicin,72,inf,h,60.8,µg*h/mL,arith. mean,22.1,µg*h/mL,arith. SD,AUC_inf,12.5,µg/mL,arith. mean,3.4,µg/mL,arith. SD,Cmax,,,,,,,,
549,Baneyx 2014,https://www.ncbi.nlm.nih.gov/pubmed/24530864,Day 7 - 600 mg po MD,Rifampicin,144,inf,h,47.3,µg*h/mL,arith. mean,19.7,µg*h/mL,arith. SD,AUC_inf,11,µg/mL,arith. mean,2.9,µg/mL,arith. SD,Cmax,,,,,,,,
104,Bornemann 1986,https://www.ncbi.nlm.nih.gov/pubmed/2936766,1 h after a meal,Midazolam,1,inf,h,184,ng*h/mL,arith. mean,73,ng*h/mL,arith. SD,AUC_inf,48,ng/mL,arith. mean,19,ng/mL,arith. SD,Cmax,,,,,,,,
105,Bornemann 1986,https://www.ncbi.nlm.nih.gov/pubmed/2936766,1 h before a meal,Midazolam,0,inf,h,197,ng*h/mL,arith. mean,57,ng*h/mL,arith. SD,AUC_inf,80,ng/mL,arith. mean,34,ng/mL,arith. SD,Cmax,,,,,,,,
106,Bornemann 1986,https://www.ncbi.nlm.nih.gov/pubmed/2936766,with a meal,Midazolam,0,inf,h,207,ng*h/mL,arith. mean,96,ng*h/mL,arith. SD,AUC_inf,63,ng/mL,arith. mean,36,ng/mL,arith. SD,Cmax,,,,,,,,
107,Bornemann 1986,https://www.ncbi.nlm.nih.gov/pubmed/2936766,fasting condition,Midazolam,0,inf,h,215,ng*h/mL,arith. mean,78,ng*h/mL,arith. SD,AUC_inf,69,ng/mL,arith. mean,26,ng/mL,arith. SD,Cmax,,,,,,,,
345,Loos 1985,http://www.ncbi.nlm.nih.gov/pubmed/4087830,oral day 2 (Patient 4),Rifampicin,24,inf,h,67.6,µg*h/mL,arith. mean,,,,AUC_inf,,,,,,,,9.8,L/h,arith. mean,,,,CL/F,
346,Loos 1985,http://www.ncbi.nlm.nih.gov/pubmed/4087830,oral day 9 (Patient 4),Rifampicin,192,inf,h,57,µg*h/mL,arith. mean,,,,AUC_inf,,,,,,,,11.7,L/h,arith. mean,,,,CL/F,
347,Loos 1985,http://www.ncbi.nlm.nih.gov/pubmed/4087830,oral day 23 (Patient 4),Rifampicin,528,inf,h,18.4,µg*h/mL,arith. mean,,,,AUC_inf,,,,,,,,34.5,L/h,arith. mean,,,,CL/F,
348,Loos 1985,http://www.ncbi.nlm.nih.gov/pubmed/4087830,iv day 1 (Patient 4),Rifampicin,0,inf,h,110.4,µg*h/mL,arith. mean,,,,AUC_inf,,,,,,,,5.43,L/h,arith. mean,,,,CLiv,
349,Loos 1985,http://www.ncbi.nlm.nih.gov/pubmed/4087830,iv day 8 (Patient 4),Rifampicin,168,inf,h,95.4,µg*h/mL,arith. mean,,,,AUC_inf,,,,,,,,6.29,L/h,arith. mean,,,,CLiv,
350,Loos 1985,http://www.ncbi.nlm.nih.gov/pubmed/4087830,iv day 22 (Patient 4),Rifampicin,504,inf,h,69.6,µg*h/mL,arith. mean,,,,AUC_inf,,,,,,,,8.63,L/h,arith. mean,,,,CLiv,
313,Kirby 2012,https://www.ncbi.nlm.nih.gov/pubmed/22190694,Study 1 - Staggered Administration Control,Digoxin,0,inf,h,8.66,ng*h/mL,arith. mean,2.57,ng*h/mL,arith. SD,AUC_inf,1.34,ng/mL,arith. mean,0.53,ng/mL,arith. SD,Cmax,146,mL/min,arith. mean,43.3,mL/min,arith. SD,CL/F,
314,Kirby 2012,https://www.ncbi.nlm.nih.gov/pubmed/22190694,Study 1 - Staggered Administration with RIF,Digoxin,324,inf,h,6.83,ng*h/mL,arith. mean,1.68,ng*h/mL,arith. SD,AUC_inf,1.02,ng/mL,arith. mean,0.38,ng/mL,arith. SD,Cmax,162,mL/min,arith. mean,51.4,mL/min,arith. SD,CL/F,
315,Kirby 2012,https://www.ncbi.nlm.nih.gov/pubmed/22190694,Study 2 - Simultaneous Administration Control,Digoxin,0,inf,h,5.45,ng*h/mL,arith. mean,1.99,ng*h/mL,arith. SD,AUC_inf,1.24,ng/mL,arith. mean,0.35,ng/mL,arith. SD,Cmax,258,mL/min,arith. mean,64.9,mL/min,arith. SD,CL/F,
316,Kirby 2012,https://www.ncbi.nlm.nih.gov/pubmed/22190694,Study 2 - Simultaneous Administration with RIF,Digoxin,360,inf,h,7.08,ng*h/mL,arith. mean,3.25,ng*h/mL,arith. SD,AUC_inf,2.12,ng/mL,arith. mean,1.04,ng/mL,arith. SD,Cmax,225,mL/min,arith. mean,59.8,mL/min,arith. SD,CL/F,
336,Larsen 2007,https://www.ncbi.nlm.nih.gov/pubmed/17365992,Control (Perpetrator Placebo),Digoxin,0,inf,h,980,nmol*min/mL,arith. mean,,,,AUC_inf,,,,,,,,,,,,,,,
337,Larsen 2007,https://www.ncbi.nlm.nih.gov/pubmed/17365992,with Perpetrator (Rifampicin),Digoxin,144,inf,h,801,nmol*min/mL,arith. mean,,,,AUC_inf,,,,,,,,,,,,,,,
338,Larsen 2007,https://www.ncbi.nlm.nih.gov/pubmed/17365992,with Perpetrator (Ketoconazole),Digoxin,96,inf,h,1070,nmol*min/mL,arith. mean,,,,AUC_inf,,,,,,,,,,,,,,,
419,Swart 2002,https://www.ncbi.nlm.nih.gov/pubmed/11851636 ,day 5 Control (Perpetrator Placebo),Midazolam,0,inf,h,,,,,,,,,,,,,,,3.8,mL/min/kg,arith. mean,0.8,mL/min/kg,arith. SD,,
420,Swart 2002,https://www.ncbi.nlm.nih.gov/pubmed/11851636 ,day 10 Control with Perpetrator (Erythromycin),Midazolam,96,inf,h,,,,,,,,,,,,,,,2.5,mL/min/kg,arith. mean,0.9,mL/min/kg,arith. SD,,
155,"Eon Labs Manufacturing, Inc. 1997",https://www.accessdata.fda.gov/drugsatfda_docs/anda/97/064150review.pdf,2X300mg Tab (Eon),Rifampicin,0,inf,h,59.91,µg*h/mL,arith. Mean,30,%,arith. CV,AUC_inf,10.78,µg/mL,arith. mean,24,%,arith. CV,Cmax,,,,,,,,
156,"Eon Labs Manufacturing, Inc. 1997",https://www.accessdata.fda.gov/drugsatfda_docs/anda/97/064150review.pdf,2X300mg Rifadine Tab,Rifampicin,0,inf,h,58.52,µg*h/mL,arith. Mean,27,%,arith. CV,AUC_inf,10.72,µg/mL,arith. mean,23,%,arith. CV,Cmax,,,,,,,,
48,Acocella 1985,https://www.ncbi.nlm.nih.gov/pubmed/4037525,R alone,Rifampicin,0,inf,h,36,,arith. mean,5.5,,arith. SE,AUC_inf,6.3,µg/mL,arith. mean,0.5,µg/mL,arith. SE,Cmax,,,,,,,,AUC AvgUnit & AUC VarUnit in paper: mcg/ml/h (not in list; might be wrong)
270,Jalava 1997,https://www.ncbi.nlm.nih.gov/pubmed/9421099,po Control (Perpetrator Placebo),Digoxin,0,inf,h,31,nmol*h/L,arith. mean,2,nmol*h/L,arith. SEM,AUC_inf,3.5,nmol/L,arith. mean,0.5,nmol/L,arith. SEM,Cmax,2.19,mL/min/kg,arith. mean,0.11,mL/min/kg,arith. SD,,CL is here CLR: amount excreted in urine in 72 h / AUC
271,Jalava 1997,https://www.ncbi.nlm.nih.gov/pubmed/9421099,po with Perpetrator (Itraconazole),Digoxin,49,inf,h,52,nmol*h/L,arith. mean,5,nmol*h/L,arith. SEM,AUC_inf,4.7,nmol/L,arith. mean,0.4,nmol/L,arith. SEM,Cmax,1.75,mL/min/kg,arith. mean,0.06,mL/min/kg,arith. SD,,CL is here CLR: amount excreted in urine in 72 h / AUC
272,Jalava 1997,https://www.ncbi.nlm.nih.gov/pubmed/9421099,po with Perpetrator (Itraconazole),Itraconazole,48,72,h,5312,nmol*h/L,arith. Mean,1840.530117,nmol*h/L,arith. SD,AUC_tau,526.7,nmol/L,arith. mean,219.8444147,nmol/L,arith. SD,Cmax,,,,,,,,
588,Hamaguchi 1987,https://www.ncbi.nlm.nih.gov/pubmed/3783459,Treatment 1 - fasted with 50 mL of water,Mefenamic acid,0,inf,h,9.95,µg*h/mL,arith. Mean,2.46,µg*h/mL,arith. SD,AUC_inf,3.62,µg/mL,arith. mean,0.98,µg/mL,arith. SD,Cmax,,,,,,,,
589,Hamaguchi 1987,https://www.ncbi.nlm.nih.gov/pubmed/3783459,Treatment 2 - fasted with 200 mL of water,Mefenamic acid,0,inf,h,8.55,µg*h/mL,arith. Mean,2.15,µg*h/mL,arith. SD,AUC_inf,2.74,µg/mL,arith. mean,0.5,µg/mL,arith. SD,Cmax,,,,,,,,
590,Hamaguchi 1987,https://www.ncbi.nlm.nih.gov/pubmed/3783459,Treatment 3 - fasted with 500 mL of water,Mefenamic acid,0,inf,h,4.4,µg*h/mL,arith. Mean,0.85,µg*h/mL,arith. SD,AUC_inf,1.26,µg/mL,arith. mean,2.46,µg/mL,arith. SD,Cmax,,,,,,,,
591,Hamaguchi 1987,https://www.ncbi.nlm.nih.gov/pubmed/3783459,Treatment 4 - fed with 50 mL of water,Mefenamic acid,0,inf,h,9.69,µg*h/mL,arith. Mean,1.07,µg*h/mL,arith. SD,AUC_inf,3.83,µg/mL,arith. mean,0.33,µg/mL,arith. SD,Cmax,,,,,,,,
629,Boulton 2013,https://www.ncbi.nlm.nih.gov/pubmed/22823746,14C-dapagliflozin iv,Dapagliflozin,1,inf,h,6.8,ng*h/mL,geo. mean,20,%,geo. CV,AUC_inf,10.2,ng/mL,geo. mean,49,%,geo. CV,Cmax,207,mL/min,geo. mean,23,%,geo. CV,CLiv,
630,Boulton 2013,https://www.ncbi.nlm.nih.gov/pubmed/22823746,Dapagliflozin po,Dapagliflozin,0,inf,h,628,ng*h/mL,geo. mean,17,%,geo. CV,AUC_inf,143,ng/mL,geo. mean,29,%,geo. CV,Cmax,,,,,,,,
633,Imamura 2013,https://www.ncbi.nlm.nih.gov/pubmed/23307267,Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,539,ng*h/mL,geo. mean,21.7,%,geo. CV,AUC_inf,180,ng/mL,geo. mean,29.5,%,geo. CV,Cmax,,,,,,,,
634,Kasichayanula 2011a,https://www.ncbi.nlm.nih.gov/pubmed/21435141,fasted,Dapagliflozin,0,inf,h,497,ng*h/mL,geo. mean,19,%,geo. CV,AUC_inf,136,ng/mL,geo. mean,22,%,geo. CV,Cmax,,,,,,,,
635,Kasichayanula 2011a,https://www.ncbi.nlm.nih.gov/pubmed/21435141,fed,Dapagliflozin,0,inf,h,507,ng*h/mL,geo. mean,16,%,geo. CV,AUC_inf,94,ng/mL,geo. mean,33,%,geo. CV,Cmax,,,,,,,,
636,Kasichayanula 2011b,https://www.ncbi.nlm.nih.gov/pubmed/21114603,Study 1: 50 mg Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,2303,ng*h/mL,geo. mean,,,,AUC_inf,551,ng/mL,geo. mean,,,,Cmax,,,,,,,,
637,Kasichayanula 2011b,https://www.ncbi.nlm.nih.gov/pubmed/21114603,Study 2: 20 mg Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,947,ng*h/mL,geo. mean,,,,AUC_inf,134,ng/mL,geo. mean,,,,Cmax,,,,,,,,
638,Kasichayanula 2011b,https://www.ncbi.nlm.nih.gov/pubmed/21114603,Study 3: 20 mg Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,1139,ng*h/mL,geo. mean,,,,AUC_inf,151,ng/mL,geo. mean,,,,Cmax,,,,,,,,
639,Kasichayanula 2012,https://www.ncbi.nlm.nih.gov/pubmed/22271159,Study 1: Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,928,ng*h/mL,geo. mean,,,,AUC_inf,251,ng/mL,geo. mean,,,,Cmax,,,,,,,,
640,Kasichayanula 2013a,https://www.ncbi.nlm.nih.gov/pubmed/23061428,Study 1: Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,635,ng*h/mL,geo. mean,25,%,geo. CV,AUC_inf,160,ng/mL,geo. mean,34,%,geo. CV,Cmax,,,,,,,,
643,Kasichayanula 2013a,https://www.ncbi.nlm.nih.gov/pubmed/23061428,Study 1: with Perpetrator (Rifampicin),Dapagliflozin,120,inf,h,556.6,ng*h/mL,geo. mean,15,%,geo. CV,AUC_inf,164.4,ng/mL,geo. mean,17,%,geo. CV,Cmax,,,,,,,,
641,Kasichayanula 2013a,https://www.ncbi.nlm.nih.gov/pubmed/23061428,Study 2: Control (Perpetrator Placebo),Dapagliflozin,0,inf,h,905,ng*h/mL,geo. mean,28,%,geo. CV,AUC_inf,193,ng/mL,geo. mean,34,%,geo. CV,Cmax,,,,,,,,
642,Kasichayanula 2013a,https://www.ncbi.nlm.nih.gov/pubmed/23061428,Study 2: with Perpetrator (Mefenamic Acid),Dapagliflozin,24,inf,h,709,ng*h/mL,geo. mean,28,%,geo. CV,AUC_inf,114,ng/mL,geo. mean,28,%,geo. CV,Cmax,,,,,,,,
644,Kasichayanula 2013b,https://www.ncbi.nlm.nih.gov/pubmed/23210765,Healthy subjects with normal kidney function,Dapagliflozin,0,inf,h,2880,ng*h/mL,geo. mean,27,%,geo. CV,AUC_inf,710,ng/mL,geo. mean,31,%,geo. CV,Cmax,289,mL/min,geo. Mean,26,%,geo. CV,CL/F,
645,Kasichayanula 2013b,https://www.ncbi.nlm.nih.gov/pubmed/23210765,T2DM with normal kidney function,Dapagliflozin,0,inf,h,2504,ng*h/mL,geo. mean,30,%,geo. CV,AUC_inf,647,ng/mL,geo. mean,37,%,geo. CV,Cmax,333,mL/min,geo. Mean,26,%,geo. CV,CL/F,
646,Kasichayanula 2013b,https://www.ncbi.nlm.nih.gov/pubmed/23210765,T2DM with mild renal impairment,Dapagliflozin,0,inf,h,4018,ng*h/mL,geo. mean,26,%,geo. CV,AUC_inf,902,ng/mL,geo. mean,35,%,geo. CV,Cmax,207,mL/min,geo. Mean,25,%,geo. CV,CL/F,
647,Kasichayanula 2013b,https://www.ncbi.nlm.nih.gov/pubmed/23210765,T2DM with moderate renal impairment,Dapagliflozin,0,inf,h,5182,ng*h/mL,geo. mean,38,%,geo. CV,AUC_inf,897,ng/mL,geo. mean,41,%,geo. CV,Cmax,161,mL/min,geo. Mean,26,%,geo. CV,CL/F,
648,Kasichayanula 2013b,https://www.ncbi.nlm.nih.gov/pubmed/23210765,T2DM with severe renal impairment,Dapagliflozin,0,inf,h,4884,ng*h/mL,geo. mean,10,%,geo. CV,AUC_inf,772,ng/mL,geo. mean,11,%,geo. CV,Cmax,171,mL/min,geo. Mean,10,%,geo. CV,CL/F,
649,Vakkalagadda 2016,https://www.ncbi.nlm.nih.gov/pubmed/27491280,Dapagliflozin,Dapagliflozin,0,inf,h,542,ng*h/mL,geo. mean,23,%,geo. CV,AUC_inf,133,ng/mL,geo. mean,23,%,geo. CV,Cmax,305,mL/min,geo. Mean,24,%,geo. CV,CL/F,
650,DeFronzo 2013,https://www.ncbi.nlm.nih.gov/pubmed/23735727,Healthy Subjects,Dapagliflozin,144,168,h,343,ng*h/mL,arith. mean,89,ng*h/mL,arith. SD,AUC_tau,62.9,ng/mL,arith. mean,29.1,ng/mL,arith. SD,Cmax,,,,,,,,
651,Kasichayanula 2011c,https://www.ncbi.nlm.nih.gov/pubmed/22030444,Healthy Volunteers,Dapagliflozin,0,inf,h,465,ng*h/mL,geo. mean,34,%,geo. CV,AUC_inf,136,ng/mL,geo. mean,31,%,geo. CV,Cmax,,,,,,,,
652,Kasichayanula 2011c,https://www.ncbi.nlm.nih.gov/pubmed/22030444,Mild hepatic impairment,Dapagliflozin,0,inf,h,480,ng*h/mL,geo. mean,26,%,geo. CV,AUC_inf,120,ng/mL,geo. mean,28,%,geo. CV,Cmax,,,,,,,,
653,Kasichayanula 2011c,https://www.ncbi.nlm.nih.gov/pubmed/22030444,Moderate hepatic impairment,Dapagliflozin,0,inf,h,632,ng*h/mL,geo. mean,40,%,geo. CV,AUC_inf,153,ng/mL,geo. mean,51,%,geo. CV,Cmax,,,,,,,,
654,Kasichayanula 2011c,https://www.ncbi.nlm.nih.gov/pubmed/22030444,Severe hepatic impairment,Dapagliflozin,0,inf,h,776,ng*h/mL,geo. mean,22,%,geo. CV,AUC_inf,190,ng/mL,geo. mean,40,%,geo. CV,Cmax,,,,,,,,
661,Komoroski 2009,https://www.ncbi.nlm.nih.gov/pubmed/19129748,SAD 250 mg fasted,Dapagliflozin,0,inf,h,13337,ng*h/mL,geo. mean,28,%,geo. CV,AUC_inf,2510,ng/mL,geo. mean,31,%,geo. CV,Cmax,,,,,,,,
663,Komoroski 2009,https://www.ncbi.nlm.nih.gov/pubmed/19129748,SAD 250 mg fed,Dapagliflozin,0,inf,h,12455,ng*h/mL,geo. mean,31,%,geo. CV,AUC_inf,1532,ng/mL,geo. mean,24,%,geo. CV,Cmax,,,,,,,,
5295,Iwamoto 2008,https://www.ncbi.nlm.nih.gov/pubmed/19143531,400mg FCT,Raltegravir,0,24,h,11,µmol*h/L,geo. mean,122,%,CV%,AUC_inf,2.88,µmol/L,geom.mean,184,µmol/L,CV%,Cmax,,,,,,,,
5296,Markowitz 2006,https://www.ncbi.nlm.nih.gov/pubmed/17133211,100mg FCT MD,Raltegravir,0,12,h,5.7,µmol*h/L,geo. mean,,,,AUC_tau,2.1,µmol/L,geom.mean,,,,,,,,,,,,90% CI and Range were reported (not filled in)
5297,Markowitz 2006,https://www.ncbi.nlm.nih.gov/pubmed/17133211,200mg FCT MD,Raltegravir,0,12,h,9.2,µmol*h/L,geo. mean,,,,AUC_tau,3.5,µmol/L,geom.mean,,,,,,,,,,,,90% CI and Range were reported (not filled in)
5298,Markowitz 2006,https://www.ncbi.nlm.nih.gov/pubmed/17133211,400mg FCT MD,Raltegravir,0,12,h,14.2,µmol*h/L,geo. mean,,,,AUC_tau,4.5,µmol/L,geom.mean,,,,,,,,,,,,90% CI and Range were reported (not filled in)
5299,Markowitz 2006,https://www.ncbi.nlm.nih.gov/pubmed/17133211,600mg FCT MD,Raltegravir,0,12,h,14.6,µmol*h/L,geo. mean,,,,AUC_tau,3.8,µmol/L,geom.mean,,,,,,,,,,,,90% CI and Range were reported (not filled in)
5300,Kassahun 2007,https://www.ncbi.nlm.nih.gov/pubmed/17591678,200mg FCT SD,Raltegravir,0,22,h,11.28,µmol*h/L,arith. Mean,4.36,µmol*h/L,arith. SD,AUC_tau,4.94,µmol/L,arith. mean,1.8,µmol/L,arith. SD,Cmax,,,,,,,,t_end a mean of 22 (from reported 20-24h) was inputed
5301,Rizk 2015,https://www.ncbi.nlm.nih.gov/pubmed/25753401,3.5m,Raltegravir,0,12,h,21.6,µmol*h/L,geo. mean,40,%,CV%,AUC_tend,,,,,,,,,,,,,,,
5302,Rizk 2015,https://www.ncbi.nlm.nih.gov/pubmed/25753401,15m,Raltegravir,0,12,h,19.8,µmol*h/L,geo. mean,34,%,CV%,AUC_tend,,,,,,,,,,,,,,,
5303,Nachmann 2013,https://www.ncbi.nlm.nih.gov/pubmed/24145879,Cohort 1,Raltegravir,0,12,h,10.2,mg*h/L,arith. Mean,10,mg*h/L,arith. SD,AUC_tend,2813.1,ng/mL,arith. mean,2673.9,ng/mL,arith. SD,Cmax,71.7,L/h,arith.mean,56.7,L/h,arith. SD,CL/F,"Other than Arithmatic mean, also median and Geomean with CV% are reported"
5304,Nachmann 2013,https://www.ncbi.nlm.nih.gov/pubmed/24145879,Cohort 2a,Raltegravir,0,12,h,13.4,mg*h/L,arith. Mean,16.1,mg*h/L,arith. SD,AUC_tend,4055.7,ng/mL,arith. mean,5269.5,ng/mL,arith. SD,Cmax,112.8,L/h,arith.mean,161.4,L/h,arith. SD,CL/F,"Other than Arithmatic mean, also median and Geomean with CV% are reported"
5305,Nachmann 2013,https://www.ncbi.nlm.nih.gov/pubmed/24145879,Cohort 2b,Raltegravir,0,12,h,10.5,mg*h/L,arith. Mean,3.5,mg*h/L,arith. SD,AUC_tend,5314.2,ng/mL,arith. mean,2842.6,ng/mL,arith. SD,Cmax,23.6,L/h,arith.mean,8.9,L/h,arith. SD,CL/F,"Other than Arithmatic mean, also median and Geomean with CV% are reported"
5306,Nachmann 2013,https://www.ncbi.nlm.nih.gov/pubmed/24145879,Cohort 3,Raltegravir,0,12,h,9.5,mg*h/L,arith. Mean,5.5,mg*h/L,arith. SD,AUC_tend,5204.8,ng/mL,arith. mean,2640.6,ng/mL,arith. SD,Cmax,13.3,L/h,arith.mean,10.1,L/h,arith. SD,CL/F,"Other than Arithmatic mean, also median and Geomean with CV% are reported"
5307,Larson 2013,https://www.ncbi.nlm.nih.gov/pubmed/24600298,3y,Raltegravir,0,12,h,18,µmol*h/L,geo. mean,59,%,CV%,AUC_tend,,,,,,,,,,,,,,,
5308,Larson 2013,https://www.ncbi.nlm.nih.gov/pubmed/24600298,9y,Raltegravir,0,12,h,22.6,µmol*h/L,geo. mean,34,%,CV%,AUC_tend,,,,,,,,,,,,,,,
5309,Larson 2013,https://www.ncbi.nlm.nih.gov/pubmed/24600298,10.5y,Raltegravir,0,12,h,15.8,µmol*h/L,geo. mean,120,%,CV%,AUC_tend,,,,,,,,,,,,,,,
5433,Larson 2013,https://www.ncbi.nlm.nih.gov/pubmed/24600298,15y,Raltegravir,0,12,h,15.7,µmol*h/L,geo. mean,98,%,CV%,AUC_tend,,,,,,,,,,,,,,,
5435,Rhee 2014,https://www.ncbi.nlm.nih.gov/pubmed/24608069,Chewable tablet fasted,Raltegravir,0,24,h,34.2,µmol*h/L,geo. mean,,,,AUC_inf,16.1,µmol/L,Geom.mean,,,,Cmax,,,,,,,,
5436,Rhee 2014,https://www.ncbi.nlm.nih.gov/pubmed/24608069,Chewable tablet fed,Raltegravir,0,24,h,32.3,µmol*h/L,geo. mean,,,,AUC_inf,6.14,µmol/L,Geom.mean,,,,Cmax,,,,,,,,
5437,Rhee 2014,https://www.ncbi.nlm.nih.gov/pubmed/24608069,granules suspension,Raltegravir,0,24,h,50.4,µmol*h/L,geo. mean,,,,AUC_inf,23.2,µmol/L,Geom.mean,,,,Cmax,,,,,,,,
5438,Rhee 2014,https://www.ncbi.nlm.nih.gov/pubmed/24608069,filmcoated tablet,Raltegravir,0,24,h,19.2,µmol*h/L,geo. mean,,,,AUC_inf,5,µmol/L,Geom.mean,,,,Cmax,,,,,,,,
5439,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",10mg ,Raltegravir,0,12,h,0.82,µmol*h/L,geo. mean,,,,AUC_inf,0.58,µmol/L,Geom.mean,,,,Cmax,51.62,mL/min,arith.mean,,,,,
5440,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",25mg,Raltegravir,0,12,h,1.69,µmol*h/L,geo. mean,,,,AUC_inf,1.17,µmol/L,Geom.mean,,,,Cmax,78.4,mL/min,arith.mean,,,,,
5441,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",50mg,Raltegravir,0,12,h,4.49,µmol*h/L,geo. mean,,,,AUC_inf,2.37,µmol/L,Geom.mean,,,,Cmax,53.92,mL/min,arith.mean,,,,,
5442,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",100mg,Raltegravir,0,12,h,6.12,µmol*h/L,geo. mean,,,,AUC_inf,2.75,µmol/L,Geom.mean,,,,Cmax,59,mL/min,arith.mean,,,,,
5443,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",200mg,Raltegravir,0,12,h,16.9,µmol*h/L,geo. mean,,,,AUC_inf,5.83,µmol/L,Geom.mean,,,,Cmax,46.53,mL/min,arith.mean,,,,,
5444,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",400mg,Raltegravir,0,12,h,24.61,µmol*h/L,geo. mean,,,,AUC_inf,10.63,µmol/L,Geom.mean,,,,Cmax,60.88,mL/min,arith.mean,,,,,
5445,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",800mg,Raltegravir,0,12,h,63.11,µmol*h/L,geo. mean,,,,AUC_inf,24.67,µmol/L,Geom.mean,,,,Cmax,48.52,mL/min,arith.mean,,,,,
5446,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",1200mg,Raltegravir,0,12,h,84.01,µmol*h/L,geo. mean,,,,AUC_inf,30.96,µmol/L,Geom.mean,,,,Cmax,42.22,mL/min,arith.mean,,,,,
5447,Iwamoto 2008,"https://www.ncbi.nlm.nih.gov/pubmed/17713476
",1600mg,Raltegravir,0,12,h,95.6,µmol*h/L,geo. mean,,,,AUC_inf,36.06,µmol/L,Geom.mean,,,,Cmax,43.52,mL/min,arith.mean,,,,,
5448,Wenning 2009,"https://www.ncbi.nlm.nih.gov/pubmed/19433563
",400mg ,Raltegravir,0,12,h,27.57,µmol*h/L,geo. mean,,,,AUC_inf,8.61,µmol/L,Geom.mean,,,,,,,,,,,,
592,Austin 1980,https://www.ncbi.nlm.nih.gov/pubmed/7437245,250 mg over 3 min (Regimen 1),Erythromycin,0,inf,h,,,,,,,,,,,,,,,26.3,L/h,arith. mean,7.5,L/h,arith. SD,CLiv,"CLiv=Cls total body clearance (serum). Cl_R = ""renal clearance"" also available: Avg: 3.4; Var: 2.4, Unit: l/h"
593,Austin 1980,https://www.ncbi.nlm.nih.gov/pubmed/7437245,125 mg over 15 min (Regimen 2),Erythromycin,0,inf,h,4.6,mg*h/L,arith. Mean,0.9,mg*h/L,arith. SD,AUC_inf,,,,,,,,28.1,L/h,arith. mean,5.9,L/h,arith. SD,CLiv,CLiv=Cls total body clearance (serum)
594,Austin 1980,https://www.ncbi.nlm.nih.gov/pubmed/7437245,250 mg over 15 min (Regimen 2),Erythromycin,0,inf,h,10.5,mg*h/L,arith. Mean,3,mg*h/L,arith. SD,AUC_inf,,,,,,,,28.9,L/h,arith. mean,14.4,L/h,arith. SD,CLiv,CLiv=Cls total body clearance (serum)
595,Austin 1980,https://www.ncbi.nlm.nih.gov/pubmed/7437245,500 mg over 15 min (Regimen 2),Erythromycin,0,inf,h,19.4,mg*h/L,arith. Mean,3.3,mg*h/L,arith. SD,AUC_inf,,,,,,,,25.3,L/h,arith. mean,4.3,L/h,arith. SD,CLiv,CLiv=Cls total body clearance (serum)
596,Austin 1980,https://www.ncbi.nlm.nih.gov/pubmed/7437245,900 mg over 15 min (Regimen 2),Erythromycin,0,inf,h,41,mg*h/L,arith. Mean,23.1,mg*h/L,arith. SD,AUC_inf,,,,,,,,26.3,L/h,arith. mean,11.8,L/h,arith. SD,CLiv,CLiv=Cls total body clearance (serum)
597,Barre 1987,https://www.ncbi.nlm.nih.gov/pubmed/3606934,"500 mg over 30 min, total concentrations",Erythromycin,0,inf,h,,,,,,,,,,,,,,,34.2,L/h,arith. mean,12.1,L/h,1 s.d.,CLiv,CLiv=CLt clearance of total drug (serum)
598,Barre 1987,https://www.ncbi.nlm.nih.gov/pubmed/3606934,"500 mg over 30 min, unbound concentrations",Erythromycin,0,inf,h,,,,,,,,,,,,,,,113.2,L/h,arith. mean,44.2,L/h,1 s.d.,Cliv_unbound,Cliv_unbound=CLu clearance of unbound drug (serum)
601,DiSanto 1981,https://www.ncbi.nlm.nih.gov/pubmed/7283417,"Overnight fast, enteric-coated erythromycin tablets (study 1) ",Erythromycin,0,14,h,4.88,µg*h/mL,arith. Mean,,,,AUC_tend,1.01,µg/mL,arith. Mean,,,,Cmax,,,,,,,,
602,DiSanto 1981,https://www.ncbi.nlm.nih.gov/pubmed/7283417,"2h fast, enteric-coated erythromycin tablets (study 2)",Erythromycin,0,12,h,4.96,µg*h/mL,arith. Mean,,,,AUC_tend,0.79,µg/mL,arith. Mean,,,,Cmax,,,,,,,,
603,Huppertz 2011,https://www.ncbi.nlm.nih.gov/pubmed/21274983,"Treatment group, erythromycin",Erythromycin,,,,,,,,,,,,,,,,,,,,,,,,,no data available
604,Iliopoulou 1982,https://www.ncbi.nlm.nih.gov/pubmed/7138734,"fourth day, before theophylline administration",Erythromycin,72,inf,h,7.2,µg*h/mL,arith. Mean,3.6,µg*h/mL,arith. SD,AUC_inf,1.45,µg/mL,arith. Mean,0.87,µg/mL,SEM,Cmax,,,,,,,,Cmax=observed maximum steady state serum concentration. Also available: AUC (0-8h) = 6.1 +/-3.2 µg*h/mL
609,Kavi 1988,https://www.ncbi.nlm.nih.gov/pubmed/3182434,Serum levels,Erythromycin,0,inf,h,7.3,mg*h/L,arith. Mean,3.9,mg*h/L,arith. SD,AUC_inf,2.1,mg/L,arith. Mean,1.2,mg/L,arith. SD,Cmax,,,,,,,,
610,Kroboth 1982,https://www.ncbi.nlm.nih.gov/pubmed/7081971,Normal subjects,Erythromycin,0,24,h,9,µg*h/mL,arith. Mean,5.9,µg*h/mL,arith. SD,AUC_tend,1.5,µg/mL,arith. mean,0.91,µg/mL,arith. SD,Cmax,,,,,,,,Also available: AUC (0-12h) = 7.4 +/- 5.1 µg*h/mL
611,Malmborg 1978,https://www.tandfonline.com/doi/abs/10.1185/03007997809110243,Single dose after overnight fast,Erythromycin,0,inf,h,5.6,µg*h/mL,arith. Mean,0.4,µg*h/mL,SEM,AUC_inf,1.3,µg/mL,arith. Mean,0.1,µg/mL,SEM,Cmax,,,,,,,,
612,Malmborg 1978,https://www.tandfonline.com/doi/abs/10.1185/03007997809110243,Single dose before standardized breakfast,Erythromycin,0,inf,h,7.4,µg*h/mL,arith. Mean,0.8,µg*h/mL,SEM,AUC_inf,2.8,µg/mL,arith. Mean,0.3,µg/mL,SEM,Cmax,,,,,,,,
613,Malmborg 1978,https://www.tandfonline.com/doi/abs/10.1185/03007997809110243,"Day 7, every 8 h",Erythromycin,168,inf,h,12.4,µg*h/mL,arith. Mean,1.7,µg*h/mL,SEM,AUC_inf,2.9,µg/mL,arith. Mean,0.5,µg/mL,SEM,Cmax,,,,,,,,
614,Miglioli 1990,https://www.ncbi.nlm.nih.gov/pubmed/2253666,"First dose, young subjects",Erythromycin,0,inf,h,29.1,mg*h/L,arith. mean,4.7,mg*h/L,SEM,AUC_inf,8,mg/L,arith. mean,1.3,mg/L,SEM,Cmax,0.64,L/h/kg,arith. Mean,0.14,L/h/kg,SEM,CL/F,
615,Miglioli 1990,https://www.ncbi.nlm.nih.gov/pubmed/2253666,"Seventh dose, young subjects",Erythromycin,72,84,h,25.1,mg*h/L,arith. mean,4.8,mg*h/L,SEM,AUC_tau,6.8,mg/L,arith. mean,0.7,mg/L,SEM,Cmax,0.69,L/h/kg,arith. Mean,0.11,L/h/kg,SEM,CL/F,
616,Pasic 1987,https://www.ncbi.nlm.nih.gov/pubmed/3604256,Without oral theophylline co-administration,Erythromycin,0,inf,h,,,,,,,,3.6,mg/L,arith. mean,1,mg/L,arith. SD,Cmax,,,,,,,,"Available serum concentration data in the text do not clearly state assignment of values to the ""with"" or ""without theophylline"" group. Given serum concentration values are: mean 3.5 ± 0.9 and 3.6 ± 1.0 mg/l. We assume the second mentioned value is the ""without theophylline"" group."
617,Posti 1983,https://www.sciencedirect.com/science/article/pii/0378517383900352,"Formulation A1 (film-coated tabet, ery stearate), fasted",Erythromycin,0,7.5,h,5.91,mg*h/L,arith. mean,2.17,mg*h/L,SD,AUC_tend,1.8,mg/L,arith. mean,0.7,mg/L,SD,Cmax,,,,,,,,
618,Posti 1983,https://www.sciencedirect.com/science/article/pii/0378517383900352,"Formulation E (enteric-coated tablets, ery base), fasted",Erythromycin,0,7.5,h,4.7,mg*h/L,arith. mean,2.21,mg*h/L,SD,AUC_tend,1.54,mg/L,arith. mean,0.7,mg/L,SD,Cmax,,,,,,,,
619,Posti 1983,https://www.sciencedirect.com/science/article/pii/0378517383900352,"Formulation A2 (film-coated tabet, ery stearate), study 2",Erythromycin,0,8,h,7.4,mg*h/L,arith. mean,5.57,mg*h/L,SD,AUC_tend,2.45,mg/L,arith. mean,1.63,mg/L,SD,Cmax,,,,,,,,
620,Posti 1983,https://www.sciencedirect.com/science/article/pii/0378517383900352,"Formulation RN (film-coated tabet, ery stearate), study 2",Erythromycin,0,8,h,11.55,mg*h/L,arith. mean,5.22,mg*h/L,SD,AUC_tend,3.5,mg/L,arith. mean,1.61,mg/L,SD,Cmax,,,,,,,,
621,Schreiner 1984,https://www.ncbi.nlm.nih.gov/pubmed/6511088,"Part I, stearate tablet",Erythromycin,0,inf,h,8.3,mg*h/L,arith. mean,0.8,mg*h/L,SE,AUC_inf,2,mg/L,arith. mean,0.3,mg/L,SE,Cmax,,,,,,,,"values are for N = 14, since 2 subjects were excluded, see column ""comment population"""
622,Schreiner 1984,https://www.ncbi.nlm.nih.gov/pubmed/6511088,"Part I, base (enteric-coated pellets)",Erythromycin,0,inf,h,10.6,mg*h/L,arith. mean,1.1,mg*h/L,SE,AUC_inf,1.5,mg/L,arith. mean,0.5,mg/L,SE,Cmax,,,,,,,,"values are for N = 14, since 2 subjects were excluded, see column ""comment population"""
623,Schreiner 1984,https://www.ncbi.nlm.nih.gov/pubmed/6511088,"Part II, stearate tablet",Erythromycin,0,inf,h,7.4,mg*h/L,arith. mean,1.2,mg*h/L,SE,AUC_inf,2.2,mg/L,arith. mean,0.4,mg/L,SE,Cmax,,,,,,,,
624,Schreiner 1984,https://www.ncbi.nlm.nih.gov/pubmed/6511088,"Part II, base (enteric-coated pellets)",Erythromycin,0,inf,h,8.8,mg*h/L,arith. mean,1.2,mg*h/L,SE,AUC_inf,1.5,mg/L,arith. mean,0.2,mg/L,SE,Cmax,,,,,,,,
625,Sun 2010,https://www.ncbi.nlm.nih.gov/pubmed/20090676,Subjects with normal renal function,Erythromycin,0,inf,h,3580,µg*h/L,arith. mean,1020,µg*h/L,SD,AUC_inf,,,,,,,,0.53,L/h/kg,arith. mean,0.13,L/h/kg,SD,CL/F,CL=total clearance; Also available: AUC adjusted by dose weight: AUC/D (mean ± SD): 1.89 ± 0.54 kg*h/L; Renal clearance: CLr (mean ± SD): 0.03 ± 0.01  L/h/kg; Hepatic clearance: CLh (mean ± SD): 0.51 ± 0.13 L/h/kg
626,Yakatan 1980,https://www.ncbi.nlm.nih.gov/pubmed/7229110,"Stearate, single dose",Erythromycin,0,12,h,3.9,µg*h/mL,arith. mean,3.53,µg*h/mL,SD,AUC_tend,1.01,µg/mL,arith. mean,1.1,µg/mL,SD,Cmax,,,,,,,,"discrepancy in Cmax value within the paper: in text and table II 1.01 ± 1.10 µg/ml, but in table III: 1.28 ± 1.12 µg/ml"
627,Yakatan 1980,https://www.ncbi.nlm.nih.gov/pubmed/7229110,"Stearate, five doses, every 6 h",Erythromycin,0,inf,h,16.03,µg*h/mL,arith. mean,,,,AUC_inf,1.51,µg/mL,arith. mean,0.96,µg/mL,SD,Cmax,,,,,,,,Mean AUC (dose 1+2+3+5) taken from table VI. Cmax taken from PK time profile. The fourth-dose AUC was not included as samples were not drawn during that dosing interval.
628,Yakatan 1980,https://www.ncbi.nlm.nih.gov/pubmed/7229110,"Base, five doses, every 6 h",Erythromycin,0,inf,h,24.44,µg*h/mL,arith. mean,,,,AUC_inf,1.81,µg/mL,arith. mean,1.49,µg/mL,SD,Cmax,,,,,,,,Mean AUC (dose 1+2+3+5) taken from table VI. Cmax taken from PK time profile. The fourth-dose AUC was not included as samples were not drawn during that dosing interval.
599,Birkett 1990,https://www.ncbi.nlm.nih.gov/pubmed/2305423,"250 mg erythromycin, single dose",Erythromycin,0,inf,h,4.68,mg*h/L,arith. mean,1.99,mg*h/L,SD,AUC_inf,1.74,mg/L,arith. mean,0.9,mg/L,SD,Cmax,,,,,,,,
600,Birkett 1990,https://www.ncbi.nlm.nih.gov/pubmed/2305423,"250 mg erythromycin, multiple dose",Erythromycin,96,102,h,10.83,mg*h/L,arith. mean,3.38,mg*h/L,SD,AUC_tau,2.87,mg/L,arith. mean,0.83,mg/L,SD,Cmax,,,,,,,,
605,Josefsson 1982a,https://www.ncbi.nlm.nih.gov/pubmed/7082537,erythromycin base 250 mg,Erythromycin,0,inf,h,4.5,mg*h/L,arith. Mean,1.7,mg*h/L,arith. SD,AUC_inf,1.9,mg/L,arith. mean,0.8,mg/L,arith. SD,Cmax,3,L/h,arith. mean,1.2,L/h,arith. SD,CL/F,"AUC calculated with the trapezoidal rule; 23 subjects, 21 in the 250 mg group. CL/F=renal clearance
Also available: AUC calculated with AUTOAN 2/NONLIN program (same unit): 250: 5.4 +/-3.4; 500: 13.2 +/-4.1; 1000: 28.6 +/-11.2; 500 (stearate): 8.0 +/-36
Cl_R: renal clearance"
606,Josefsson 1982a,https://www.ncbi.nlm.nih.gov/pubmed/7082537,erythromycin base 500 mg,Erythromycin,0,inf,h,11.2,mg*h/L,arith. Mean,4.3,mg*h/L,arith. SD,AUC_inf,3.8,mg/L,arith. mean,1.4,mg/L,arith. SD,Cmax,3.5,L/h,arith. mean,1.6,L/h,arith. SD,CL/F,"AUC calculated with the trapezoidal rule; 23 subjects, 21 in the 250 mg group.
Also available: AUC calculated with AUTOAN 2/NONLIN program (same unit): 250: 5.4 +/-3.4; 500: 13.2 +/-4.1; 1000: 28.6 +/-11.2; 500 (stearate): 8.0 +/-36
Cl_R: renal clearance"
607,Josefsson 1982a,https://www.ncbi.nlm.nih.gov/pubmed/7082537,erythromycin base 1000 mg,Erythromycin,0,inf,h,27.2,mg*h/L,arith. Mean,10.6,mg*h/L,arith. SD,AUC_inf,6.5,mg/L,arith. mean,2.9,mg/L,arith. SD,Cmax,2.9,L/h,arith. mean,1.4,L/h,arith. SD,CL/F,"AUC calculated with the trapezoidal rule; 23 subjects, 21 in the 250 mg group.
Also available: AUC calculated with AUTOAN 2/NONLIN program (same unit): 250: 5.4 +/-3.4; 500: 13.2 +/-4.1; 1000: 28.6 +/-11.2; 500 (stearate): 8.0 +/-36
Cl_R: renal clearance"
608,Josefsson 1982a,https://www.ncbi.nlm.nih.gov/pubmed/7082537,erythromycin stearate 500 mg (base equivalent),Erythromycin,0,inf,h,7.5,mg*h/L,arith. Mean,3.4,mg*h/L,arith. SD,AUC_inf,2.9,mg/L,arith. mean,1.7,mg/L,arith. SD,Cmax,2.7,L/h,arith. mean,1.1,L/h,arith. SD,CL/F,"AUC calculated with the trapezoidal rule; 23 subjects, 21 in the 250 mg group.
Also available: AUC calculated with AUTOAN 2/NONLIN program (same unit): 250: 5.4 +/-3.4; 500: 13.2 +/-4.1; 1000: 28.6 +/-11.2; 500 (stearate): 8.0 +/-36
Cl_R: renal clearance"
758,Ferrier 1985,https://www.ncbi.nlm.nih.gov/pubmed/3920934,healthy control patients,Alfentanil,,,h,,,,,,,,,,,,,,,3.1,mL/min/kg,arith. mean,1.3,mL/min/kg,arith. SD,CL/F,
759,Ferrier 1985,https://www.ncbi.nlm.nih.gov/pubmed/3920934,cirrhosis patients patients,Alfentanil,,,h,,,,,,,,,,,,,,,1.5,mL/min/kg,arith. mean,1,mL/min/kg,arith. SD,CL/F,
760,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Control sequential,Alfentanil,,,h,59,ng*h/mL,arith. Mean,27,ng*h/mL,arith. SD,AUC_inf,80,ng/mL,arith. mean,40,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
761,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Grapefruit coadmin sequential,Alfentanil,,,h,57,ng*h/mL,arith. Mean,30,ng*h/mL,arith. SD,AUC_inf,59,ng/mL,arith. mean,31,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
762,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Ketoconazole coadmin sequential,Alfentanil,,,h,145.5,ng*h/mL,arith. Mean,79.5,ng*h/mL,arith. SD,AUC_inf,36.5,ng/mL,arith. mean,9.5,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
763,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Rifampin coadmin sequential,Alfentanil,,,h,21,ng*h/mL,arith. Mean,8,ng*h/mL,arith. SD,AUC_inf,54,ng/mL,arith. mean,10,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
764,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Control simultaneous,Alfentanil,,,h,51,ng*h/mL,arith. Mean,19,ng*h/mL,arith. SD,AUC_inf,58,ng/mL,arith. mean,15,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
765,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Grapefruit coadmin simultaneous,Alfentanil,,,h,58,ng*h/mL,arith. Mean,22,ng*h/mL,arith. SD,AUC_inf,55,ng/mL,arith. mean,12,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
766,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Ketoconazole coadmin simultaneous,Alfentanil,,,h,151,ng*h/mL,arith. Mean,122,ng*h/mL,arith. SD,AUC_inf,36.5,ng/mL,arith. mean,13,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
767,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil IV Rifampin coadmin simultaneous,Alfentanil,,,h,18,ng*h/mL,arith. Mean,3,ng*h/mL,arith. SD,AUC_inf,57,ng/mL,arith. mean,8,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
768,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Control sequential,Alfentanil,,,h,108,ng*h/mL,arith. Mean,68,ng*h/mL,arith. SD,AUC_inf,48,ng/mL,arith. mean,24,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
769,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Grapefruit coadmin sequential,Alfentanil,,,h,180,ng*h/mL,arith. Mean,108,ng*h/mL,arith. SD,AUC_inf,52,ng/mL,arith. mean,28,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
770,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Ketoconazole coadmin sequential,Alfentanil,,,h,253,ng*h/mL,arith. Mean,178,ng*h/mL,arith. SD,AUC_inf,33,ng/mL,arith. mean,10,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
771,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Rifampin coadmin sequential,Alfentanil,,,h,6.4,ng*h/mL,arith. Mean,3.2,ng*h/mL,arith. SD,AUC_inf,6,ng/mL,arith. mean,3.6,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
772,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Control simultaneous,Alfentanil,,,h,88,ng*h/mL,arith. Mean,56,ng*h/mL,arith. SD,AUC_inf,28.4,ng/mL,arith. mean,12,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
773,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Grapefruit coadmin simultaneous,Alfentanil,,,h,184,ng*h/mL,arith. Mean,84,ng*h/mL,arith. SD,AUC_inf,52,ng/mL,arith. mean,36,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
774,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Ketoconazole coadmin simultaneous,Alfentanil,,,h,298,ng*h/mL,arith. Mean,255,ng*h/mL,arith. SD,AUC_inf,36,ng/mL,arith. mean,20,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
775,Kharasch 2011b,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584707/,Alfentanil PO Rifampin coadmin simultaneous,Alfentanil,,,h,4.4,ng*h/mL,arith. Mean,2,ng*h/mL,arith. SD,AUC_inf,3.6,ng/mL,arith. mean,2,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax/D and AUC/D is reported, in this table, these PK parameter values are multiplied with dose"
2014,Chen 2006,https://www.ncbi.nlm.nih.gov/pubmed/16842393,Midazolam post treatment with fluvoxamine (28 days of fluvoxamine) Male,Midazolam,336,inf,h,,,,,,,,,,,,,,,4.7,mL/min/kg,arith. Mean,0.9,mL/min/kg,arith. SD,CLiv,Values were pooled of visits 78 for each subject. 
2015,Chen 2006,https://www.ncbi.nlm.nih.gov/pubmed/16842393,Midazolam at baseline female,Midazolam,0,inf,h,,,,,,,,,,,,,,,8.1,mL/min/kg,arith. Mean,2.4,mL/min/kg,arith. SD,CLiv,Values were pooled of visits 16 for each subject.
2016,Chen 2006,https://www.ncbi.nlm.nih.gov/pubmed/16842393,Midazolam post treatment with fluvoxamine (28 days of fluvoxamine) female,Midazolam,336,inf,h,,,,,,,,,,,,,,,5.9,mL/min/kg,arith. Mean,2.7,mL/min/kg,arith. SD,CLiv,Values were pooled of visits 78 for each subject. 
2034,Kim 2018,https://www.ncbi.nlm.nih.gov/pubmed/28877336,Midazolam alone Male,Midazolam,0,inf,h,36.21,ng*h/mL,arith. Mean,11.47,ng*h/mL,arith. SD,AUC_inf,,,,,,,,30.8,L/h,arith. Mean,9.04,L/h,arith. Mean,CLiv,AUCinf corrected to match unit of ng*h/mL
2035,Kim 2018,https://www.ncbi.nlm.nih.gov/pubmed/28877336,Midazolam + Ketoconazole Male,Midazolam,72,inf,h,102.54,ng*h/mL,arith. Mean,22.48,ng*h/mL,arith. SD,AUC_inf,,,,,,,,10.26,L/h,arith. Mean,2.59,L/h,arith. Mean,CLiv,AUCinf corrected to match unit of ng*h/mL
2036,Kim 2018,https://www.ncbi.nlm.nih.gov/pubmed/28877336,Midazolam + Rifampicin Male,Midazolam,216,inf,h,40.375,ng*h/mL,arith. Mean,7.7,ng*h/mL,arith. SD,AUC_inf,,,,,,,,64.16,L/h,arith. Mean,12.44,L/h,arith. Mean,CLiv,AUCinf corrected to match unit of ng*h/mL
2037,Kim 2018,https://www.ncbi.nlm.nih.gov/pubmed/28877336,Midazolam alone Female,Midazolam,0,inf,h,43.22,ng*h/mL,arith. Mean,8.29,ng*h/mL,arith. SD,AUC_inf,,,,,,,,23.1,L/h,arith. Mean,4.26,L/h,arith. Mean,CLiv,AUCinf corrected to match unit of ng*h/mL
2038,Kim 2018,https://www.ncbi.nlm.nih.gov/pubmed/28877336,Midazolam + Ketoconazole Female,Midazolam,72,inf,h,211.58,ng*h/mL,arith. Mean,42.97,ng*h/mL,arith. SD,AUC_inf,,,,,,,,5.01,L/h,arith. Mean,1.19,L/h,arith. Mean,CLiv,AUCinf corrected to match unit of ng*h/mL
2039,Kim 2018,https://www.ncbi.nlm.nih.gov/pubmed/28877336,Midazolam + Rifampicin Female,Midazolam,216,inf,h,53.9,ng*h/mL,arith. Mean,9.5,ng*h/mL,arith. SD,AUC_inf,,,,,,,,47.8,L/h,arith. Mean,9.05,L/h,arith. Mean,CLiv,AUCinf corrected to match unit of ng*h/mL
2008,Gashaw 2003,https://www.ncbi.nlm.nih.gov/pubmed/?term=14586385,"Alprazolam 10h concentration before Rifampin treatment (control conditions, day 2)",Alprazolam,0,inf,h,,,,,,,,,,,,,,,3.3,L/h,arith. mean,0.8,L/h,arith. SD,CL/F,"No Cmax available, only 10-h concentration values in plasma (µg/L) in mean (SD) given: 8.4 (1.9); CL= estimated oral clearance: CLoral (L/h) = Dose (mg)/[0.038 * Plasma alprazolam concentration10h (µg/L)  0.001]"
2009,Gashaw 2003,https://www.ncbi.nlm.nih.gov/pubmed/?term=14586385,"Alprazolam 10h concentration after Rifampin treatment (5 day rifampin treatment, day 7)",Alprazolam,100,inf,h,,,,,,,,,,,,,,,18.4,L/h,arith. mean,10.9,L/h,arith. SD,CL/F,"No Cmax available, only 10-h concentration values in plasma (µg/L) in mean (SD) given: 1.8 (0.8); CL= estimated oral clearance: CLoral (L/h) = Dose (mg)/[0.038 * Plasma alprazolam concentration10h (µg/L)  0.001]"
2010,Gashaw 2003,https://www.ncbi.nlm.nih.gov/pubmed/?term=14586385,Alprazolam 10h concentration after wash out (day 22),Alprazolam,436,inf,h,,,,,,,,,,,,,,,3.6,L/h,arith. mean,0.9,L/h,arith. SD,CL/F,"No Cmax available, only 10-h concentration values in plasma (µg/L) in mean (SD) given: 7.8 (1.9); CL= estimated oral clearance: CLoral (L/h) = Dose (mg)/[0.038 * Plasma alprazolam concentration10h (µg/L)  0.001]"
2019,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Control iv Midazolam Female,Midazolam,0,inf,h,118,µg*h/L,arith. Mean,"96, 140",µg*h/L,95% CI,AUC_inf,58,µg/L,arith. Mean,"48, 68",µg/L,95% CI,Cmax,36,L/h,arith. Mean,"29.5, 42.8",L/h,95% CI,CLiv,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2020,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Control iv Midazolam Male,Midazolam,0,inf,h,142,µg*h/L,arith. Mean,"112, 171",µg*h/L,95% CI,AUC_inf,59,µg/L,arith. Mean,"53, 64",µg/L,95% CI,Cmax,30.4,L/h,arith. Mean,"24.5, 36.3",L/h,95% CI,CLiv,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2021,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Control iv Midazolam All,Midazolam,0,inf,h,130,µg*h/L,arith. Mean,"111, 149",µg*h/L,95% CI,AUC_inf,58,µg/L,arith. Mean,"53, 64",µg/L,95% CI,Cmax,33.2,L/h,arith. Mean,"28.7, 37.8",L/h,95% CI,CLiv,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2022,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Control po Midazolam Female,Midazolam,0,inf,h,46,µg*h/L,arith. Mean,"27, 65",µg*h/L,95% CI,AUC_inf,12,µg/L,arith. Mean,"7.2, 17",µg/L,95% CI,Cmax,124,L/h,arith. Mean,"71, 177",L/h,95% CI,CL/F,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2023,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Control po Midazolam Male,Midazolam,0,inf,h,48,µg*h/L,arith. Mean,"21, 75",µg*h/L,95% CI,AUC_inf,12,µg/L,arith. Mean,"8.0, 15",µg/L,95% CI,Cmax,119,L/h,arith. Mean,"76, 161",L/h,95% CI,CL/F,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2024,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Control po Midazolam All,Midazolam,0,inf,h,47,µg*h/L,arith. Mean,"31, 63",µg*h/L,95% CI,AUC_inf,12,µg/L,arith. Mean,"9.0, 15",µg/L,95% CI,Cmax,121,L/h,arith. Mean,"88, 154",L/h,95% CI,CL/F,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2025,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,iv Midazolam Female after clarithromycin,Midazolam,146,inf,h,409,µg*h/L,arith. Mean,"311, 507",µg*h/L,95% CI,AUC_inf,70,µg/L,arith. Mean,"54, 85",µg/L,95% CI,Cmax,10.6,L/h,arith. Mean,"8.6, 12.6",L/h,95% CI,CLiv,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2026,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,iv Midazolam Male after clarithromycin,Midazolam,146,inf,h,397,µg*h/L,arith. Mean,"291, 503",µg*h/L,95% CI,AUC_inf,66,µg/L,arith. Mean,"50, 82",µg/L,95% CI,Cmax,12.4,L/h,arith. Mean,"7.0, 17.9",L/h,95% CI,CLiv,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2027,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,iv Midazolam All after clarithromycin,Midazolam,146,inf,h,403,µg*h/L,arith. Mean,"333, 473",µg*h/L,95% CI,AUC_inf,68,µg/L,arith. Mean,"57, 79",µg/L,95% CI,Cmax,11.5,L/h,arith. Mean,"8.7, 14.4",L/h,95% CI,CLiv,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2028,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,po Midazolam Female after clarithromycin,Midazolam,146,inf,h,304,µg*h/L,arith. Mean,"183, 426",µg*h/L,95% CI,AUC_inf,34,µg/L,arith. Mean,"28, 40",µg/L,95% CI,Cmax,16.2,L/h,arith. Mean,"11.6, 20.7",L/h,95% CI,CL/F,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2029,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,po Midazolam Male after clarithromycin,Midazolam,146,inf,h,290,µg*h/L,arith. Mean,"205, 375",µg*h/L,95% CI,AUC_inf,31,µg/L,arith. Mean,"27, 35",µg/L,95% CI,Cmax,18.6,L/h,arith. Mean,"9.2, 28.0",L/h,95% CI,CL/F,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2030,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,po Midazolam All after clarithromycin,Midazolam,146,inf,h,297,µg*h/L,arith. Mean,"226, 369",µg*h/L,95% CI,AUC_inf,33,µg/L,arith. Mean,"29, 36",µg/L,95% CI,Cmax,17.4,L/h,arith. Mean,"12.3, 22.5",L/h,95% CI,CL/F,The concentrations were normalized to a midazolam dose of 4mg for all individuals.
2031,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,Clarithromycin,Clarithromycin,144,156,h,38.7,µmol*h/L,arith. Mean,"33.0, 44.4",µmol*h/L,95% CI,AUC_tau,,,,,,,,10.9,L/h,arith. Mean,"8.5, 13.2",L/h,95% CI,CL/F,AUC unit displayed in the paper is: AUC0-12 ( µM h-1) - no available unit present in dropdown here
2032,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,14-hydroxyclarithromycin,14-hydroxyclarithromycin,144,156,h,5.7,µmol*h/L,arith. Mean,"4.9, 6.6",µmol*h/L,95% CI,AUC_tau,,,,,,,,,,,,,,,AUC unit displayed in the paper is: AUC0-12 ( µM h-1) - no available unit present in dropdown here
2033,Quinney 2008,https://www.ncbi.nlm.nih.gov/pubmed/17635500,N-desmethylclarithromycin,N-desmethylclarithromycin,144,156,h,5.5,µmol*h/L,arith. Mean,"4.0, 7.0",µmol*h/L,95% CI,AUC_tau,,,,,,,,,,,,,,,AUC unit displayed in the paper is: AUC0-12 ( µM h-1) - no available unit present in dropdown here
2000,van Dyk 2018,https://www.ncbi.nlm.nih.gov/pubmed/29572563,Midazolam in Caucasian at baseline ,Midazolam,0,6,h,1057,µg*min/L,geom. Mean,880-1270,µg*min/L,95% CI,AUC_tend,7.2,µg/L,geom. Mean,5.5-8.9,µg/L,95% CI,Cmax,,,,,,,,
2001,van Dyk 2018,https://www.ncbi.nlm.nih.gov/pubmed/29572563,Midazolam in South Asian at baseline,Midazolam,0,6,h,768,µg*min/L,geom. Mean,648-1037,µg*min/L,95% CI,AUC_tend,5.5,µg/L,geom. Mean,4.3-6.8,µg/L,95% CI,Cmax,,,,,,,,
2002,van Dyk 2018,https://www.ncbi.nlm.nih.gov/pubmed/29572563,Midazolam in Caucasian following 7d of Rifampicin (between day 1 and 8),Midazolam,156,162,h,308,µg*min/L,geom. Mean,150-464,µg*min/L,95% CI,AUC_tend,2.7,µg/L,geom. Mean,1.7-3.6,µg/L,95% CI,Cmax,,,,,,,,
2003,van Dyk 2018,https://www.ncbi.nlm.nih.gov/pubmed/29572563,Midazolam in South Asian following 7d of Rifampicin (between day 1 and 8),Midazolam,156,162,h,154,µg*min/L,geom. Mean,74-234,µg*min/L,95% CI,AUC_tend,1.2,µg/L,geom. Mean,0.7-1.7,µg/L,95% CI,Cmax,,,,,,,,
2004,van Dyk 2018,https://www.ncbi.nlm.nih.gov/pubmed/29572563,Midazolam in Caucasian following 3d of Clarithromycin (between day 12 and 14),Midazolam,72,78,h,1834,µg*min/L,geom. Mean,1209-2460,µg*min/L,95% CI,AUC_tend,12.6,µg/L,geom. Mean,7.6-17.7,µg/L,95% CI,Cmax,,,,,,,,
2005,van Dyk 2018,https://www.ncbi.nlm.nih.gov/pubmed/29572563,Midazolam in South Asian following 3d of Clarithromycin (between day 12 and 14),Midazolam,72,78,h,1079,µg*min/L,geom. Mean,"632, 1526",µg*min/L,95% CI,AUC_tend,8.3,µg/L,geom. Mean,"4.6, 11.9",µg/L,95% CI,Cmax,,,,,,,,
2006,Kashuba 1998,https://www.ncbi.nlm.nih.gov/pubmed/9757149,Midazolam at baseline,Midazolam,0,inf,h,,,,,,,,,,,,,,,0.0081,L/min/kg,arith. Mean,0.0024,L/min/kg,arith. SD,CLiv,Mean ± SD of six measures (visit 1-6)
2007,Kashuba 1998,https://www.ncbi.nlm.nih.gov/pubmed/9757149,Midazolam after Fluvoxamine,Midazolam,339,inf,h,,,,,,,,,,,,,,,0.0054,L/min/kg,arith. Mean,0.0021,L/min/kg,arith. SD,CLiv,Mean ± SD of two measures (visit 7-8)
749,Schmider 1999,https://www.ncbi.nlm.nih.gov/pubmed/10634135,Alprazolam alone,Alprazolam,0,inf,h,242.2,µg*h/L,arith. Mean,37.9,µg*h/L,SE,AUC_inf,15.2,µg/L,arith. Mean,1.5,µg/L,SE,Cmax,1.1,mL/min/kg,arith. Mean,0.1,mL/min/kg,SE,CL/F,CL = CL_(oral/kg)
1001,Schmider 1999,https://www.ncbi.nlm.nih.gov/pubmed/10634135,Alprazolam + Rifampin,Alprazolam,96,inf,h,28.4,µg*h/L,arith. Mean,3.4,µg*h/L,SE,AUC_inf,9.7,µg/L,arith. Mean,2.6,µg/L,SE,Cmax,8.3,mL/min/kg,arith. Mean,1.6,mL/min/kg,SE,CL/F,CL = CL_(oral/kg)
1002,Schmider 1999,https://www.ncbi.nlm.nih.gov/pubmed/10634135,Alprazolam + Ketoconazole,Alprazolam,48,inf,h,426.2,µg*h/L,arith. Mean,43.1,µg*h/L,SE,AUC_inf,16.4,µg/L,arith. Mean,2.9,µg/L,SE,Cmax,0.6,mL/min/kg,arith. Mean,0.1,mL/min/kg,SE,CL/F,CL = CL_(oral/kg)
726,Villikka 1997,https://www.ncbi.nlm.nih.gov/pubmed/9024169,Triazolam + placebo,Triazolam,0,inf,h,14.8,ng*h/mL,arith. Mean,1,ng*h/mL,SEM,AUC_inf,2.9,ng/mL,arith. Mean,0.2,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-10) (mean +/- SEM in ng*h/ml): 13.2 +/- 0.9
1004,Villikka 1997,https://www.ncbi.nlm.nih.gov/pubmed/9024169,"Treatment arm (pretreatment with rifampin, 600 mg, 5 days)",Triazolam,113,inf,h,0.74,ng*h/mL,arith. Mean,0.14,ng*h/mL,SEM,AUC_inf,0.36,ng/mL,arith. Mean,0.06,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-10) (mean +/- SEM in ng*h/ml): 0.74 +/- 0.14
1025,Yasui 1998,https://www.ncbi.nlm.nih.gov/pubmed/9784084,Alprazolam with placebo,Alprazolam,0,inf,h,252,ng*h/mL,arith. Mean,47,ng*h/mL,arith. SD,AUC_inf,12.9,ng/mL,arith. mean,2.3,ng/mL,arith. SD,Cmax,0.89,mL/min/kg,arith. Mean,0.21,mL/min/kg,arith. SD,CL/F,Also available: AUC(0-48): (mean ± SD in ng*h/ml): 221 ± 33
1026,Yasui 1998,https://www.ncbi.nlm.nih.gov/pubmed/9784084,Alprazolam with itraconazole,Alprazolam,73,inf,h,671,ng*h/mL,arith. Mean,205,ng*h/mL,arith. SD,AUC_inf,16.6,ng/mL,arith. mean,5.2,ng/mL,arith. SD,Cmax,0.35,mL/min/kg,arith. Mean,0.1,mL/min/kg,arith. SD,CL/F,Also available: AUC(0-48): (mean ± SD in ng*h/ml): 357 ± 69
1077,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,Control phase (Triazolam without Itraconazole),Triazolam,0,inf,h,12.3,ng*h/mL,arith. Mean,0.8,ng*h/mL,SEM,AUC_inf,1.7,ng/mL,arith. mean,0.1,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-17) (mean ± SEM in ng*h/ml): 11.5 ± 0.7
1078,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,Treatment phase (triazolam + ITZ simultaneously),Triazolam,0,inf,h,38.2,ng*h/mL,arith. Mean,3.7,ng*h/mL,SEM,AUC_inf,2.4,ng/mL,arith. mean,0.1,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-17) (mean ± SEM in ng*h/ml): 24.1 ± 1.2
1079,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,Treatment phase (triazolam + ITZ 3 hr before),Triazolam,3,inf,h,55.1,ng*h/mL,arith. Mean,5.7,ng*h/mL,SEM,AUC_inf,3,ng/mL,arith. mean,0.2,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-17) (mean ± SEM in ng*h/ml): 32.5 ± 2.3
1080,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,Treatment phase (triazolam + ITZ 12 hr before),Triazolam,12,inf,h,53.2,ng*h/mL,arith. Mean,6.2,ng*h/mL,SEM,AUC_inf,3,ng/mL,arith. mean,0.2,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-17) (mean ± SEM in ng*h/ml): 33.7 ± 2.9
1081,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,Treatment phase (triazolam + ITZ 24 hr before),Triazolam,24,inf,h,43.9,ng*h/mL,arith. Mean,4.3,ng*h/mL,SEM,AUC_inf,2.9,ng/mL,arith. mean,0.2,ng/mL,SEM,Cmax,,,,,,,,Also available: AUC(0-17) (mean ± SEM in ng*h/ml): 29.6 ± 9.5
1082,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,ITZ simultaneously with triazolam,Itraconazole,0,17,h,897,ng*h/mL,arith. Mean,79,ng*h/mL,SEM,AUC_tend,98.9,ng/mL,arith. mean,8.3,ng/mL,SEM,Cmax,,,,,,,,
1083,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,ITZ 3 hr before triazolam,Itraconazole,3,20,h,1634,ng*h/mL,arith. Mean,279,ng*h/mL,SEM,AUC_tend,175,ng/mL,arith. mean,30,ng/mL,SEM,Cmax,,,,,,,,
1084,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,ITZ 12 hr before triazolam,Itraconazole,12,29,h,528,ng*h/mL,arith. Mean,78,ng*h/mL,SEM,AUC_tend,55.2,ng/mL,arith. mean,8.5,ng/mL,SEM,Cmax,,,,,,,,
1085,Neuvonen 1996,https://www.ncbi.nlm.nih.gov/pubmed/8841155,ITZ 24 hr before triazolam,Itraconazole,24,41,h,499,ng*h/mL,arith. Mean,77,ng*h/mL,SEM,AUC_tend,45.3,ng/mL,arith. mean,6.8,ng/mL,SEM,Cmax,,,,,,,,
1086,Lam 2003,https://www.ncbi.nlm.nih.gov/pubmed/14551182,Midazolam before Ketoconazole,Midazolam,0,inf,h,195,ng*h/mL,arith. Mean,115,ng*h/mL,arith. SD,AUC_inf,64.7,ng/mL,arith. Mean,32.3,ng/mL,arith. SD,Cmax,78.4,L/h,arith. Mean,58.2,L/h,arith. SD,CL/F,
1087,Lam 2003,https://www.ncbi.nlm.nih.gov/pubmed/14551182,Midazolam after Ketoconazole,Midazolam,265,inf,h,1280,ng*h/mL,arith. Mean,617,ng*h/mL,arith. SD,AUC_inf,193,ng/mL,arith. Mean,55.1,ng/mL,arith. SD,Cmax,9.5,L/h,arith. Mean,4.3,L/h,arith. SD,CL/F,
1088,Lam 2003,https://www.ncbi.nlm.nih.gov/pubmed/14551182,Midazolam before Fluvoxamine,Midazolam,0,inf,h,203,ng*h/mL,arith. Mean,136,ng*h/mL,arith. SD,AUC_inf,85,ng/mL,arith. Mean,33.5,ng/mL,arith. SD,Cmax,69.2,L/h,arith. Mean,36.4,L/h,arith. SD,CL/F,
1089,Lam 2003,https://www.ncbi.nlm.nih.gov/pubmed/14551182,Midazolam after Fluvoxamine,Midazolam,265,inf,h,283,ng*h/mL,arith. Mean,129,ng*h/mL,arith. SD,AUC_inf,117,ng/mL,arith. Mean,56.6,ng/mL,arith. SD,Cmax,43,L/h,arith. Mean,20.6,L/h,arith. SD,CL/F,
1090,Shin 2013,https://www.ncbi.nlm.nih.gov/pubmed/23784264,Control phase (Midazolam alone),Midazolam,0,inf,h,36.21,µg*h/L,arith. Mean,11.47,µg*h/L,arith. SD,AUC_inf,,,,,,,,30.08,L/h,arith. Mean,9.04,L/h,arith. SD,CLiv,AUCinf is given as AUCinf/dose in µg*h/L/mg in the paper - value multuiplied by dose; CL (determined as dose/AUCinf)
1091,Shin 2013,https://www.ncbi.nlm.nih.gov/pubmed/23784264,CYP3A4 inhibited phase (Midazolam + ketoconazole),Midazolam,73,inf,h,102.54,µg*h/L,arith. Mean,22.48,µg*h/L,arith. SD,AUC_inf,,,,,,,,10.26,L/h,arith. Mean,2.59,L/h,arith. SD,CLiv,AUCinf is given as AUCinf/dose in µg*h/L/mg in the paper - value multuiplied by dose; CL (determined as dose/AUCinf)
1092,Shin 2013,https://www.ncbi.nlm.nih.gov/pubmed/23784264,CYP3A4 induced phase (Midazolam + rifampicin),Midazolam,216,inf,h,40.375,µg*h/L,arith. Mean,7.7,µg*h/L,arith. SD,AUC_inf,,,,,,,,64.16,L/h,arith. Mean,12.44,L/h,arith. SD,CLiv,AUCinf is given as AUCinf/dose in µg*h/L/mg in the paper - value multuiplied by dose; CL (determined as dose/AUCinf)
1093,Shin 2016,https://www.ncbi.nlm.nih.gov/pubmed/27317471,Midazolam alone,Midazolam,0,inf,h,42.7,µg*h/L,arith. Mean,8.76,µg*h/L,arith. SD,AUC_inf,28.1,ng/mL,arith. Mean,3.11,ng/mL,arith. SD,Cmax,23.1,L/h,arith. Mean,4.26,L/h,arith. SD,CLiv,AUCinf is given as AUCinf/dose in µg*h/L/mg in the paper - value multuiplied by dose; CL (determined as dose/AUCinf)
1094,Shin 2016,https://www.ncbi.nlm.nih.gov/pubmed/27317471,Midazolam + ketoconazole,Midazolam,73,inf,h,204.2,µg*h/L,arith. Mean,43.1,µg*h/L,arith. SD,AUC_inf,40.7,ng/mL,arith. Mean,3.19,ng/mL,arith. SD,Cmax,5.01,L/h,arith. Mean,1.19,L/h,arith. SD,CLiv,AUCinf is given as AUCinf/dose in µg*h/L/mg in the paper - value multuiplied by dose; CL (determined as dose/AUCinf)
1095,Shin 2016,https://www.ncbi.nlm.nih.gov/pubmed/27317471,Midazolam + rifampicin,Midazolam,216,inf,h,52.25,µg*h/L,arith. Mean,8.95,µg*h/L,arith. SD,AUC_inf,50.6,ng/mL,arith. Mean,8.45,ng/mL,arith. SD,Cmax,47.8,L/h,arith. Mean,9.05,L/h,arith. SD,CLiv,AUCinf is given as AUCinf/dose in µg*h/L/mg in the paper - value multuiplied by dose; CL (determined as dose/AUCinf)
1096,Prueksaritanont 2017,https://www.ncbi.nlm.nih.gov/pubmed/27943276,Midazolam in microdosecocktail alone,Midazolam,0,inf,h,197,pg*h/mL,geom. Mean,122 - 319,pg*h/mL,95% CI,AUC_inf,55.7,pg/mL,geom. Mean,49 - 63.2,pg/mL,95% CI,Cmax,,,,,,,,Also available: AUC(0-last): geom. Mean (95% CI) in pg*h/ml: 198 (128 - 309)
1097,Prueksaritanont 2017,https://www.ncbi.nlm.nih.gov/pubmed/27943276,Midazolam in microdosecocktail + Itraconazole,Midazolam,72,inf,h,1390,pg*h/mL,geom. Mean,864 - 2230,pg*h/mL,95% CI,AUC_inf,207,pg/mL,geom. Mean,173 - 247,pg/mL,95% CI,Cmax,,,,,,,,Also available: AUC(0-last): geom. Mean (95% CI) in pg*h/ml: 1350 (834 - 2170)
1098,Prueksaritanont 2017,https://www.ncbi.nlm.nih.gov/pubmed/27943276,Midazolam in microdosecocktail + Rifampin,Midazolam,0,inf,h,186,pg*h/mL,geom. Mean,114 - 303,pg*h/mL,95% CI,AUC_inf,72.6,pg/mL,geom. Mean,64.9 - 81.3,pg/mL,95% CI,Cmax,,,,,,,,Also available: AUC(0-last): geom. Mean (95% CI) in pg*h/ml: 171 (106 - 276)
1099,Prueksaritanont 2017,https://www.ncbi.nlm.nih.gov/pubmed/27943276,Midazolam in microdosecocktail + Clarithromycin,Midazolam,72,inf,h,955,pg*h/mL,geom. Mean,653 - 1400,pg*h/mL,95% CI,AUC_inf,150,pg/mL,geom. Mean,135 - 166,pg/mL,95% CI,Cmax,,,,,,,,Also available: AUC(0-last): geom. Mean (95% CI) in pg*h/ml: 933 (634 - 1370)
1103,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Alprazolam alone,Alprazolam,0,5,h,48.6,ng*h/mL,arith. Mean,9.9,ng*h/mL,arith. SD,AUC_tend,13,ng/mL,arith. Mean,2.26,ng/mL,arith. SD,Cmax,,,,,,,,
1103,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Alprazolam alone,Alprazolam,216,240,h,1058,ng*h/mL,arith. Mean,224,ng*h/mL,arith. SD,AUC_tend,53.6,ng/mL,arith. Mean,11.4,ng/mL,arith. SD,Cmax,3.97,L/h,arith. Mean,0.96,L/h,arith. SD,CL/F,CLpo= oral clearance
1104,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Alprazolam + fluvoxamine,Alprazolam,144,149,h,61,ng*h/mL,arith. Mean,9.86,ng*h/mL,arith. SD,AUC_tend,15.3,ng/mL,arith. Mean,2.07,ng/mL,arith. SD,Cmax,,,,,,,,
1113,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Alprazolam + fluvoxamine (day 10),Alprazolam,216,240,h,2077,ng*h/mL,arith. Mean,460,ng*h/mL,arith. SD,AUC_tend,99.8,ng/mL,arith. Mean,21.6,ng/mL,arith. SD,Cmax,2.03,L/h,arith. Mean,0.513,L/h,arith. SD,CL/F,CLpo= oral clearance
1105,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Fluvoxamine alone,Fluvoxamine,0,24,h,328,ng*h/mL,arith. Mean,84.6,ng*h/mL,arith. SD,AUC_tend,21.5,ng/mL,arith. Mean,4.89,ng/mL,arith. SD,Cmax,,,,,,,,
1105,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Fluvoxamine alone,Fluvoxamine,216,240,h,1762,ng*h/mL,arith. Mean,737,ng*h/mL,arith. SD,AUC_tend,99.3,ng/mL,arith. Mean,35,ng/mL,arith. SD,Cmax,,,,,,,,
1106,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Fluvoxamine + alprazolam,Fluvoxamine,0,24,h,302,ng*h/mL,arith. Mean,111,ng*h/mL,arith. SD,AUC_tend,20.7,ng/mL,arith. Mean,10.4,ng/mL,arith. SD,Cmax,,,,,,,,
1114,Fleishaker 1994,https://www.ncbi.nlm.nih.gov/pubmed/8005185,Fluvoxamine + alprazolam (day 10),Fluvoxamine,216,240,h,1341,ng*h/mL,arith. Mean,547,ng*h/mL,arith. SD,AUC_tend,78.2,ng/mL,arith. Mean,25.3,ng/mL,arith. SD,Cmax,,,,,,,,
1107,Backman 1994,https://www.ncbi.nlm.nih.gov/pubmed/8198928,Midazolam with placebo,Midazolam,0,inf,h,12,µg*min/mL,arithm. Mean,1,µg*min/mL,SEM,AUC_inf,65,ng/ml,arithm. Mean,9,ng/ml,SEM,Cmax,,,,,,,,
1108,Backman 1994,https://www.ncbi.nlm.nih.gov/pubmed/8198928,Midazolam with verapamil,Midazolam,25,inf,h,35,µg*min/mL,arithm. Mean,5,µg*min/mL,SEM,AUC_inf,128,ng/ml,arithm. Mean,16,ng/ml,SEM,Cmax,,,,,,,,
704,Greenblatt 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9757151,Triazolam + Placebo (Trial B),Triazolam,0,inf,h,5.5,ng*h/mL,arithm. Mean,0.5,ng*h/mL,SE,AUC_inf,1.25,ng/mL,arithm. Mean,0.14,ng/mL,SE,Cmax,413,mL/min,arithm. Mean,39,mL/min,SE,CL/F,
781,Greenblatt 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9757151,Triazolam + Erythromycin (Trial D),Triazolam,25,inf,h,20.9,ng*h/mL,arithm. Mean,3,ng*h/mL,SE,AUC_inf,2.21,ng/mL,arithm. Mean,0.24,ng/mL,SE,Cmax,146,mL/min,arithm. Mean,32,mL/min,SE,CL/F,
1102,Greenblatt 1998a,https://www.ncbi.nlm.nih.gov/pubmed/9757151,Triazolam + Clarithromycin (Trial E),Triazolam,25,inf,h,28.9,ng*h/mL,arithm. Mean,4,ng*h/mL,SE,AUC_inf,2.46,ng/mL,arithm. Mean,0.26,ng/mL,SE,Cmax,95,mL/min,arithm. Mean,17,mL/min,SE,CL/F,
1027,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo,Triazolam,0,inf,h,5.9,ng*h/mL,arith. Mean,0.7,ng*h/mL,SEM,AUC_inf,1.5,ng/mL,arith. Mean,0.2,ng/mL,SEM,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1028,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole,Triazolam,73,inf,h,132,ng*h/mL,arith. Mean,25,ng*h/mL,SEM,AUC_inf,4.6,ng/mL,arith. Mean,0.5,ng/mL,SEM,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1029,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole,Triazolam,73,inf,h,160,ng*h/mL,arith. Mean,68,ng*h/mL,SEM,AUC_inf,4.2,ng/mL,arith. Mean,0.9,ng/mL,SEM,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1030,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4,Ketoconazole,0,inf,h,,,,,,,,7.311111111,µg/mL,arith. Mean,,,,Cmax,,,,,,,,
1031,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 1,Ketoconazole,0,inf,h,,,,,,,,8.7,µg/mL,individual,,,,Cmax,,,,,,,,
1032,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 2,Ketoconazole,0,inf,h,,,,,,,,8.2,µg/mL,individual,,,,Cmax,,,,,,,,
1033,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 3,Ketoconazole,0,inf,h,,,,,,,,4.8,µg/mL,individual,,,,Cmax,,,,,,,,
1034,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 4,Ketoconazole,0,inf,h,,,,,,,,7.1,µg/mL,individual,,,,Cmax,,,,,,,,
1035,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 5,Ketoconazole,0,inf,h,,,,,,,,6.6,µg/mL,individual,,,,Cmax,,,,,,,,
1036,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 6,Ketoconazole,0,inf,h,,,,,,,,7.7,µg/mL,individual,,,,Cmax,,,,,,,,
1037,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 7,Ketoconazole,0,inf,h,,,,,,,,11.1,µg/mL,individual,,,,Cmax,,,,,,,,
1038,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 8,Ketoconazole,0,inf,h,,,,,,,,1,µg/mL,individual,,,,Cmax,,,,,,,,
1039,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Ketoconazole on day 4 Subject 9,Ketoconazole,0,inf,h,,,,,,,,10.6,µg/mL,individual,,,,Cmax,,,,,,,,
1040,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4,Itraconazole,0,inf,h,,,,,,,,337.6666667,ng/mL,arith. Mean,,,,Cmax,,,,,,,,
1041,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 1,Itraconazole,0,inf,h,,,,,,,,410,ng/mL,individual,,,,Cmax,,,,,,,,
1042,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 2,Itraconazole,0,inf,h,,,,,,,,546,ng/mL,individual,,,,Cmax,,,,,,,,
1043,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 3,Itraconazole,0,inf,h,,,,,,,,307,ng/mL,individual,,,,Cmax,,,,,,,,
1044,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 4,Itraconazole,0,inf,h,,,,,,,,205,ng/mL,individual,,,,Cmax,,,,,,,,
1045,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 5,Itraconazole,0,inf,h,,,,,,,,492,ng/mL,individual,,,,Cmax,,,,,,,,
1046,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 6,Itraconazole,0,inf,h,,,,,,,,173,ng/mL,individual,,,,Cmax,,,,,,,,
1047,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 7,Itraconazole,0,inf,h,,,,,,,,142,ng/mL,individual,,,,Cmax,,,,,,,,
1048,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 8,Itraconazole,0,inf,h,,,,,,,,252,ng/mL,individual,,,,Cmax,,,,,,,,
1049,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Itraconazole on day 4 Subject 9,Itraconazole,0,inf,h,,,,,,,,512,ng/mL,individual,,,,Cmax,,,,,,,,
1050,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 1,Triazolam,0,inf,h,3.8,ng*h/mL,individual,,,,AUC_inf,1.1,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1051,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 2,Triazolam,0,inf,h,6.7,ng*h/mL,individual,,,,AUC_inf,1.9,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1052,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 3,Triazolam,0,inf,h,10.5,ng*h/mL,individual,,,,AUC_inf,2.4,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1053,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 4,Triazolam,0,inf,h,7.7,ng*h/mL,individual,,,,AUC_inf,1.4,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1054,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 5,Triazolam,0,inf,h,5.5,ng*h/mL,individual,,,,AUC_inf,1.3,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1055,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 6,Triazolam,0,inf,h,3.4,ng*h/mL,individual,,,,AUC_inf,1,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1056,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 7,Triazolam,0,inf,h,5.5,ng*h/mL,individual,,,,AUC_inf,1.4,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1057,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 8,Triazolam,0,inf,h,6.2,ng*h/mL,individual,,,,AUC_inf,1.7,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1058,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with placebo Subject 9,Triazolam,0,inf,h,4.1,ng*h/mL,individual,,,,AUC_inf,1,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1059,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 1,Triazolam,73,inf,h,270,ng*h/mL,individual,,,,AUC_inf,4.8,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1060,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 2,Triazolam,73,inf,h,127,ng*h/mL,individual,,,,AUC_inf,7.9,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1061,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 3,Triazolam,73,inf,h,133,ng*h/mL,individual,,,,AUC_inf,3.5,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1062,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 4,Triazolam,73,inf,h,224,ng*h/mL,individual,,,,AUC_inf,4.4,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1063,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 5,Triazolam,73,inf,h,90,ng*h/mL,individual,,,,AUC_inf,2.8,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1064,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 6,Triazolam,73,inf,h,72,ng*h/mL,individual,,,,AUC_inf,3.2,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1065,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 7,Triazolam,73,inf,h,141,ng*h/mL,individual,,,,AUC_inf,5.5,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1066,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 8,Triazolam,73,inf,h,31,ng*h/mL,individual,,,,AUC_inf,4,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1067,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with ketoconazole Subject 9,Triazolam,73,inf,h,98,ng*h/mL,individual,,,,AUC_inf,5.1,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1068,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 1,Triazolam,73,inf,h,689,ng*h/mL,individual,,,,AUC_inf,11.4,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1069,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 2,Triazolam,73,inf,h,161,ng*h/mL,individual,,,,AUC_inf,3.2,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1070,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 3,Triazolam,73,inf,h,76,ng*h/mL,individual,,,,AUC_inf,2.8,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1071,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 4,Triazolam,73,inf,h,185,ng*h/mL,individual,,,,AUC_inf,3.7,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1072,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 5,Triazolam,73,inf,h,72,ng*h/mL,individual,,,,AUC_inf,3.8,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1073,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 6,Triazolam,73,inf,h,54,ng*h/mL,individual,,,,AUC_inf,2.5,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1074,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 7,Triazolam,73,inf,h,54,ng*h/mL,individual,,,,AUC_inf,3.6,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1075,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 8,Triazolam,73,inf,h,64,ng*h/mL,individual,,,,AUC_inf,3.7,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1076,Varhe 1994,https://www.ncbi.nlm.nih.gov/pubmed/7995001,Triazolam with Itraconazole Subject 9,Triazolam,73,inf,h,84,ng*h/mL,individual,,,,AUC_inf,3.3,ng/mL,individual,,,,Cmax,,,,,,,,Also available: Values for AUC(0-17)
1110,Wang 2005,https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1016/j.clpt.2004.11.014,Midazolam before treatment,Midazolam,0,inf,h,,,,,,,,,,,,,,,24.4,L/h,arith. Mean,9.1,L/h,arith. SD,CL/F,
1111,Wang 2005,https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1016/j.clpt.2004.11.014,Midazolam after VER treatment,Midazolam,168,inf,h,,,,,,,,,,,,,,,16.8,L/h,arith. Mean,10.3,L/h,arith. SD,CL/F,
1115,Wang 2005,https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1016/j.clpt.2004.11.014,Midazolam before treatment,Midazolam,0,inf,h,,,,,,,,,,,,,,,93.6,L/h,arith. Mean,67.7,L/h,arith. SD,CLiv,
1116,Wang 2005,https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1016/j.clpt.2004.11.014,Midazolam after VER treatment,Midazolam,192,inf,h,,,,,,,,,,,,,,,26.7,L/h,arith. Mean,17.1,L/h,arith. SD,CLiv,
2011,Chen 2006,https://www.ncbi.nlm.nih.gov/pubmed/16842393,Midazolam at baseline overall,Midazolam,,,,,,,,,,,,,,,,,,7.9,mL/min/kg,arith. Mean,1.8,mL/min/kg,arith. SD,CLiv,
2012,Chen 2006,https://www.ncbi.nlm.nih.gov/pubmed/16842393,Midazolam post treatment with fluvoxamine (28 days of fluvoxamine) overall,Midazolam,,,,,,,,,,,,,,,,,,5.3,mL/min/kg,arith. Mean,2,mL/min/kg,arith. SD,CLiv,
2013,Chen 2006,https://www.ncbi.nlm.nih.gov/pubmed/16842393,Midazolam at baseline Male,Midazolam,,,,,,,,,,,,,,,,,,7.6,mL/min/kg,arith. Mean,0.9,mL/min/kg,arith. SD,CLiv,
2042,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Midazolam control PO,Midazolam,0,6,h,50.8,ng*h/mL,geom. Mean,42.5-60.6,ng*h/mL,95% CI,AUC_tend,,,,,,,,1313,mL/min,arith. Mean,1100-1568,mL/min,arith. SD,CL/F,
2043,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Midazolam control IV,Midazolam,6,14,h,84.8,ng*h/mL,geom. Mean,76.3-94.4,ng*h/mL,95% CI,AUC_tend,,,,,,,,393,mL/min,arith. Mean,353-437,mL/min,arith. SD,CLiv,
2044,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam PO day 1,Midazolam,12,18,h,30,ng*h/mL,geom. Mean,22.9-39.0,ng*h/mL,95% CI,AUC_tend,,,,,,,,2231,mL/min,arith. Mean,1708-2915,mL/min,arith. SD,CL/F,
2045,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam IV day 1,Midazolam,18,26,h,66.6,ng*h/mL,geom. Mean,57.7-77.6,ng*h/mL,95% CI,AUC_tend,,,,,,,,500,mL/min,arith. Mean,430-583,mL/min,arith. SD,CLiv,
2047,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam PO day 6,Midazolam,132,138,h,31.2,ng*h/mL,geom. Mean,27.0-36.0,ng*h/mL,95% CI,AUC_tend,,,,,,,,2138,mL/min,arith. Mean,1852-2468,mL/min,arith. SD,CL/F,
2048,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam IV day 6,Midazolam,138,146,h,65.9,ng*h/mL,geom. Mean,56.5-77.0,ng*h/mL,95% CI,AUC_tend,,,,,,,,506,mL/min,arith. Mean,433-590,mL/min,arith. SD,CLiv,
2049,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam PO day 11,Midazolam,252,258,h,39.1,ng*h/mL,geom. Mean,33.3-46.0,ng*h/mL,95% CI,AUC_tend,,,,,,,,1703,mL/min,arith. Mean,1449-2002,mL/min,arith. SD,CL/F,
2050,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam IV day 11,Midazolam,258,266,h,79.5,ng*h/mL,geom. Mean,69.2-91.3,ng*h/mL,95% CI,AUC_tend,,,,,,,,420,mL/min,arith. Mean,365-482,mL/min,arith. SD,CLiv,
2051,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam PO day 16,Midazolam,372,378,h,38,ng*h/mL,geom. Mean,31.4-45.9,ng*h/mL,95% CI,AUC_tend,,,,,,,,1755,mL/min,arith. Mean,1452-2123,mL/min,arith. SD,CL/F,
2052,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam IV day 16,Midazolam,378,386,h,72.4,ng*h/mL,geom. Mean,62.6-83.6,ng*h/mL,95% CI,AUC_tend,,,,,,,,461,mL/min,arith. Mean,399-532,mL/min,arith. SD,CLiv,
2053,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam PO  day 22,Midazolam,516,522,h,42.6,ng*h/mL,geom. Mean,33.3-54.5,ng*h/mL,95% CI,AUC_tend,,,,,,,,1564,mL/min,arith. Mean,1223-2001,mL/min,arith. SD,CL/F,
2054,Mikus 2017,https://www.ncbi.nlm.nih.gov/pubmed/28194792,Efavirenz + Midazolam IV  day 22,Midazolam,522,530,h,78.2,ng*h/mL,geom. Mean,65.8-93.0,ng*h/mL,95% CI,AUC_tend,,,,,,,,426,mL/min,arith. Mean,359-507,mL/min,arith. SD,CLiv,
194,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Control CYP3A5*1/*1,Midazolam,0,inf,h,,,,,,,,,,,,,,,32.5,L/h,arith. Mean,10.2,L/h,arith. SD,Cliv,reported values are L/h/70kg
195,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Control CYP3A5*1/*3,Midazolam,0,inf,h,,,,,,,,,,,,,,,32.1,L/h,arith. Mean,14.5,L/h,arith. SD,Cliv,reported values are L/h/70kg
196,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Control CYP3A5*3/*3,Midazolam,0,inf,h,,,,,,,,,,,,,,,28.4,L/h,arith. Mean,12.5,L/h,arith. SD,Cliv,reported values are L/h/70kg
197,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Treatment Itraconazole CYP3A5*1/*1,Midazolam,72,inf,h,,,,,,,,,,,,,,,13.5,L/h,arith. Mean,2.7,L/h,arith. SD,Cliv,reported values are L/h/70kg
198,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Treatment Itraconazole CYP3A5*1/*3,Midazolam,72,inf,h,,,,,,,,,,,,,,,11.5,L/h,arith. Mean,4.5,L/h,arith. SD,Cliv,reported values are L/h/70kg
199,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Treatment Itraconazole CYP3A5*3/*3,Midazolam,72,inf,h,,,,,,,,,,,,,,,8.5,L/h,arith. Mean,3.8,L/h,arith. SD,Cliv,reported values are L/h/70kg
200,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Treatment Rifampicin CYP3A5*1/*1,Midazolam,240,inf,h,,,,,,,,,,,,,,,62.3,L/h,arith. Mean,35.9,L/h,arith. SD,Cliv,reported values are L/h/70kg
201,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Treatment Rifampicin CYP3A5*1/*3,Midazolam,240,inf,h,,,,,,,,,,,,,,,75.6,L/h,arith. Mean,35.9,L/h,arith. SD,Cliv,reported values are L/h/70kg
202,Yu 2004,https://www.ncbi.nlm.nih.gov/pubmed/15289787,Treatment Rifampicin CYP3A5*3/*3,Midazolam,240,inf,h,,,,,,,,,,,,,,,65.3,L/h,arith. Mean,32.4,L/h,arith. SD,Cliv,reported values are L/h/70kg
203,Wiesinger 2020,https://www.ncbi.nlm.nih.gov/pubmed/32275771,Control phase (no RIF),Midazolam,0,inf,h,12.7,µg*h/L,geom. Mean,36.7,%,geom. CV,AUC_inf,4.9,µg/L,geom. Mean,33,%,geom. CV,,,,,,,,,
204,Wiesinger 2020,https://www.ncbi.nlm.nih.gov/pubmed/32275771,Weak-induction phase (RIF 10 mg),Midazolam,180,444,h,6.84,µg*h/L,geom. Mean,37.3,%,geom. CV,AUC_inf,3.1,µg/L,geom. Mean,38.6,%,geom. CV,,,,,,,,,
205,Wiesinger 2020,https://www.ncbi.nlm.nih.gov/pubmed/32275771,Strong-induction phase (RIF 600 mg),Midazolam,444,9999,h,1.73,µg*h/L,geom. Mean,49.3,%,geom. CV,AUC_inf,0.919,µg/L,geom. Mean,46.2,%,geom. CV,,,,,,,,,
2055,Barbarash 1988,https://www.ncbi.nlm.nih.gov/pubmed/3180898,Verapamil IV control,Verapamil,0,inf,h,173.7,ng*h/mL,arith. Mean,29.5,ng*h/mL,arith. SD,AUC_inf,,,,,,,,991,mL/min,arith. Mean,185.4,mL/min,arith. SD,CLiv,
2056,Barbarash 1988,https://www.ncbi.nlm.nih.gov/pubmed/3180898,Verapamil IV after 2 weeks of Rifampicin therapy,Verapamil,300,inf,h,142.2,ng*h/mL,arith. Mean,30.4,ng*h/mL,arith. SD,AUC_inf,,,,,,,,1228.2,mL/min,arith. Mean,267.8,mL/min,arith. SD,CLiv,
2057,Barbarash 1988,https://www.ncbi.nlm.nih.gov/pubmed/3180898,Verapamil PO control,Verapamil,0,inf,h,526.8,ng*h/mL,arith. Mean,173.8,ng*h/mL,arith. SD,AUC_inf,194.8,ng/mL,arith. Mean,107.8,ng/mL,arith. SD,Cmax,,,,,,,,
2058,Barbarash 1988,https://www.ncbi.nlm.nih.gov/pubmed/3180898,Verapamil PO after 2 weeks of Rifampicin therapy,Verapamil,348,inf,h,34.3,ng*h/mL,arith. Mean,16.2,ng*h/mL,arith. SD,AUC_inf,7.2,ng/mL,arith. Mean,4.2,ng/mL,arith. SD,Cmax,,,,,,,,
2065,Maeda 2011,https://www.ncbi.nlm.nih.gov/pubmed/21716273,Verapamil 0.1 mg,Verapamil,0,inf,h,0.139,ng*h/mL,arith. Mean,0.09,ng*h/mL,arith. SD,AUC_inf,0.0338,ng/mL,arith. Mean,0.0292,ng/mL,arith. SD,Cmax,,,,,,,,Also available AUC(0-12): arith. mean +/- SD in (ng*h/ml): 0.132 +/- 0.087
2066,Maeda 2011,https://www.ncbi.nlm.nih.gov/pubmed/21716273,Verapamil 3 mg,Verapamil,0,inf,h,4.95,ng*h/mL,arith. Mean,2.68,ng*h/mL,arith. SD,AUC_inf,1.03,ng/mL,arith. Mean,0.64,ng/mL,arith. SD,Cmax,,,,,,,,Also available AUC(0-12): arith. mean +/- SD in (ng*h/ml): 4.54 +/- 2.48
2067,Maeda 2011,https://www.ncbi.nlm.nih.gov/pubmed/21716273,Verapamil 16 mg,Verapamil,0,inf,h,40.8,ng*h/mL,arith. Mean,43.9,ng*h/mL,arith. SD,AUC_inf,10.4,ng/mL,arith. Mean,12.6,ng/mL,arith. SD,Cmax,,,,,,,,Also available AUC(0-12): arith. mean +/- SD in (ng*h/ml): 38.1 +/- 41.3
2068,Maeda 2011,https://www.ncbi.nlm.nih.gov/pubmed/21716273,Verapamil 80 mg,Verapamil,0,inf,h,256,ng*h/mL,arith. Mean,143,ng*h/mL,arith. SD,AUC_inf,63.3,ng/mL,arith. Mean,34.2,ng/mL,arith. SD,Cmax,,,,,,,,Also available AUC(0-12): arith. mean +/- SD in (ng*h/ml): 236 +/- 131
2072,Jorgensen 1988,https://www.ncbi.nlm.nih.gov/pubmed/3186615,Conventional Verapamil 120 mg BID (day 8),Verapamil,168,192,h,2487.8,µg*h/L,arith. Mean,841.8,µg*h/L,arith. SD,AUC_tend,,,,,,,,,,,,,,,AUC_tend = AUC(0-24)
2074,Jorgensen 1988,https://www.ncbi.nlm.nih.gov/pubmed/3186615,Sustained release Verapamil 240 mg OD (day 8),Verapamil,168,192,h,2169.4,µg*h/L,arith. Mean,764,µg*h/L,arith. SD,AUC_tend,,,,,,,,,,,,,,,AUC_tend = AUC(0-24)
2077,Shand 1981,https://www.ncbi.nlm.nih.gov/pubmed/7297027,Verapamil day 1,Verapamil,0,inf,h,788,ng*h/mL,arith. Mean,224,ng*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,,
2078,Shand 1981,https://www.ncbi.nlm.nih.gov/pubmed/7297027,Verapamil day 3 (after 7th dose),Verapamil,48,56,h,1999,ng*h/mL,arith. Mean,435,ng*h/mL,arith. SD,AUC_tend,,,,,,,,,,,,,,,AUC_tend = AUC(0-8)
2079,Johnson 2001,https://www.ncbi.nlm.nih.gov/pubmed/11697758,Verapamil Steady State,Verapamil,48,56,h,829,ng*h/mL,geom. Mean,472,ng*h/mL,geom. SD,AUC_tend,230,ng/mL,geom. Mean,122,ng/mL,geom. SD,Cmax,,,,,,,,AUC_tend = AUC(0-8); also available AUC(0-4): geom. mean +/- SD in (ng*h*ml-1): 519 +/- 280
2069,Hla 1987,https://www.ncbi.nlm.nih.gov/pubmed/3435694,conventional Verapamil 120mg once daily (day 1),Verapamil,0,inf,h,450,ng*h/mL,arith. Mean,130,ng*h/mL,arith. SD,AUC_inf,123,ng/mL,arith. Mean,43,ng/mL,arith. SD,Cmax,,,,,,,,
2070,Hla 1987,https://www.ncbi.nlm.nih.gov/pubmed/3435694,conventional Verapamil 120mg twice daily (day 10),Verapamil,216,240,h,1107,ng*h/mL,arith. Mean,411,ng*h/mL,arith. SD,AUC_tend,272,ng/mL,arith. Mean,117,ng/mL,arith. SD,Cmax,,,,,,,,AUC_tend = AUC(0-24)
2059,Johnston 1981,https://www.ncbi.nlm.nih.gov/pubmed/7295469,Verapamil IV,Verapamil,0,inf,h,118.4,ng*h/mL,arith. Mean,45.1,ng*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,,
2060,Johnston 1981,https://www.ncbi.nlm.nih.gov/pubmed/7295469,Verapamil PO,Verapamil,0,inf,h,494,ng*h/mL,arith. Mean,316.5,ng*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,,
2075,Karim 1995,https://www.ncbi.nlm.nih.gov/pubmed/7648767,Verapamil total IR fasting,Verapamil,0,48,h,1626,ng*h/mL,arith. Mean,53,%,arith. CV,AUC_tend,,,,,,,,,,,,,,,
2076,Karim 1995,https://www.ncbi.nlm.nih.gov/pubmed/7648767,Verapamil total SR fed,Verapamil,0,48,h,1099,ng*h/mL,arith. Mean,48,%,arith. CV,AUC_tend,,,,,,,,,,,,,,,
2075,Karim 1995,https://www.ncbi.nlm.nih.gov/pubmed/7648767,Verapamil total IR fasting,Verapamil,0,inf,h,1656,ng*h/mL,arith. Mean,52,%,arith. CV,AUC_inf,327,ng/mL,arith. Mean,44,%,arith. CV,Cmax,40.8,mL/min/kg,arith. Mean,52,%,arith. CV,CL/F,
2076,Karim 1995,https://www.ncbi.nlm.nih.gov/pubmed/7648767,Verapamil total SR fed,Verapamil,0,inf,h,1215,ng*h/mL,arith. Mean,44,%,arith. CV,AUC_inf,73.5,ng/mL,arith. Mean,58,%,arith. CV,Cmax,,,,,,,,
2061,McAllister 1982,https://www.ncbi.nlm.nih.gov/pubmed/7060323,Verapamil 10 mg IV,Verapamil,0,inf,h,214.6,ng*h/mL,arith. Mean,66.8,ng*h/mL,arith. SD,AUC_inf,80.4,ng/mL,arith. Mean,43.1,ng/mL,arith. SD,Cmax,0.71,L/h/kg,arith. Mean,0.3,L/h/kg,arith. SD,CL/F,
2062,McAllister 1982,https://www.ncbi.nlm.nih.gov/pubmed/7060323,Verapamil 80 mg PO,Verapamil,0,inf,h,34.5,ng*h/mL,arith. Mean,14.5,ng*h/mL,arith. SD,AUC_inf,49.3,ng/mL,arith. Mean,25.2,ng/mL,arith. SD,Cmax,0.82,L/h/kg,arith. Mean,0.3,L/h/kg,arith. SD,CL/F,
2063,McAllister 1982,https://www.ncbi.nlm.nih.gov/pubmed/7060323,Verapamil 120 mg PO,Verapamil,0,inf,h,37.1,ng*h/mL,arith. Mean,23.3,ng*h/mL,arith. SD,AUC_inf,85,ng/mL,arith. Mean,50.3,ng/mL,arith. SD,Cmax,0.86,L/h/kg,arith. Mean,0.3,L/h/kg,arith. SD,CL/F,
2064,McAllister 1982,https://www.ncbi.nlm.nih.gov/pubmed/7060323,Verapamil 160 mg PO,Verapamil,0,inf,h,38.7,ng*h/mL,arith. Mean,18.5,ng*h/mL,arith. SD,AUC_inf,108.3,ng/mL,arith. Mean,44.5,ng/mL,arith. SD,Cmax,0.83,L/h/kg,arith. Mean,0.4,L/h/kg,arith. SD,CL/F,
2080,Streit 2005,https://www.ncbi.nlm.nih.gov/pubmed/15692829,intravenous verapamil during normoxia (5 mg),Verapamil,0,14,h,58.7,ng*h/mL,arith. Mean,10.5,ng*h/mL,arith. SD,AUC_tend,72.1,ng/mL,arith. Mean,25.1,ng/mL,arith. SD,Cmax,87.7,L/h,arith. Mean,16.1,L/h,arith. SD,CLiv,
1207,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"IV 100 mg, Individual LH",Cimetidine,0,inf,h,1.1,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,1.15,L/h/kg,arith. Mean,,,,CLiv,
1208,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"IV 100 mg, Individual KN",Cimetidine,0,inf,h,2.4,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,0.65,L/h/kg,arith. Mean,,,,CLiv,
1209,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"IV 100 mg, Individual LOE",Cimetidine,0,inf,h,1.6,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,1,L/h/kg,arith. Mean,,,,CLiv,
1210,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"IV 100 mg, urine mean % of dose",Cimetidine,0,inf,h,2.2,µg*h/mL,arith. Mean,0.6,µg*h/mL,arith. SD,AUC_inf,,,,,,,,0.74,L/h/kg,arith. Mean,0.2,L/h/kg,arith. SD,CLiv,
1211,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"PO 400 mg, Individual LH",Cimetidine,0,inf,h,9.6,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1212,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"PO 400 mg, Individual LOE",Cimetidine,0,inf,h,8.6,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1213,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"PO 400 mg, Individual UB",Cimetidine,0,inf,h,7.6,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1214,Grahnen 1979,https://pubmed.ncbi.nlm.nih.gov/520401/,"PO 400 mg, urine mean % of dose",Cimetidine,0,inf,h,10.4,µg*h/mL,arith. Mean,2,µg*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,,
1215,Larsson 1982,https://pubmed.ncbi.nlm.nih.gov/7059413/,IV 200 mg in normal renal function group,Cimetidine,0,inf,h,5.04,µg*h/mL,arith. Mean,0.47,µg*h/mL,SEM,AUC_inf,,,,,,,,718,mL/min,arith. Mean,80,mL/min,SEM,CLiv,CL: Total plasma clearance; Renal clearance: 326 +/- 40; Non-renal clearance: 392 +/- 72
1216,Larsson 1982,https://pubmed.ncbi.nlm.nih.gov/7059413/,IV 200 mg in normal renal function group,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1217,Mihaly 1984,https://pubmed.ncbi.nlm.nih.gov/6318788/,"IV 200 mg, beginning of treatment",Cimetidine,0,inf,h,4369,ng*h/mL,arith. Mean,944,ng*h/mL,arith. SD,AUC_inf,,,,,,,,30.7,L/h,arith. Mean,10.9,L/h,arith. SD,CLiv,"CL: CL_R; CL_syst: 46,8 +/- 8,7"
1218,Mihaly 1984,https://pubmed.ncbi.nlm.nih.gov/6318788/,"PO 200 mg, beginning of treatment",Cimetidine,0,inf,h,3460,ng*h/mL,arith. Mean,1008,ng*h/mL,arith. SD,AUC_inf,,,,,,,,29,L/h,arith. Mean,11.9,L/h,arith. SD,CL/F,"CL: CL_R; CL_syst: 46,8 +/- 8,7"
1219,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,IV 200 mg,Cimetidine,0,inf,h,5.296,µg*h/mL,arith. Mean,0.526,µg*h/mL,SE,AUC_inf,,,,,,,,655.2,mL/min,arith. Mean,54.7,mL/min,SE,CLiv,
1220,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,PO 200 mg,Cimetidine,0,inf,h,4.112,µg*h/mL,arith. Mean,0.42,µg*h/mL,SE,AUC_inf,1.06,µg/mL,arith. Mean,0.1,µg/mL,SE,Cmax,,,,,,,,
1221,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,PO 400 mg,Cimetidine,0,inf,h,8.429,µg*h/mL,arith. Mean,0.984,µg*h/mL,SE,AUC_inf,2.27,µg/mL,arith. Mean,0.22,µg/mL,SE,Cmax,,,,,,,,
1222,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,PO 800 mg,Cimetidine,0,inf,h,17.887,µg*h/mL,arith. Mean,2.438,µg*h/mL,SE,AUC_inf,4.45,µg/mL,arith. Mean,0.61,µg/mL,SE,Cmax,,,,,,,,
1223,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,"IV 200 mg, Urine",Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1224,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,"PO 200 mg, Urine",Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1225,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,"PO 400 mg, Urine",Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1226,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,"PO 800 mg, Urine",Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1227,Bodemar 1979,https://pubmed.ncbi.nlm.nih.gov/760739/,PO 200 mg,Cimetidine,0,inf,h,373.5,µg*h/mL,arith. Mean,19.3,µg*h/mL,arith. SEM,AUC_inf,1.03,µg/mL,arith. Mean,0.24,µg/mL,SEM,Cmax,,,,,,,,"AUC Unit: µg h kg ml-1; AUC corrected to kg body weight; Cmax = 1-120min; Cmax(120-300min): 1,01 +/- 0,12"
1228,Bodemar 1979,https://pubmed.ncbi.nlm.nih.gov/760739/,PO 400 mg,Cimetidine,0,inf,h,764.2,µg*h/mL,arith. Mean,8.7,µg*h/mL,arith. SEM,AUC_inf,1.84,µg/mL,arith. Mean,0.31,µg/mL,SEM,Cmax,,,,,,,,"AUC Unit: µg h kg ml-1; AUC corrected to kg body weight; Cmax = 1-120min; Cmax(120-300min): 2,12 +/- 0,27"
1229,Bodemar 1979,https://pubmed.ncbi.nlm.nih.gov/760739/,PO 200 mg fasted,Cimetidine,0,inf,h,406.6,µg*h/mL,arith. Mean,33.87,µg*h/mL,arith. SEM,AUC_inf,1.18,µg/mL,arith. Mean,0.14,µg/mL,SEM,Cmax,,,,,,,,"AUC Unit: µg h kg ml-1; AUC corrected to kg body weight; Cmax = 1-120min; Cmax(120-300min): 0,97 +/- 0,07"
1230,Bodemar 1979,https://pubmed.ncbi.nlm.nih.gov/760739/,PO 200 mg fed,Cimetidine,0,inf,h,371.7,µg*h/mL,arith. Mean,29.03,µg*h/mL,arith. SEM,AUC_inf,1.09,µg/mL,arith. Mean,0.1,µg/mL,SEM,Cmax,,,,,,,,AUC Unit: µg h kg ml-1; AUC corrected to kg body weight
1231,Morgan 1983,https://pubmed.ncbi.nlm.nih.gov/6617722/,IV 200 mg 5 min,Cimetidine,0,inf,h,,,,,,,,7.33,µg/mL,arith. Mean,1.38,µg/mL,arith. SD,Cmax,,,,,,,,Cmax: Obtained from AUTOAN fit of 5min infusion study data
1232,Morgan 1983,https://pubmed.ncbi.nlm.nih.gov/6617722/,IV 200 mg 30 min,Cimetidine,0,inf,h,,,,,,,,4.57,µg/mL,arith. Mean,0.53,µg/mL,arith. SD,Cmax,,,,,,,,
1233,Lebert 1981,https://pubmed.ncbi.nlm.nih.gov/6269789/,IV 300 mg,Cimetidine,0,inf,h,8.16,µg*h/mL,arith. Mean,0.65,µg*h/mL,arith. SEM,AUC_inf,,,,,,,,0.55,L/h/kg,arith. Mean,0.05,L/h/kg,SEM,CLiv,
1234,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 1,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1235,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 2,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1236,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 3,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1237,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 4,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1238,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 5,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1239,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 6,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1240,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 7,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1241,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 8,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1242,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 9,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1243,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 10,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1244,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 11,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1245,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg Subject 12,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1246,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 1,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1247,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 2,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1248,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 3,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1249,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 4,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1250,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 5,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1251,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 6,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1252,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 7,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1253,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 8,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1254,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 9,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1255,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 10,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1256,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 11,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1257,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 12,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1258,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 13,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1259,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 14,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1260,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 15,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1261,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 16,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1262,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 17,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1263,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 18,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1264,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 19,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1265,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 20,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1266,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 21,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1267,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 22,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1268,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 23,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1269,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg sol Subject 24,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1270,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 13,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1271,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 14,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1272,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 15,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1273,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 16,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1274,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 17,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1275,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 18,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1276,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 19,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1277,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 20,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1278,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 21,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1279,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 22,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1280,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 23,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1281,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg tab Subject 24,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1282,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 1,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1283,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 2,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1284,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 3,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1285,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 4,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1286,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 5,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1287,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 6,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1288,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 7,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1289,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 8,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1290,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 9,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1291,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 10,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1292,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 11,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1293,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,IV 300 mg urine Subject 12,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1294,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 1,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1295,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 2,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1296,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 3,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1297,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 4,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1298,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 5,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1299,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 6,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1300,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 7,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1301,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 8,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1302,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 9,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1303,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 10,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1304,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 11,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1305,Walkenstein 1978,https://pubmed.ncbi.nlm.nih.gov/620910/,PO 300 mg urine Subject 12,Cimetidine,,,,,,,,,,,,,,,,,,,,,,,,,
1306,Kanto 1981,https://pubmed.ncbi.nlm.nih.gov/7272182/,PO  200 mg,Cimetidine,0,inf,h,3.52,µg*h/mL,arith. Mean,0.25,µg*h/mL,SEM,AUC_inf,1.12,µg/mL,arith. Mean,0.15,µg/mL,SEM,Cmax,,,,,,,,
1307,Burland 1975,https://pubmed.ncbi.nlm.nih.gov/9952/,PO 200 mg sol,Cimetidine,,,,,,,,,,,2.8,µmol/L,average,"1,2-4,3",µmol/L,range,Cmax,,,,,,,,
1308,Burland 1975,https://pubmed.ncbi.nlm.nih.gov/9952/,PO 200 mg caps,Cimetidine,,,,,,,,,,,2.8,µmol/L,average,"1,2-4,3",µmol/L,range,Cmax,,,,,,,,
1309,D'Angio 1986,https://pubmed.ncbi.nlm.nih.gov/3755052/,PO 300 mg tab subject 1,Cimetidine,0,inf,h,3.36,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1310,D'Angio 1986,https://pubmed.ncbi.nlm.nih.gov/3755052/,PO 300 mg tab subject 2,Cimetidine,0,inf,h,6.43,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1311,D'Angio 1986,https://pubmed.ncbi.nlm.nih.gov/3755052/,PO 300 mg tab subject 3,Cimetidine,0,inf,h,8.75,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1312,D'Angio 1986,https://pubmed.ncbi.nlm.nih.gov/3755052/,PO 300 mg tab subject 4,Cimetidine,0,inf,h,7.01,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1313,D'Angio 1986,https://pubmed.ncbi.nlm.nih.gov/3755052/,PO 300 mg tab subject 5,Cimetidine,0,inf,h,7.11,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1314,D'Angio 1986,https://pubmed.ncbi.nlm.nih.gov/3755052/,PO 300 mg tab subject 6,Cimetidine,0,inf,h,6.27,µg*h/mL,arith. Mean,,,,AUC_inf,,,,,,,,,,,,,,,
1315,Barbhaiya 1995,https://pubmed.ncbi.nlm.nih.gov/8562300/,PO 300 mg QID,Cimetidine,144,150,h,4390,ng*h/mL,arith. Mean,1107,ng*h/mL,arith. SD,AUC_tau,1315,ng/mL,arith. Mean,365,ng/mL,arith. SD,Cmax,,,,,,,,
1316,Somogyi 1981,https://pubmed.ncbi.nlm.nih.gov/7238562/,PO 400 mg tab,Cimetidine,0,inf,h,11.91,µg*h/mL,arith. Mean,32.8,%,%CV,AUC_inf,2.99,µg/mL,arith. Mean,39.5,%,%CV,Cmax,394.2,mL/min,arith. Mean,33.8,%,%CV,CL/F,"CL: Renal clearance; AUC(0-10): 11,41 (32,9)"
1317,Tiseo 1998,https://pubmed.ncbi.nlm.nih.gov/9839762/,PO 800 mg QD,Cimetidine,144,168,h,20.6,ng*h/mL,arith. Mean,1,ng*h/mL,SE,AUC_tend,4,ng/mL,arith. Mean,0.3,ng/mL,SE,Cmax,,,,,,,,
1318,Greenblatt 1986,https://pubmed.ncbi.nlm.nih.gov/2935051/,5 mg Midazolam IV control,Midazolam,0,inf,h,,,,,,,,,,,,,,,10.8,mL/min/kg,arith. Mean,1.4,mL/min/kg,SEM,CLiv,
1319,Greenblatt 1986,https://pubmed.ncbi.nlm.nih.gov/2935051/,"300 mg QD Cimetidine, 5 mg Midazolam IV",Midazolam,24,inf,h,,,,,,,,,,,,,,,12.1,mL/min/kg,arith. Mean,0.92,mL/min/kg,SEM,CLiv,
1320,Greenblatt 1986,https://pubmed.ncbi.nlm.nih.gov/2935051/,15 mg Midazolam PO control,Midazolam,0,inf,h,297,ng*h/mL,arith. Mean,114,ng*h/mL,SEM,AUC_inf,90,ng/mL,arith. Mean,27,ng/mL,SEM,Cmax,16.2,mL/min/kg,arith. Mean,4.4,mL/min/kg,SEM,CL/F,CL: Apparent oral clearance
1321,Greenblatt 1986,https://pubmed.ncbi.nlm.nih.gov/2935051/,"300 mg QD Cimetidine, 15 mg Midazolam PO",Midazolam,24,inf,h,267,ng*h/mL,arith. Mean,45,ng*h/mL,SEM,AUC_inf,95,ng/mL,arith. Mean,30,ng/mL,SEM,Cmax,14.3,mL/min/kg,arith. Mean,3,mL/min/kg,SEM,CL/F,CL: Apparent oral clearance
1322,Martinez 1999,https://pubmed.ncbi.nlm.nih.gov/10223772/,"800 mg Cimetidine, 7.5 mg Midazolam PO",Midazolam,0,inf,h,786.1,nmol*min/mL,arith. Mean,365.2,nmol*min/mL,arith. SD,AUC_inf,,,,,,,,425.9,mL/min,arith. Mean,185,mL/min,arith. SD,CLiv,AUC(0-12): 507.0 ± 265.1
1323,Fee 1987,https://pubmed.ncbi.nlm.nih.gov/3802710/,15 mg Midazolam control,Midazolam,0,inf,h,298,ng*h/mL,arith. Mean,124.5,ng*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,,"Midazolam, 10mg: CL (L/kg/hr): 0.366 ± 0.201"
1324,Fee 1987,https://pubmed.ncbi.nlm.nih.gov/3802710/,"400 mg BID Cimetidine, 15 mg Midazolam",Midazolam,25,inf,h,401,ng*h/mL,arith. Mean,157,ng*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,,
1325,Salonen 1986,https://pubmed.ncbi.nlm.nih.gov/2939688/,15 mg Midazolam PO control,Midazolam,0,inf,h,212.4,ng*h/mL,arith. Mean,58.2,ng*h/mL,arith. SD,AUC_inf,76.9,ng/mL,arith. Mean,17.6,ng/mL,arith. SD,Cmax,,,,,,,,"AUC(0-2): 51,6 ± 33,2"
1326,Salonen 1986,https://pubmed.ncbi.nlm.nih.gov/2939688/,"400 mg Cimetidine, 15 mg Midazolam",Midazolam,2,inf,h,289.9,ng*h/mL,arith. Mean,102.6,ng*h/mL,arith. SD,AUC_inf,105.6,ng/mL,arith. Mean,30.2,ng/mL,arith. SD,Cmax,,,,,,,,"AUC(0-2): 85,9 ± 41,1"
1327,Smith 1984,https://pubmed.ncbi.nlm.nih.gov/6478741/,IV 10 mg Verapamil control,Verapamil,0,inf,h,130,ng*h/mL,arith. Mean,81,ng*h/mL,arith. SD,AUC_inf,368,ng/mL,arith. Mean,187,ng/mL,arith. SD,Cmax,1908,mL/min,arith. Mean,1263,mL/min,arith. SD,CLiv,
1328,Smith 1984,https://pubmed.ncbi.nlm.nih.gov/6478741/,IV 10 mg Verapamil + Cimetidine,Verapamil,168 or 192,inf,h,92,ng*h/mL,arith. Mean,56,ng*h/mL,arith. SD,AUC_inf,353,ng/mL,arith. Mean,192,ng/mL,arith. SD,Cmax,2261,mL/min,arith. Mean,893,mL/min,arith. SD,CLiv,
1329,Smith 1984,https://pubmed.ncbi.nlm.nih.gov/6478741/,PO 120 mg Verapamil control,Verapamil,0,inf,h,376,ng*h/mL,arith. Mean,282,ng*h/mL,arith. SD,AUC_inf,150,ng/mL,arith. Mean,116,ng/mL,arith. SD,Cmax,8713,mL/min,arith. Mean,6145,mL/min,arith. SD,CL/F,
1330,Smith 1984,https://pubmed.ncbi.nlm.nih.gov/6478741/,PO 120 mg Verapamil + Cimetidine,Verapamil,168 or 192,inf,h,515,ng*h/mL,arith. Mean,416,ng*h/mL,arith. SD,AUC_inf,170,ng/mL,arith. Mean,79,ng/mL,arith. SD,Cmax,5320,mL/min,arith. Mean,2344,mL/min,arith. SD,CL/F,
1331,Abernethy 1983,https://pubmed.ncbi.nlm.nih.gov/6137021/,Alprazolam control,Alprazolam,0,inf,h,,,,,,,,15.5,ng/mL,arith. Mean,"6,6-39,4",ng/mL,range,Cmax,1.66,mL/min/kg,arith. Mean,"0,57-2,96",mL/min/kg,range,CL/F,CL: Total clearance
1332,Abernethy 1983,https://pubmed.ncbi.nlm.nih.gov/6137021/,Alprazolam + Cimetidine,Alprazolam,12,inf,h,,,,,,,,16,ng/mL,arith. Mean,"8,7-39,5",ng/mL,range,Cmax,1.05,mL/min/kg,arith. Mean,"0,38-1,88",mL/min/kg,range,CL/F,CL: Total clearance
1333,Abernethy 1983,https://pubmed.ncbi.nlm.nih.gov/6137021/,Triazolam control,Triazolam,0,inf,h,24.5,ng*h/mL,arith. Mean,"13,3-37,1",ng*h/mL,range,AUC_inf,4.9,ng/mL,arith. Mean,"2,4-13",ng/mL,range,Cmax,5.9,mL/min/kg,arith. Mean,"2,2-9,7",mL/min/kg,range,CL/F,CL: Total oral clearance
1334,Abernethy 1983,https://pubmed.ncbi.nlm.nih.gov/6137021/,Triazolam + Cimetidine,Triazolam,12,inf,h,37.8,ng*h/mL,arith. Mean,"13,6-58,3",ng*h/mL,range,AUC_inf,5.9,ng/mL,arith. Mean,"2,1-8,6",ng/mL,range,Cmax,3.9,mL/min/kg,arith. Mean,"1,6-10,4",mL/min/kg,range,CL/F,CL: Total oral clearance
1335,Friedman 1988,https://pubmed.ncbi.nlm.nih.gov/3360971/,Triazolam control,Triazolam,0,inf,h,23.1,ng*h/mL,arith. Mean,4.7,ng*h/mL,arith. SD,AUC_inf,5.7,ng/mL,arith. Mean,1.9,ng/mL,arith. SD,Cmax,,,,,,,,
1336,Friedman 1988,https://pubmed.ncbi.nlm.nih.gov/3360971/,Triazolam + Cimetidine,Triazolam,13,inf,h,35.7,ng*h/mL,arith. Mean,6,ng*h/mL,arith. SD,AUC_inf,7.7,ng/mL,arith. Mean,1.1,ng/mL,arith. SD,Cmax,,,,,,,,
1337,Cox 1986,https://pubmed.ncbi.nlm.nih.gov/3828486/,triazolam control,Triazolam,0,inf,h,16.1,ng*h/mL,arith. Mean,2.3,ng*h/mL,arith. SD,AUC_inf,3.87,ng/mL,arith. Mean,0.32,ng/mL,arith. SD,Cmax,668,mL/min,arith. Mean,68,mL/min,arith. SD,CL/F,
1338,Cox 1986,https://pubmed.ncbi.nlm.nih.gov/3828486/,triazolam + cimetidine,Triazolam,24,inf,h,21.3,ng*h/mL,arith. Mean,2.5,ng*h/mL,arith. SD,AUC_inf,5.38,ng/mL,arith. Mean,0.43,ng/mL,arith. SD,Cmax,485,mL/min,arith. Mean,53,mL/min,arith. SD,CL/F,
1339,Pourbaix 1985,https://pubmed.ncbi.nlm.nih.gov/2864320/,Alprazolam control,Alprazolam,168,inf,h,294,ng*h/mL,arith. Mean,134,ng*h/mL,arith. SD,AUC_inf,18.2,ng/mL,arith. Mean,8.65,ng/mL,arith. SD,Cmax,5.35,mL/min/kg,arith. Mean,1.38,mL/min/kg,arith. SD,,"AUC(0-8): 101 +/- 33,7; AUC(0-72): 279 +/- 128"
1340,Pourbaix 1985,https://pubmed.ncbi.nlm.nih.gov/2864320/,Alprazolam + Cimetidine,Alprazolam,336,inf,h,508,ng*h/mL,arith. Mean,168,ng*h/mL,arith. SD,AUC_inf,33.1,ng/mL,arith. Mean,7.29,ng/mL,arith. SD,Cmax,3.09,mL/min/kg,arith. Mean,0.52,mL/min/kg,arith. SD,,"AUC(0-8): 166 +/- 29,4; AUC(0-72): 483 +/- 147"
1341,Pourbaix 1985,https://pubmed.ncbi.nlm.nih.gov/2864320/,Triazolam control,Triazolam,144,inf,h,31.3,ng*h/mL,arith. Mean,12.6,ng*h/mL,arith. SD,AUC_inf,7.81,ng/mL,arith. Mean,2.59,ng/mL,arith. SD,Cmax,17.9,mL/min/kg,arith. Mean,6.12,mL/min/kg,arith. SD,,"AUC(0-24): 28,6 +/- 10,9"
1342,Pourbaix 1985,https://pubmed.ncbi.nlm.nih.gov/2864320/,Triazolam + Cimetidine,Triazolam,327,inf,h,68.9,ng*h/mL,arith. Mean,26.8,ng*h/mL,arith. SD,AUC_inf,11.8,ng/mL,arith. Mean,4.66,ng/mL,arith. SD,Cmax,8.12,mL/min/kg,arith. Mean,2.67,mL/min/kg,arith. SD,,"AUC(0-24): 59,7 +/- 20,7"
1343,Kienlen 1993,https://link.springer.com/article/10.1007/BF03259596,Alfentanil control,Alfentanil,0,inf,h,,,,,,,,,,,,,,,3.56,mL/min/kg,arith. Mean,1.17,mL/min/kg,arith. SD,CLiv,"CL = total clearance; Unbound fraction of ALF (%): 8,06 +/- 2,86"
1344,Kienlen 1993,https://link.springer.com/article/10.1007/BF03259596,Alfentanil + Cimetidine,Alfentanil,48,inf,h,,,,,,,,,,,,,,,1.27,mL/min/kg,arith. Mean,0.5,mL/min/kg,arith. SD,CLiv,"CL = total clearance; Unbound fraction of ALF (%): 7,73 +/- 2,43"
1345,Elliott 1984,https://pubmed.ncbi.nlm.nih.gov/6152615/,Midazolam/H2O,Midazolam,0,inf,h,187,ng*h/L,arith. Mean,20.3,ng*h/L,SEM,AUC_inf,60,ng/mL,arith. Mean,,,,Cmax,1.2,L/h/kg,arith. Mean,0.13,L/h/kg,SEM,CL/F,
1346,Elliott 1984,https://pubmed.ncbi.nlm.nih.gov/6152615/,Midazolam/cimetidine,Midazolam,26.5,inf,h,377,ng*h/L,arith. Mean,57.8,ng*h/L,SEM,AUC_inf,143,ng/mL,arith. Mean,,,,Cmax,0.62,L/h/kg,arith. Mean,0.08,L/h/kg,SEM,CL/F,
1347,Bodemar 1981,https://pubmed.ncbi.nlm.nih.gov/7249489/,200/400 mg QID,Cimetidine,168,192,h,22.76,µg*h/mL,arith. Mean,2.06,µg*h/mL,SE,AUC_tend,,,,,,,,,,,,,,,"AUC(200mg): 4,118 (2,091-8,616); AUC(400mg): 10,404 (6,161-17,514); Cmax(200mg): 1,43 +/- 0,10 (0,40-3,03); Cmax(400mg): 2,41 +/- 0,29 (1,39-4,35); Cmax(4h after 200mg): 0,64 +/- 0,04 (0,34-1,22)"
210,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Control (without Itraconazole),Pravastatin,0,inf,h,188,ng*h/mL,geo. Mean,,,,AUC_inf,64,ng/mL,arith. Mean,,,,,,,,,,,,
211,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Pravastatin with Itraconazole,Pravastatin,696,inf,h,210,ng*h/mL,geo. Mean,,,,AUC_inf,73,ng/mL,arith. Mean,,,,,,,,,,,,
212,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,11187GA subjects,Pravastatin,0,12,h,203.7,,arith. Mean,126.4,,arith. SD,AUC_tend,93.8,ng/mL,arith. mean,60.6,ng/mL,arith. SD,Cmax,,,,,,,,
213,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,11187GG subjects,Pravastatin,0,12,h,102.7,,arith. Mean,69.1,,arith. SD,AUC_tend,45.6,ng/mL,arith. mean,34.3,ng/mL,arith. SD,Cmax,,,,,,,,
241,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,521CC subjects,Pravastatin,0,12,h,140.1,,arith. Mean,39.3,,arith. SD,AUC_tend,51.9,ng/mL,arith. mean,19.0,ng/mL,arith. SD,Cmax,,,,,,,,
242,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,521TC subjects,Pravastatin,0,12,h,184.7,,arith. Mean,105.0,,arith. SD,AUC_tend,84.4,ng/mL,arith. mean,56.6,ng/mL,arith. SD,Cmax,,,,,,,,
408,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,521TT subjects,Pravastatin,0,12,h,89.5,,arith. Mean,64.0,,arith. SD,AUC_tend,40.3,ng/mL,arith. mean,"28,9",ng/mL,arith. SD,Cmax,,,,,,,,
409,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,Heterozygous carriers of *15B,Pravastatin,0,12,h,207.8,,arith. Mean,119.3,,arith. SD,AUC_tend,91.9,ng/mL,arith. mean,56.6,ng/mL,arith. SD,Cmax,,,,,,,,
410,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,Non-carriers of *15B,Pravastatin,0,12,h,107.7,,arith. Mean,77.4,,arith. SD,AUC_tend,48.4,ng/mL,arith. mean,38.7,ng/mL,arith. SD,Cmax,,,,,,,,
411,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,Heterozygous carriers of *17,Pravastatin,0,12,h,246.4,,arith. Mean,72.5,,arith. SD,AUC_tend,120.6,ng/mL,arith. mean,48.2,ng/mL,arith. SD,Cmax,,,,,,,,
412,Niemi 2004,https://pubmed.ncbi.nlm.nih.gov/15226675/,Non-carriers of *17,Pravastatin,0,12,h,107.3,,arith. Mean,78.9,,arith. SD,AUC_tend,47.3,ng/mL,arith. mean,37.0,ng/mL,arith. SD,Cmax,,,,,,,,
413,Pan 1990,https://pubmed.ncbi.nlm.nih.gov/2125605/,Pravastatin (GC/MS),Pravastatin,0,24,h,152.2,ng*h/mL,arith. Mean,13.5,ng*h/mL,SEM,AUC_tend,64.1,ng/mL,arith. Mean,6.9,ng/mL,SEM,Cmax,,,,,,,,
433,Nishizato 2003,https://pubmed.ncbi.nlm.nih.gov/12811365/,*1b/*1b subjects,Pravastatin,0,24,h,44.2,ng*h/mL,arith. Mean,6.38,ng*h/mL,arith. SD,AUC_tend,14,ng/mL,arith. Mean,,,,,2.39,L/h/kg,arith. Mean,0.44,L/h/kg,arith. SD,,"Cmax data from another paper: Escobar 2005, table II"
434,Nishizato 2003,https://pubmed.ncbi.nlm.nih.gov/12811365/,*1b/*15 subjects,Pravastatin,0,24,h,62.1,ng*h/mL,arith. Mean,21.8,ng*h/mL,arith. SD,AUC_tend,27,ng/mL,arith. Mean,,,,,1.57,L/h/kg,arith. Mean,0.32,L/h/kg,arith. SD,,"Cmax data from another paper: Escobar 2005, table II"
435,Nishizato 2003,https://pubmed.ncbi.nlm.nih.gov/12811365/,*15/*15 subjects,Pravastatin,0,24,h,111.8,ng*h/mL,arith. Mean,,,,AUC_tend,49,ng/mL,arith. Mean,,,,,0.79,L/h/kg,arith. Mean,,,,,"Cmax data from another paper: Escobar 2005, table II"
436,Niemi 2006,https://pubmed.ncbi.nlm.nih.gov/17047488/,SLCO1B1*17 carriers,Pravastatin,0,12,h,246.4,ng*h/mL,arith. Mean,72.5,ng*h/mL,arith. SD,AUC_tend,120.6,ng/ml,arith. Mean,48.2,ng/ml,arith. SD,Cmax,,,,,,,,
437,Niemi 2006,https://pubmed.ncbi.nlm.nih.gov/17047488/,SLCO1B1*17 and ABCC2 c.1446C>G noncarriers,Pravastatin,0,12,h,113.4,ng*h/mL,arith. Mean,79.4,ng*h/mL,arith. SD,AUC_tend,50.0,ng/ml,arith. Mean,37.4,ng/ml,arith. SD,Cmax,,,,,,,,
438,Niemi 2006,https://pubmed.ncbi.nlm.nih.gov/17047488/, ABCC2 c.1446C>G carriers,Pravastatin,0,12,h,36.8,ng*h/mL,arith. Mean,4.3,ng*h/mL,arith. SD,AUC_tend,16.0,ng/ml,arith. Mean,4.3,ng/ml,arith. SD,Cmax,,,,,,,,
439,Bauer 2005,https://pubmed.ncbi.nlm.nih.gov/15734167/,Healthy Volunteers,Pravastatin,,,,,,,,,,,,,,,,,,,,,,,,,
441,Pan 1990,https://pubmed.ncbi.nlm.nih.gov/2116260/,5 mg pravastatin twice daily,Pravastatin,660,672,h,21,ng*h/mL,arith. Mean,2.8,ng*h/mL,SEM,AUC_tend,6.1,ng/mL,arith. Mean,0.9,ng/mL,SEM,Cmax,,,,,,,,"Initial PRA dose (week 0): AUC: 15,5 +/- 2,5, Cmax: 4,9 +/- 0,8"
442,Pan 1990,https://pubmed.ncbi.nlm.nih.gov/2116260/,10 mg pravastatin twice daily,Pravastatin,660,672,h,30,ng*h/mL,arith. Mean,4,ng*h/mL,SEM,AUC_tend,10.6,ng/mL,arith. Mean,1.4,ng/mL,SEM,Cmax,,,,,,,,"Initial PRA dose (week 0): 31,3 +/- 4,8, Cmax: 11,6 +/- 2"
443,Pan 1990,https://pubmed.ncbi.nlm.nih.gov/2116260/,20 mg pravastatin twice daily,Pravastatin,660,672,h,75.4,ng*h/mL,arith. Mean,11.4,ng*h/mL,SEM,AUC_tend,30.6,ng/mL,arith. Mean,7.3,ng/mL,SEM,Cmax,,,,,,,,"Initial PRA dose (week 0): 60,2 +/- 8, Cmax: 26,1 +/- 5,6"
444,Oo 1999,https://link.springer.com/article/10.2165/00044011-199917030-00006,Pravastatin + placebo,Pravastatin,120,132,h,55.6,µg*h/L,arith. Mean,23.5,µg*h/L,arith. SD,AUC_tend,28.8,µg/L,arith. Mean,15.4,µg/L,arith. SD,Cmax,845,L/h,arith. Mean,415,L/h,arith. SD,CL/F,
445,Keskitalo 2009,https://pubmed.ncbi.nlm.nih.gov/19694740/,ABCB1 c.1236T/T-c.2677T/T-c.3435T/T,Pravastatin,0,inf,h,47.8,ng*h/mL,estimated marginal mean,"32,6-70,2",ng*h/mL,95% CI,AUC_inf,22.1,ng/mL,estimated marginal mean,"15-32,6",ng/mL,95% CI,Cmax,,,,,,,,"AUC(0-t): 47,5 (32.4, 69.6)"
446,Ho 2007,https://pubmed.ncbi.nlm.nih.gov/17622941/,Group C/C,Pravastatin,0,5,h,,,,,,,,,,,,,,,,,,,,,,
447,Ho 2007,https://pubmed.ncbi.nlm.nih.gov/17622941/,Group T/C,Pravastatin,0,5,h,,,,,,,,,,,,,,,,,,,,,,
448,Ho 2007,https://pubmed.ncbi.nlm.nih.gov/17622941/,Group T/T,Pravastatin,0,5,h,,,,,,,,,,,,,,,,,,,,,,
449,Ho 2007,https://pubmed.ncbi.nlm.nih.gov/17622941/,European-Americans,Pravastatin,0,5,h,98.3,ng*h/mL,arith. Mean,60.7,ng*h/mL,arith. SD,AUC_tend,53.3,ng/mL,arith. Mean,33.3,ng/mL,arith. SD,Cmax,,,,,,,,
450,Ho 2007,https://pubmed.ncbi.nlm.nih.gov/17622941/,African-Americans,Pravastatin,0,5,h,69.5,ng*h/mL,arith. Mean,56.3,ng*h/mL,arith. SD,AUC_tend,37.4,ng/mL,arith. Mean,29.2,ng/mL,arith. SD,Cmax,,,,,,,,
451,Escobar 2005,https://pubmed.ncbi.nlm.nih.gov/24672127/,Mexican subjects,Pravastatin,0,inf,h,35.7,ng*h/mL,arith. Mean,19.7,ng*h/mL,arith. SD,AUC_inf,9.5,ng/mL,arith. Mean,"2,4",ng/mL,arith. SD,Cmax,,,,,,,,
452,Almeida 2006,https://pubmed.ncbi.nlm.nih.gov/16572920/,Male subjects test formulation,Pravastatin,0,inf,h,186.5,ng*h/mL,arith. Mean,96.14,ng*h/mL,arith. SD,AUC_inf,102.44,ng/mL,arith. Mean,56.06,ng/mL,arith. SD,Cmax,,,,,,,,"(Normalised dose/weight): AUC(inf): 335.73 +/- 163.98, Cmax: 183.4 +/- 92.34; AUC(last): 330.98 +/- 162.43"
453,Almeida 2006,https://pubmed.ncbi.nlm.nih.gov/16572920/,Male subjects reference formulation,Pravastatin,0,inf,h,192.27,ng*h/mL,arith. Mean,82.96,ng*h/mL,arith. SD,AUC_inf,102.49,ng/mL,arith. Mean,46.34,ng/mL,arith. SD,Cmax,,,,,,,,"(Normalised dose/weight): AUC(inf): 348.05 +/- 158.56, Cmax: 185.39 +/- 89.18; AUC(last): 342.94 +/- 158.66"
454,Almeida 2006,https://pubmed.ncbi.nlm.nih.gov/16572920/,Female subjects test formulation,Pravastatin,0,inf,h,274.26,ng*h/mL,arith. Mean,97.61,ng*h/mL,arith. SD,AUC_inf,155.43,ng/mL,arith. Mean,58.25,ng/mL,arith. SD,Cmax,,,,,,,,"(Normalised dose/weight): AUC(inf): 401.67 +/- 143.42, Cmax: 227.04 +/- 82.95; AUC(last): 398.33 +/- 144.94"
455,Almeida 2006,https://pubmed.ncbi.nlm.nih.gov/16572920/,Female subjects reference formulation,Pravastatin,0,inf,h,250.18,ng*h/mL,arith. Mean,66.66,ng*h/mL,arith. SD,AUC_inf,148.37,ng/mL,arith. Mean,50.74,ng/mL,arith. SD,Cmax,,,,,,,,"(Normalised dose/weight): AUC(inf): 365.30 +/- 90.55, Cmax: 217.61 +/- 75.44; AUC(last): 362.90 +/- 91.04"
456,Ogawa 2003,https://pubmed.ncbi.nlm.nih.gov/14551181/,Japanese subjects,Pravastatin,0,inf,h,36.04,ng*h/mL,arith. Mean,18.6,ng*h/mL,arith. SD,AUC_inf,14.04,ng/mL,arith. Mean,8.93,ng/mL,arith. SD,Cmax,,,,,,,,
1117,Mwinyi 2004,https://pubmed.ncbi.nlm.nih.gov/15116054/,Group 1 OATP-C *1a/*1a,Pravastatin,0,6,h,114.5,µg*h/L,arith. Mean,68.5,µg*h/L,arith. SD,AUC_tend,58.3,µg/L,arith. Mean,37.7,µg/L,arith. SD,Cmax,,,,,,,,
1118,Mwinyi 2004,https://pubmed.ncbi.nlm.nih.gov/15116054/,Group 3 OATP-C *1a/*5,Pravastatin,0,6,h,163,µg*h/L,arith. Mean,64.6,µg*h/L,arith. SD,AUC_tend,84.3,µg/L,arith. Mean,32.1,µg/L,arith. SD,Cmax,,,,,,,,
1119,Mwinyi 2004,https://pubmed.ncbi.nlm.nih.gov/15116054/,Group 2 OATP-C *1a/*1b; *1b/*1b,Pravastatin,0,6,h,74.8,µg*h/L,arith. Mean,35.6,µg*h/L,arith. SD,AUC_tend,36.7,µg/L,arith. Mean,21.4,µg/L,arith. SD,Cmax,,,,,,,,
1120,Niemi 2006,https://pubmed.ncbi.nlm.nih.gov/17015053/,SLCO1B1 c.521CC,Pravastatin,0,inf,h,287.4,ng*h/mL,arith. Mean,102.9,ng*h/mL,arith. SD,AUC_inf,141.6,ng/mL,arith. Mean,46.8,ng/mL,arith. SD,Cmax,,,,,,,,
1121,Niemi 2006,https://pubmed.ncbi.nlm.nih.gov/17015053/,SLCO1B1 c.521TC,Pravastatin,0,inf,h,164.8,ng*h/mL,arith. Mean,85.7,ng*h/mL,arith. SD,AUC_inf,73.8,ng/mL,arith. Mean,42.2,ng/mL,arith. SD,Cmax,,,,,,,,
1122,Niemi 2006,https://pubmed.ncbi.nlm.nih.gov/17015053/,SLCO1B1 c.521TT,Pravastatin,0,inf,h,150.3,ng*h/mL,arith. Mean,78.1,ng*h/mL,arith. SD,AUC_inf,68.5,ng/mL,arith. Mean,38.9,ng/mL,arith. SD,Cmax,,,,,,,,
1123,Neuvonen 1998,https://pubmed.ncbi.nlm.nih.gov/9542477/,Pravastatin without Itraconzaole (placebo),Pravastatin,0,inf,h,88.6,ng*h/mL,arith. Mean,32.9,ng*h/mL,SEM,AUC_inf,36.9,ng/mL,arith. Mean,12.6,ng/mL,SEM,Cmax,,,,,,,,
1124,Neuvonen 1998,https://pubmed.ncbi.nlm.nih.gov/9542477/,Pravastatin with Itraconazole,Pravastatin,74,inf,h,152,ng*h/mL,arith. Mean,46.5,ng*h/mL,SEM,AUC_inf,66.4,ng/mL,arith. Mean,23.4,ng/mL,SEM,Cmax,,,,,,,,
1125,Kantola 2000,https://pubmed.ncbi.nlm.nih.gov/10952477/,Pravastatin without Fluconazole (placebo),Pravastatin,0,inf,h,109,ng*h/mL,arith. Mean,85.4,ng*h/mL,arith. SD,AUC_inf,49.5,ng/mL,arith. Mean,39.1,ng/mL,arith. SD,Cmax,,,,,,,,
1126,Kantola 2000,https://pubmed.ncbi.nlm.nih.gov/10952477/,Pravastatin with Fluconazole,Pravastatin,73,inf,h,148,ng*h/mL,arith. Mean,126,ng*h/mL,arith. SD,AUC_inf,66.1,ng/mL,arith. Mean,64.3,ng/mL,arith. SD,Cmax,,,,,,,,
1127,Aberg 2006,https://pubmed.ncbi.nlm.nih.gov/16514303/,Pravastatin without Nelfinivir (placebo),Pravastatin,48,72,h,86.5,ng*h/mL,median,,,,AUC_tend,27.9,ng/mL,median,,,,Cmax,,,,,,,,
1128,Maeda 2011,https://pubmed.ncbi.nlm.nih.gov/21832990/,Pravastatin alone (control),Pravastatin,0,8,h,5.97,pg*h/mL,arith. Mean,2.42,pg*h/mL,arith. SD,AUC_tend,,,,,,,,21.7,L/h,arith. Mean,5.1,L/h,arith. SD,CL/F,"AUC = AUC(0-t)/dose, area under the plasma concentration-time curve from time 0 to t hours normalized by dose in each phase; CL: Renal clearance in relation to plasma concentration"
1129,Maeda 2011,https://pubmed.ncbi.nlm.nih.gov/21832990/,Pravastatin with Itraconazole,Pravastatin,1,9,h,8.79,pg*h/mL,arith. Mean,5.79,pg*h/mL,arith. SD,AUC_tend,,,,,,,,20.7,L/h,arith. Mean,8.6,L/h,arith. SD,CLiv,"AUC = AUC(0-t)/dose, area under the plasma concentration-time curve from time 0 to t hours normalized by dose in each phase; CL: Renal clearance in relation to plasma concentration"
1130,Maeda 2011,https://pubmed.ncbi.nlm.nih.gov/21832990/,Pravastatin with Rifampicin,Pravastatin,0,8,h,27.7,pg*h/mL,arith. Mean,5.2,pg*h/mL,arith. SD,AUC_tend,,,,,,,,18.4,L/h,arith. Mean,1.7,L/h,arith. SD,CL/F,"AUC = AUC(0-t)/dose, area under the plasma concentration-time curve from time 0 to t hours normalized by dose in each phase; CL: Renal clearance in relation to plasma concentration"
1134,Pan 1991,https://pubmed.ncbi.nlm.nih.gov/1907839/,Pravastatin 20 mg,Pravastatin,0,24,h,90.2,ng*h/mL,arith. Mean,11,ng*h/mL,SEM,AUC_tend,38.4,ng/mL,arith. Mean,5.5,ng/mL,SEM,Cmax,,,,,,,,
1135,Keskitalo 2009,https://pubmed.ncbi.nlm.nih.gov/19694740/,ABCB1 c.1236C/C-c.2677G/G-c.3435C/C,Pravastatin,0,inf,h,51.7,ng*h/mL,geom. Mean,,,,AUC_inf,24,ng/mL,geom. Mean,,,,Cmax,,,,,,,,"AUC(0-t): 51.2 (34.9, 75.0); AUC(0-inf): 51.7 (35.2, 75.9); Cmax: (16.3, 35.3)"
1136,Igel 2006,https://pubmed.ncbi.nlm.nih.gov/16678544/,Control,Pravastatin,480,490,h,144.9,ng*h/mL,arith. Mean,48.2,ng*h/mL,arith. SD,AUC_tend,52.7,ng/mL,arith. Mean,22.1,ng/mL,arith. SD,Cmax,23.3,L/h,arith. Mean,9.8,L/h,arith. SD,,CL_R: renal clearance
1137,Igel 2006,https://pubmed.ncbi.nlm.nih.gov/16678544/,Variant,Pravastatin,480,490,h,305,ng*h/mL,arith. Mean,149.4,ng*h/mL,arith. SD,AUC_tend,174.5,ng/mL,arith. Mean,98.6,ng/mL,arith. SD,Cmax,25.9,L/h,arith. Mean,18,L/h,arith. SD,,CL_R: renal clearance
1138,Fukazawa 2003,https://pubmed.ncbi.nlm.nih.gov/15025743/,Water intake group,Pravastatin,0,inf,h,40,ng*h/mL,arith. Mean,,,,AUC_inf,13.3,ng/mL,arith. Mean,,,,Cmax,287,L/h,arith. Mean,,,,CL/F,"AUC(0-24): 37,2(25,6, 54); AUC(0-inf): 40(28,1, 57), Cmax: 13,3(8,2, 21,3), CL/F: 287(140, 434)"
1139,Fukazawa 2003,https://pubmed.ncbi.nlm.nih.gov/15025743/,GFJ intake group,Pravastatin,0,inf,h,39.9,ng*h/mL,arith. Mean,,,,AUC_inf,11.6,ng/mL,arith. Mean,,,,Cmax,264,L/h,arith. Mean,,,,CL/F,"AUC(0-24): 37,1(29,3, 46,8); AUC(0-inf): 39,9(31,4, 50,5), Cmax: 11,6(9,3, 14,5), CL/F: 264(199, 328)"
1140,Koitabashi 2006,https://pubmed.ncbi.nlm.nih.gov/16412477/,Control,Pravastatin,0,4,h,9.5,ng*h/mL,arith. Mean,1.6,ng*h/mL,SEM,AUC_tend,7.6,ng/mL,arith. Mean,1.7,ng/mL,SEM,Cmax,,,,,,,,
1141,Koitabashi 2006,https://pubmed.ncbi.nlm.nih.gov/16412477/,Orange Juice,Pravastatin,0,4,h,14.4,ng*h/mL,arith. Mean,2.1,ng*h/mL,SEM,AUC_tend,9.5,ng/mL,arith. Mean,1.4,ng/mL,SEM,Cmax,,,,,,,,
1142,Liu 2018,https://pubmed.ncbi.nlm.nih.gov/29786857/,Pravastatin alone,Pravastatin,0,inf,h,15.6,ng*h/mL,geom. Mean,62.1,,CV%,AUC_inf,6.1,ng/mL,geom. Mean,61.8,,CV%,Cmax,610,L/h,geo. Mean,62.1,,CV%,CL/F,"AUC(0-t): 15(63,3)"
1143,Ieiri 2014,https://pubmed.ncbi.nlm.nih.gov/23381882/,Control (without Ritonavir),Pravastatin,0,24,h,432,pg*h/mL,arith. Mean,278,pg*h/mL,arith. SD,AUC_tend,142,pg/mL,arith. Mean,108,pg/mL,arith. SD,Cmax,265,L/h,arith. Mean,105,L/h,arith. SD,CL/F,
1145,Azie 1998,https://pubmed.ncbi.nlm.nih.gov/9797793/,Control (without Diltiazem),Pravastatin,0,inf,h,74,ng*min/mL,arith. Mean,58,ng*min/mL,arith. SD,AUC_inf,33,ng/mL,arith. Mean,24,ng/mL,arith. SD,Cmax,,,,,,,,"Table II: (Control): AUC: 2,128-7,330; Cmax: 3-10"
1146,Azie 1998,https://pubmed.ncbi.nlm.nih.gov/9797793/,with Diltiazem,Pravastatin,325,inf,h,76,ng*min/mL,arith. Mean,58,ng*min/mL,arith. SD,AUC_inf,43,ng/mL,arith. Mean,34,ng/mL,arith. SD,Cmax,,,,,,,,"Table II: (Diltiazem): AUC: 6,360-29,834; Cmax: 14-43"
1147,Lutz 2018,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 1, Control",Pravastatin,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1148,Lutz 2018,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 2, Control",Pravastatin,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1149,Lutz 2018,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 2, 2 mg Rifampicin",Pravastatin,276,inf,h,,,,,,,,,,,,,,,,,,,,,,
1150,Lutz 2018,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 1, 10 mg Rifampicin",Pravastatin,276,inf,h,,,,,,,,,,,,,,,,,,,,,,
1151,Lutz 2018,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 1, 75 mg Rifampicin",Pravastatin,708,inf,h,,,,,,,,,,,,,,,,,,,,,,
1152,Lutz 2018,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 2, 600 mg Rifampicin",Pravastatin,708,inf,h,,,,,,,,,,,,,,,,,,,,,,
1165,Sugimoto 2001,https://pubmed.ncbi.nlm.nih.gov/11753267/,Control (without St John's Wort),Pravastatin,0,24,h,109.4,ng*h/mL,arith. Mean,17.4,ng*h/mL,SE,AUC_tend,36.5,ng/mL,arith. Mean,5.7,ng/mL,SE,Cmax,,,,,,,,
1166,Kovarik 2002,https://pubmed.ncbi.nlm.nih.gov/11831546/,Control (without Everolimus),Pravastatin,0,inf,h,72,ng*h/mL,arith. Mean,40,ng*h/mL,arith. SD,AUC_inf,24.4,ng/mL,arith. Mean,19.4,ng/mL,arith. SD,Cmax,,,,,,,,
1167,Wu 2012,https://pubmed.ncbi.nlm.nih.gov/22114872/,Control (with Placebo),Pravastatin,0,10,h,354.6,ng*h/mL,arith. Mean,89.6,ng*h/mL,arith. SD,AUC_tend,123.2,ng/mL,arith. Mean,48.3,ng/mL,arith. SD,Cmax,119.5,L/h,geo. Mean,29.2,L/h,arith. SD,CL/F,
1168,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Control (without Verapamil),Pravastatin,0,24,h,76,ng*h/mL,geom. Mean,,,,AUC_tend,32,ng/mL,geom. Mean,,,,Cmax,,,,,,,,
1169,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Pravastatin with Verapamil,Pravastatin,72,96,h,100,ng*h/mL,geom. Mean,,,,AUC_tend,45,ng/mL,geom. Mean,,,,Cmax,,,,,,,,
1170,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Control (without Mibefradil),Pravastatin,144,154,h,60,ng*h/mL,arith. Mean,,,,AUC_tend,19,ng/mL,median,,,,,,,,,,,,
1171,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Control (without Clarithromycin),Pravastatin,144,154,h,54,ng*h/mL,geom. Mean,,,,AUC_tend,18,ng/mL,geom. Mean,,,,,,,,,,,,
1172,Jacobson 2004,https://pubmed.ncbi.nlm.nih.gov/15518608/,Pravastatin with Clarithromycin,Pravastatin,168,181.5,h,114,ng*h/mL,geom. Mean,,,,AUC_tend,41,ng/mL,geom. Mean,,,,,,,,,,,,
1173,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Control (without Cyclosporin),Pravastatin,0,12,h,162,ng*h/mL,arith. Mean,129,ng*h/mL,arith. SD,AUC_tend,106,ng/mL,arith. Mean,100,ng/mL,arith. SD,Cmax,5.17,L/h/kg,arith. Mean,4.44,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 61.8 +/- 64.6; Cmax: 39.2 +/- 53.1
1174,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Pravastatin with Cyclosporin,Pravastatin,11,23,h,554,ng*h/mL,arith. Mean,380,ng*h/mL,arith. SD,AUC_tend,339,ng/mL,arith. Mean,266,ng/mL,arith. SD,Cmax,1.34,L/h/kg,arith. Mean,0.85,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 169 +/- 126; Cmax: 122 +/- 112
1175,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Genotype TT (without Cyclosporin),Pravastatin,0,12,h,154,ng*h/mL,arith. Mean,153,ng*h/mL,arith. SD,AUC_tend,98.8,ng/mL,arith. Mean,114,ng/mL,arith. SD,Cmax,6.12,L/h/kg,arith. Mean,5.34,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 43.3 +/- 14.7; Cmax: 22 +/- 9.3
1176,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Genotype TC (without Cyclosporin),Pravastatin,0,12,h,124,ng*h/mL,arith. Mean,58,ng*h/mL,arith. SD,AUC_tend,79.1,ng/mL,arith. Mean,50,ng/mL,arith. SD,Cmax,5.42,L/h/kg,arith. Mean,3.77,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 48 +/- 23.2; Cmax: 31.4 +/- 19
1177,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Genotype CC (without Cyclosporin),Pravastatin,0,12,h,290,ng*h/mL,arith. Mean,148,ng*h/mL,arith. SD,AUC_tend,201,ng/mL,arith. Mean,136,ng/mL,arith. SD,Cmax,1.65,L/h/kg,arith. Mean,0.68,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 154 +/- 147; Cmax: 111 +/- 126
1178,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Genotype TT (with Cyclosporin),Pravastatin,11,23,h,572,ng*h/mL,arith. Mean,488,ng*h/mL,arith. SD,AUC_tend,364,ng/mL,arith. Mean,360,ng/mL,arith. SD,Cmax,1.47,L/h/kg,arith. Mean,0.98,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 187 +/- 175; Cmax: 136 +/- 158
1179,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Genotype TC (with Cyclosporin),Pravastatin,11,23,h,436,ng*h/mL,arith. Mean,198,ng*h/mL,arith. SD,AUC_tend,266,ng/mL,arith. Mean,153,ng/mL,arith. SD,Cmax,1.45,L/h/kg,arith. Mean,0.74,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 131 +/- 57.9; Cmax: 99.5 +/- 52.3
1180,Yee 2019,https://pubmed.ncbi.nlm.nih.gov/30982223/,Genotype CC (with Cyclosporin),Pravastatin,11,23,h,818,ng*h/mL,arith. Mean,351,ng*h/mL,arith. SD,AUC_tend,458,ng/mL,arith. Mean,166,ng/mL,arith. SD,Cmax,0.64,L/h/kg,arith. Mean,0.48,L/h/kg,arith. SD,CL/F,Values from Table 1 = acc. to Table S3 = Pravastatin Pravastatin plus 3'alpha-hydroxy pravastatin); PRA only (Table S3): AUC_last: 212 +/- 89.8; Cmax: 143 +/- 87.6
1181,Becquemont 1999,https://pubmed.ncbi.nlm.nih.gov/10226769/,Control Day 1 (without Mibefradil),Pravastatin,0,inf,h,170,ng*h/mL,geom. Mean,,,,AUC_inf,91,ng/mL,geom. Mean,,,,Cmax,,,,,,,,AUC(0-inf): 170(117-395); Cmax: 91(72-200)
1182,Becquemont 2007,https://pubmed.ncbi.nlm.nih.gov/17301736/,Control (without Amiodarone),Pravastatin,0,24,h,137.8,ng*h/mL,arith. Mean,58.8,ng*h/mL,arith. SD,AUC_tend,67.1,ng/mL,arith. Mean,37.7,ng/mL,arith. SD,Cmax,,,,,,,,
1183,Becquemont 2007,https://pubmed.ncbi.nlm.nih.gov/17301736/,with Amiodarone,Pravastatin,72,96,h,124,ng*h/mL,arith. Mean,59.3,ng*h/mL,arith. SD,AUC_tend,51.5,ng/mL,arith. Mean,28.8,ng/mL,arith. SD,Cmax,,,,,,,,
1184,Mazzu 2000,https://pubmed.ncbi.nlm.nih.gov/11061579/,Pravastatin alone,Pravastatin,0,inf,h,50.6,µg*h/L,geom. Mean,60.6,%,%CV,AUC_inf,20.9,µg/L,geom. Mean,73.7,µg/L,% CV,Cmax,,,,,,,,"AUC(0-tn)=48,4 (59,5) : Geo mean (%CV)"
1185,Mazzu 2000,https://pubmed.ncbi.nlm.nih.gov/11061579/,Pravastatin + Itraconazole,Pravastatin,100,inf,h,75.2,µg*h/L,geom. Mean,60.6,%,%CV,AUC_inf,25.9,µg/L,geom. Mean,78,µg/L,% CV,Cmax,,,,,,,,"AUC(0-tn)=75,4 (61,6) : Geo mean (%CV)"
1186,Lilja 1999,https://pubmed.ncbi.nlm.nih.gov/10460065/,Water,Pravastatin,0,inf,h,112.3,ng*h/mL,arith. Mean,66.3,ng*h/mL,arith. SD,AUC_inf,45.3,ng/mL,arith. Mean,28,ng/mL,arith. SD,Cmax,,,,,,,,"AUC(0-24): 111,7 +/- 68,1"
1187,Lilja 1999,https://pubmed.ncbi.nlm.nih.gov/10460065/,GFJ,Pravastatin,0,inf,h,103,ng*h/mL,arith. Mean,48.4,ng*h/mL,arith. SD,AUC_inf,42.6,ng/mL,arith. Mean,25.3,ng/mL,arith. SD,Cmax,,,,,,,,"AUC(0-24): 102,8 +/- 49,6(49-193)"
1188,Pan 2000,https://pubmed.ncbi.nlm.nih.gov/10709162/,Pravastatin (without Fenofibrate),Pravastatin,0,inf,h,71.2,ng*h/mL,arith. mean,36.5,ng*h/mL,arith. SD,AUC_inf,35.2,ng/mL,arith. Mean,20.67,ng/mL,arith. SD,Cmax,800,L/h,arith. mean,611.6,L/h,arith. SD,CL/F,
1189,Gustavson 2005,https://pubmed.ncbi.nlm.nih.gov/16027406/,Pravastatin (without Fenofibrate),Pravastatin,96,120,h,61,ng*h/mL,arith. Mean,33.7,ng*h/mL,arith. SD,AUC_tend,24.8,ng/mL,arith. Mean,16.7,ng/mL,arith. SD,Cmax,901.1,L/h,arith. Mean,533.4,L/h,arith. SD,CL/F,
1190,Aquilante 2012,https://pubmed.ncbi.nlm.nih.gov/22174437/,Pravastatin alone Day 4 Group 1,Pravastatin,72,96,h,63,ng*h/mL,arith. Mean,25,ng*h/mL,arith. SD,AUC_tau,28,ng/mL,arith. Mean,15,ng/mL,arith. SD,Cmax,9.1,L/h/kg,arith. Mean,3.5,L/h/kg,arith. SD,CL/F,(n=28); weight-adjusted CL/F
1191,Aquilante 2012,https://pubmed.ncbi.nlm.nih.gov/22174437/,Pravastatin alone Day 4 Group 2,Pravastatin,72,96,h,87,ng*h/mL,arith. Mean,36,ng*h/mL,arith. SD,AUC_tau,33,ng/mL,arith. Mean,17,ng/mL,arith. SD,Cmax,9.9,L/h/kg,arith. Mean,10.3,L/h/kg,arith. SD,CL/F,(n=28); weight-adjusted CL/F
1192,Aquilante 2012,https://pubmed.ncbi.nlm.nih.gov/22174437/,Pravastatin alone Day 4 Group 3,Pravastatin,72,96,h,123,ng*h/mL,arith. Mean,80,ng*h/mL,arith. SD,AUC_tau,46,ng/mL,arith. Mean,39,ng/mL,arith. SD,Cmax,7.3,L/h/kg,arith. Mean,5,L/h/kg,arith. SD,CL/F,(n=28); weight-adjusted CL/F
1193,Van Luin 2010,https://pubmed.ncbi.nlm.nih.gov/20395869/,Pravastatin (without Raltegravir),Pravastatin,72,96,h,157,µg*h/L,geom. Mean,,,,AUC_tend,58.4,µg/L,geom. Mean,,,,Cmax,255,L/h,geo. Mean,,,,CL/F,"95% CI for Geom.Mean: AUC(0-24): 127-194, Cmax: 45.1-75.6, CL/F: 206-315"
1195,Derks 2010,https://pubmed.ncbi.nlm.nih.gov/20489031/,Pravastatin (without Dalcetrapib),Pravastatin,168,192,h,67.9,ng*h/mL,arith. Mean,55.9,ng*h/mL,arith. SD,AUC_tend,27.5,ng/mL,arith. Mean,23.9,ng/mL,arith. SD,Cmax,,,,,,,,
1196,Park 2002,https://pubmed.ncbi.nlm.nih.gov/12395976/,healthy individuals,Pravastatin,0,inf,h,172,ng*h/mL,arith. Mean,128.7,ng*h/mL,arith. SD,AUC_inf,82.3,ng/mL,arith. Mean,64.1,ng/mL,arith. SD,Cmax,,,,,,,,"Cmax: Median = 68,5, Range = 1.0-2.5; AUC(0-inf): Median  =126.0, Range = 54.0-428.0); AUC (0-24): Mean +/- SD = 157.5 +/- 121.9, Median = 119.2, Range = 49.4-388.7"
1197,Kyrklund 2003,https://pubmed.ncbi.nlm.nih.gov/12811363/,with Placebo,Pravastatin,0,inf,h,139,ng*h/mL,arith. mean,67.6,ng*h/mL,arith. SD,AUC_inf,66.3,ng/mL,arith. Mean,43,ng/mL,arith. SD,Cmax,25,L/h,arith. mean,6.3,L/h,arith. SD,CL/F,"AUC(0-24) =138,7 ±  67,6 (Arith mean± SD) (ng*h/ml); CL = CL_renal(0-24)"
1198,Kyrklund 2003,https://pubmed.ncbi.nlm.nih.gov/12811363/,with Gemfibrozil,Pravastatin,49,inf,h,280.6,ng*h/mL,arith. mean,190.1,ng*h/mL,arith. SD,AUC_inf,120,ng/mL,arith. Mean,89.3,ng/mL,arith. SD,Cmax,14.3,L/h,arith. mean,5.6,L/h,arith. SD,CL/F,"AUC(0-24) =279,8 ±  189,5 (Arith mean± SD) (ng*h/ml); CL = CL_renal(0-24)"
1199,Kyrklund 2004,https://pubmed.ncbi.nlm.nih.gov/14748817/,with Placebo,Pravastatin,0,inf,h,142,ng*h/mL,arith. mean,99.6,ng*h/mL,arith. SD,AUC_inf,65.1,ng/mL,arith. Mean,46,ng/mL,arith. SD,Cmax,24.2,L/h,arith. mean,3.5,L/h,arith. SD,CL/F,"Parameter CL is renal clearance from 0-12 h; AUC(0-12) =141 ±  99,6 (Arith mean± SD) (ng*h/ml)"
1200,Kyrklund 2004,https://pubmed.ncbi.nlm.nih.gov/14748817/,with Rifampicin (MD 600 mg),Pravastatin,113,inf,h,98.1,ng*h/mL,arith. mean,79.8,ng*h/mL,arith. SD,AUC_inf,51.3,ng/mL,arith. Mean,44.7,ng/mL,arith. SD,Cmax,26.2,L/h,arith. mean,3.3,L/h,arith. SD,CL/F,"Parameter CL is renal clearance from 0-12 h; AUC(0-12) =97,5 ±  79,5 (Arith mean± SD) (ng*h/ml)"
1201,Deng 2009,https://pubmed.ncbi.nlm.nih.gov/19695392/,with Placebo,Pravastatin,0,inf,h,275.1,ng*h/mL,arith. Mean,58.5,ng*h/mL,arith. SD,AUC_inf,115.8,ng/mL,arith. Mean,77.5,ng/mL,arith. SD,Cmax,1.3,L/h/kg,arith. Mean,0.58,L/h/kg,arith. SD,CL/F,"AUC(0-12): 259(133,4)"
1202,Deng 2009,https://pubmed.ncbi.nlm.nih.gov/19695392/,with Rifampicin (SD 600 mg),Pravastatin,0,inf,h,623.3,ng*h/mL,arith. Mean,248.8,ng*h/mL,arith. SD,AUC_inf,315.7,ng/mL,arith. Mean,227.2,ng/mL,arith. SD,Cmax,0.52,L/h/kg,arith. Mean,0.18,L/h/kg,arith. SD,CL/F,"AUC(0-12): 604,8(73,3)"
1203,Singhvi 1990,https://pubmed.ncbi.nlm.nih.gov/2106337/,intravenous 9.9 mg,Pravastatin,0,inf,h,171.2,ng*h/mL,arith. mean,28.7,ng*h/mL,arith. SD,AUC_inf,,,,,,,,13.5,mL/min/kg,arith. Mean,2.4,mL/min/kg,arith. SD,CLiv,"IV dose: Renal clearance: 6,3 +/- 1,0 (mL/min/kg)"
1204,Singhvi 1990,https://pubmed.ncbi.nlm.nih.gov/2106337/,oral 19.2 mg,Pravastatin,0,inf,h,66.2,ng*h/mL,arith. mean,32.1,ng*h/mL,arith. SD,AUC_inf,27.4,ng/mL,arith. Mean,10.7,ng/mL,arith. SD,Cmax,,,,,,,,
1205,Singhvi 1990,https://pubmed.ncbi.nlm.nih.gov/2106337/,intravenous 9.9 mg (urine),Pravastatin,0,48,h,,,,,,,,,,,,,,,,,,,,,,47% excreted in Urine after 48h
1206,Singhvi 1990,https://pubmed.ncbi.nlm.nih.gov/2106337/,oral 19.2 mg (urine),Pravastatin,0,48,h,,,,,,,,,,,,,,,,,,,,,,8% excreted in Urine after 48h
1348,Lutz 2018,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 1, Control",Midazolam,inf,inf,h,,,,,,,,,,,,,,,,,,,,,,
1349,Lutz 2018,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 2, Control",Midazolam,inf,inf,h,,,,,,,,,,,,,,,,,,,,,,
1350,Lutz 2018,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 2, 2 mg Rifampicin",Midazolam,228,inf,h,,,,,,,,,,,,,,,,,,,,,,
1351,Lutz 2018,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 1, 10 mg Rifampicin",Midazolam,228,inf,h,,,,,,,,,,,,,,,,,,,,,,
1352,Lutz 2018,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 1, 75 mg Rifampicin",Midazolam,660,inf,h,,,,,,,,,,,,,,,,,,,,,,
1353,Lutz 2018,https://pubmed.ncbi.nlm.nih.gov/29569723/,"Cohort 2, 600 mg Rifampicin",Midazolam,660,inf,h,,,,,,,,,,,,,,,,,,,,,,
1361,Chattopadhyay 2018,https://pubmed.ncbi.nlm.nih.gov/30171692/,Control (without Rifampicin),Midazolam,0,inf,h,9750,ng*h/mL,geo. Mean,25,%,%CV,AUC_inf,3470,ng/mL,geo. mean,31.9,%,%CV,Cmax,103,L/h,geo. mean,25,%,%CV,CL/F,
1362,Chattopadhyay 2018,https://pubmed.ncbi.nlm.nih.gov/30171692/,with Perpetrator (Rifampicin),Midazolam,168,inf,h,1420,ng*h/mL,geo. Mean,36.8,%,%CV,AUC_inf,554,ng/mL,geo. mean,43.7,%,%CV,Cmax,702,L/h,geo. mean,36.8,%,%CV,CL/F,
1363,Chattopadhyay 2018,https://pubmed.ncbi.nlm.nih.gov/30171692/,Rifampicin,Rifampicin,,,,,,,,,,,,,,,,,,,,,,,,,
1364,Ahonen 1997,https://pubmed.ncbi.nlm.nih.gov/9049584/,Fluconazole i.v.,Fluconazole,0,18,h,118,mg*h/L,arith. Mean,7.5,mg*h/L,SEM,AUC_tend,8.4,mg/L,arith. Mean,0.6,mg/L,SEM,Cmax,,,,,,,,
1365,Ahonen 1997,https://pubmed.ncbi.nlm.nih.gov/9049584/,Fluconazole oral,Fluconazole,0,18,h,121,mg*h/L,arith. Mean,9.5,mg*h/L,SEM,AUC_tend,8.2,mg/L,arith. Mean,0.6,mg/L,SEM,Cmax,,,,,,,,
1366,Brammer 1990,https://pubmed.ncbi.nlm.nih.gov/2184510/,Fluconazole i.v. ,Fluconazole,,,,,,,,,,,,,,,,,,,,,,,,,
1367,Brammer 1990,https://pubmed.ncbi.nlm.nih.gov/2184510/,Fluconazole SD 50 mg oral,Fluconazole,,,,,,,,,,,,,,,,,,,,,,,,,
1368,Brammer 1990,https://pubmed.ncbi.nlm.nih.gov/2184510/,Fluconazole MD 200 mg oral,Fluconazole,,,,,,,,,,,,,,,,,,,,,,,,,
1369,Brammer 1990,https://pubmed.ncbi.nlm.nih.gov/2184510/,Fluconazole MD 300 mg oral,Fluconazole,,,,,,,,,,,,,,,,,,,,,,,,,
1370,Brammer 1990,https://pubmed.ncbi.nlm.nih.gov/2184510/,Fluconazole MD 400 mg oral,Fluconazole,,,,,,,,,,,,,,,,,,,,,,,,,
1371,Palkama 1998,https://pubmed.ncbi.nlm.nih.gov/9661572/,Fluconazole i.v ,Fluconazole,0,11,h,75,µg*h/mL,arith. Mean,19,µg*h/mL,arith. SD,AUC_tend,8.9,µg/mL,arith. Mean,2.5,µg/mL,arith. SD,Cmax,,,,,,,,
1372,Palkama 1998,https://pubmed.ncbi.nlm.nih.gov/9661572/,Fluconazole oral ,Fluconazole,0,11,h,66.8,µg*h/mL,arith. Mean,15.6,µg*h/mL,arith. SD,AUC_tend,7.7,µg/mL,arith. Mean,2,µg/mL,arith. SD,Cmax,,,,,,,,
1373,Ripa 1993,https://pubmed.ncbi.nlm.nih.gov/8444063/,Fluconazole i.v.,Fluconazole,0,inf,h,81.12,mg*h/L,arith. Mean,12.87,mg*h/L,arith. SD,AUC_inf,2.86,µg/mL,arith. Mean,0.51,µg/mL,arith. SD,Cmax,,,,,,,,
1374,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole i.v. 25 mg,Fluconazole,0,inf,h,19.2,µg*h/mL,arith. Mean,1.3,µg*h/mL,SE,AUC_inf,0.76,µg/mL,arith. Mean,0.08,µg/mL,arith. SD,Cmax,,,,,,,,
1375,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole i.v. 50 mg,Fluconazole,0,inf,h,39,µg*h/mL,arith. Mean,3.1,µg*h/mL,SE,AUC_inf,1.33,µg/mL,arith. Mean,0.1,µg/mL,arith. SD,Cmax,,,,,,,,
1376,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole i.v. 25 mg urine,Fluconazole,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1377,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole i.v. 50 mg urine,Fluconazole,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1378,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole oral 25 mg,Fluconazole,0,inf,h,20.3,µg*h/mL,arith. Mean,0.6,µg*h/mL,SE,AUC_inf,0.53,µg/mL,arith. Mean,0.03,µg/mL,SE,Cmax,,,,,,,,
1379,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole oral 50 mg,Fluconazole,0,inf,h,34.7,µg*h/mL,arith. Mean,1.8,µg*h/mL,SE,AUC_inf,0.92,µg/mL,arith. Mean,0.03,µg/mL,SE,Cmax,,,,,,,,
1380,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole oral 100 mg,Fluconazole,0,inf,h,86.9,µg*h/mL,arith. Mean,4.5,µg*h/mL,SE,AUC_inf,1.88,µg/mL,arith. Mean,0.08,µg/mL,SE,Cmax,,,,,,,,
1381,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole oral 25 mg urine,Fluconazole,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1382,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole oral 50 mg urine,Fluconazole,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1383,Shiba 1990,https://pubmed.ncbi.nlm.nih.gov/2379224/,Fluconazole oral 100 mg urine,Fluconazole,0,inf,h,,,,,,,,,,,,,,,,,,,,,,
1384,Sobue 2004,https://pubmed.ncbi.nlm.nih.gov/15206988/,Fluconazole i.v.,Fluconazole,312,336,h,608,µg*h/mL,arith. Mean,115.4,µg*h/mL,arith. SD,AUC_tau,33.6,µg/mL,arith. Mean,6.11,µg/mL,arith. SD,Cmax,23,mL/min,arith. Mean,4,mL/min,arith. SD,CLiv,
1385,Yeates 1994,https://pubmed.ncbi.nlm.nih.gov/7946940/,Fluconazole i.v. healthy,Fluconazole,0,inf,h,,,,,,,,2.8,µg/mL,arith. Mean,0.4,µg/mL,arith. SD,Cmax,,,,,,,,
1386,Brammer 1991,https://pubmed.ncbi.nlm.nih.gov/1680653/,Fluconazole 50 mg oral,Fluconazole,0,inf,h,,,,,,,,1.13,µg/mL,arith. Mean,0.19,µg/mL,arith. SD,Cmax,,,,,,,,
1387,Thorpe 1990,https://pubmed.ncbi.nlm.nih.gov/2291673/,Fluconazole oral without antacida,Fluconazole,0,inf,h,93,µg*h/mL,arith. Mean,13.82,µg*h/mL,arith. SD,AUC_inf,1.7,µg/mL,arith. Mean,0.26,µg/mL,arith. SD,Cmax,,,,,,,,
1388,Varhe 1996c,https://pubmed.ncbi.nlm.nih.gov/8904618/,Fluconazole 50 mg oral,Fluconazole,72,96,h,,,,,,,,2.2,mg/L,arith. Mean,0.1,mg/L,SEM,Cmax,,,,,,,,
1389,Varhe 1996c,https://pubmed.ncbi.nlm.nih.gov/8904618/,Fluconazole 100 mg oral,Fluconazole,72,96,h,,,,,,,,4.4,mg/L,arith. Mean,0.3,mg/L,SEM,Cmax,,,,,,,,
1390,Varhe 1996c,https://pubmed.ncbi.nlm.nih.gov/8904618/,Fluconazole 200 mg oral,Fluconazole,72,96,h,,,,,,,,10.6,mg/L,arith. Mean,0.4,mg/L,SEM,Cmax,,,,,,,,
1391,Ahonen 1997,https://pubmed.ncbi.nlm.nih.gov/9049584/,Midazolam placebo,Midazolam,1,18,h,112,ng*h/mL,arith. Mean,15.6,ng*h/mL,arith. SD,AUC_tend,37.4,ng/mL,arith. Mean,3.9,ng/mL,arith. SD,Cmax,,,,,,,,
1392,Ahonen 1997,https://pubmed.ncbi.nlm.nih.gov/9049584/,Midazolam with perpetrator fluconazole i.v,Midazolam,1,18,h,345,ng*h/mL,arith. Mean,30.2,ng*h/mL,arith. SD,AUC_tend,66.8,ng/mL,arith. Mean,8,ng/mL,arith. SD,Cmax,,,,,,,,
1393,Ahonen 1997,https://pubmed.ncbi.nlm.nih.gov/9049584/,Midazolam with perpetrator fluconazole oral,Midazolam,1,18,h,382,ng*h/mL,arith. Mean,35.4,ng*h/mL,arith. SD,AUC_tend,85.9,ng/mL,arith. Mean,9.8,ng/mL,arith. SD,Cmax,,,,,,,,
1394,Varhe 1996c,https://pubmed.ncbi.nlm.nih.gov/8904618/,Triazolam with perpetrator fluconazole 50mg ,Triazolam,1,19,h,14.6,ng*h/mL,arith. Mean,1.6,ng*h/mL,SEM,AUC_tend,2.2,ng/mL,arith. Mean,0.3,ng/mL,SEM,Cmax,,,,,,,,
1395,Varhe 1996c,https://pubmed.ncbi.nlm.nih.gov/8904618/,Triazolam with perpetrator fluconazole 100mg ,Triazolam,1,19,h,18.3,ng*h/mL,arith. Mean,1.4,ng*h/mL,SEM,AUC_tend,2.1,ng/mL,arith. Mean,0.1,ng/mL,SEM,Cmax,,,,,,,,
1396,Varhe 1996c,https://pubmed.ncbi.nlm.nih.gov/8904618/,Triazolam with perpetrator fluconazole 200mg ,Triazolam,1,19,h,33.6,ng*h/mL,arith. Mean,4,ng*h/mL,SEM,AUC_tend,3.5,ng/mL,arith. Mean,0.4,ng/mL,SEM,Cmax,,,,,,,,
1397,Palkama 1998,https://pubmed.ncbi.nlm.nih.gov/9661572/,Alfentanil placebo,Alfentanil,1,11,h,117.8,ng*h/mL,arith. Mean,41.1,ng*h/mL,arith. SD,AUC_tend,65.9,ng/mL,arith. Mean,,,,,,,,,,,,
1398,Palkama 1998,https://pubmed.ncbi.nlm.nih.gov/9661572/,Alfentanil with perpetrator fluconazole i.v.,Alfentanil,1,11,h,243.8,ng*h/mL,arith. Mean,49.5,ng*h/mL,arith. SD,AUC_tend,79.1,ng/mL,arith. Mean,,,,,,,,,,,,
1399,Palkama 1998,https://pubmed.ncbi.nlm.nih.gov/9661572/,Alfentanil with perpetrator fluconazole po,Alfentanil,1,11,h,231.5,ng*h/mL,arith. Mean,62.2,ng*h/mL,arith. SD,AUC_tend,68.4,ng/mL,arith. Mean,,,,,,,,,,,,
5082,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,mean,Amikacin,0,72,h,,,,,,,,,,,,,,,0.123,L/h/kg,Arith. Mean,52,%,geoSD,CLiv,Table 2
5083,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID1,Amikacin,0,72,h,,,,,,,,,,,,,,,0.053,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5084,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID2,Amikacin,0,72,h,,,,,,,,,,,,,,,0.073,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5085,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID3,Amikacin,0,72,h,,,,,,,,,,,,,,,0.095,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5086,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID4,Amikacin,0,72,h,,,,,,,,,,,,,,,0.106,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5087,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID5,Amikacin,0,72,h,,,,,,,,,,,,,,,0.118,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5088,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID6,Amikacin,0,72,h,,,,,,,,,,,,,,,0.12,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5089,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID7,Amikacin,0,72,h,,,,,,,,,,,,,,,0.127,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5090,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID8,Amikacin,0,72,h,,,,,,,,,,,,,,,0.15,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5091,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID9,Amikacin,0,72,h,,,,,,,,,,,,,,,0.181,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5092,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID10,Amikacin,0,72,h,,,,,,,,,,,,,,,0.19,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5093,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID11,Amikacin,0,72,h,,,,,,,,,,,,,,,0.196,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5094,Treluyer 2002,https://www.ncbi.nlm.nih.gov/pubmed/11959572,ID12,Amikacin,0,72,h,,,,,,,,,,,,,,,0.177,L/h/kg,individual,,,,CLiv,POP-PK Point estimate Scanned from figure 1
5095,Vogelstein,https://www.ncbi.nlm.nih.gov/pubmed/874697,mean,Amikacin,0,225,min,,,,,,,,,,,,,,,2.49,mL/min/kg,arith. Mean,0.75,mL/min/kg,arith. SD,CLiv,Table 1
5096,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID1,Amikacin,0,225,min,,,,,,,,,,,,,,,1.74,mL/min/kg,individual,,,,CLiv,Table 1
5097,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID2,Amikacin,0,225,min,,,,,,,,,,,,,,,1.44,mL/min/kg,individual,,,,CLiv,Table 1
5098,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID3,Amikacin,0,225,min,,,,,,,,,,,,,,,2.56,mL/min/kg,individual,,,,CLiv,Table 1
5099,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID4,Amikacin,0,225,min,,,,,,,,,,,,,,,1.35,mL/min/kg,individual,,,,CLiv,Table 1
5100,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID5,Amikacin,0,225,min,,,,,,,,,,,,,,,2.64,mL/min/kg,individual,,,,CLiv,Table 1
5101,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID6,Amikacin,0,225,min,,,,,,,,,,,,,,,2.19,mL/min/kg,individual,,,,CLiv,Table 1
5102,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID7,Amikacin,0,225,min,,,,,,,,,,,,,,,4.22,mL/min/kg,individual,,,,CLiv,Table 1
5103,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID8,Amikacin,0,225,min,,,,,,,,,,,,,,,2.63,mL/min/kg,individual,,,,CLiv,Table 1
5104,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID9,Amikacin,0,225,min,,,,,,,,,,,,,,,4.26,mL/min/kg,individual,,,,CLiv,Table 1
5105,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID10,Amikacin,0,225,min,,,,,,,,,,,,,,,2.3,mL/min/kg,individual,,,,CLiv,Table 1
5106,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID11,Amikacin,0,225,min,,,,,,,,,,,,,,,1.91,mL/min/kg,individual,,,,CLiv,Table 1
5107,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID12,Amikacin,0,225,min,,,,,,,,,,,,,,,2.3,mL/min/kg,individual,,,,CLiv,Table 1
5108,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID13,Amikacin,0,225,min,,,,,,,,,,,,,,,2.23,mL/min/kg,individual,,,,CLiv,Table 1
5109,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID14,Amikacin,0,225,min,,,,,,,,,,,,,,,2.58,mL/min/kg,individual,,,,CLiv,Table 1
5110,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID15,Amikacin,0,225,min,,,,,,,,,,,,,,,2.86,mL/min/kg,individual,,,,CLiv,Table 1
5111,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID16,Amikacin,0,225,min,,,,,,,,,,,,,,,2.88,mL/min/kg,individual,,,,CLiv,Table 1
5112,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID17,Amikacin,0,225,min,,,,,,,,,,,,,,,3.31,mL/min/kg,individual,,,,CLiv,Table 1
5113,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID18,Amikacin,0,225,min,,,,,,,,,,,,,,,1.88,mL/min/kg,individual,,,,CLiv,Table 1
5114,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID19,Amikacin,0,225,min,,,,,,,,,,,,,,,2.06,mL/min/kg,individual,,,,CLiv,Table 1
5115,Vogelstein 1977,https://www.ncbi.nlm.nih.gov/pubmed/874697,ID20,Amikacin,0,225,min,,,,,,,,,,,,,,,2.47,mL/min/kg,individual,,,,CLiv,Table 1
5116,Belfayol 1996,https://www.ncbi.nlm.nih.gov/pubmed/11866842,mean,Amikacin,0,24,h,,,,,,,,,,,,,,,56.3,mL/min,arith. Mean,33.8,mL/min,arith. SD,CLiv,Table 1
5399,Walker 1979,https://www.ncbi.nlm.nih.gov/pubmed/762009,Volunteer 9,Amikacin,0,8,h,,,,,,,,,,,,,,,90.1,mL/min,Individual,,,,CLiv,
5400,Walker 1979,https://www.ncbi.nlm.nih.gov/pubmed/762009,population,Amikacin,0,8,h,,,,,,,,,,,,,,,84.6,mL/min,Arith.mean,18,mL/min,arith. SD,CLiv,
5417,Walker 1979,https://www.ncbi.nlm.nih.gov/pubmed/762009,Volunteer 6,Amikacin,0,8,h,,,,,,,,,,,,,,,66,mL/min,Individual,,,,CLiv,
5117,Boekh 1988,https://www.ncbi.nlm.nih.gov/pubmed/3279907,mean 0.5g,vancomycin,0,720,min,,,,,,,,,,,,,,,94.5,mL/min,arith. Mean,15.9,mL/min,arith. SD,CLiv,Table 1
5118,Boekh 1988,https://www.ncbi.nlm.nih.gov/pubmed/3279907,mean 1g,vancomycin,0,720,min,,,,,,,,,,,,,,,96.5,mL/min,arith. Mean,18.1,mL/min,arith. SD,CLiv,Table 1
5119,Healy 1987,https://www.ncbi.nlm.nih.gov/pubmed/3579256,mean 0.5g,vancomycin,0,61.00335,h,,,,,,,,,,,,,,,84.8,mL/min,arith. Mean,11.5,mL/min/1.73m2,arith. SD,CLiv,At steady state (Table 1)
5120,Healy 1987,https://www.ncbi.nlm.nih.gov/pubmed/3579256,mean 1g,vancomycin,0,61.28713,h,,,,,,,,,,,,,,,86.1,mL/min,arith. Mean,8.9,mL/min/1.73m2,arith. SD,CLiv,At steady state (Table 2)
5121,Schaad 1980,https://www.ncbi.nlm.nih.gov/pubmed/7350291,ID 1,vancomycin,0,6.5,h,,,,,,,,,,,,,,,3.641618497,mL/min,arith. Mean,,,,CLiv,
5122,Schaad 1980,https://www.ncbi.nlm.nih.gov/pubmed/7350291,ID 2,vancomycin,0,7,h,,,,,,,,,,,,,,,8.092485549,mL/min,arith. Mean,,,,CLiv,
5123,Schaad 1980,https://www.ncbi.nlm.nih.gov/pubmed/7350291,ID 3,vancomycin,0,7,h,,,,,,,,,,,,,,,14.04624277,mL/min,arith. Mean,,,,CLiv,
5124,Schaad 1980,https://www.ncbi.nlm.nih.gov/pubmed/7350291,ID 4,vancomycin,0,7,h,,,,,,,,,,,,,,,61.24277457,mL/min,arith. Mean,,,,CLiv,
5125,Schaad 1980,https://www.ncbi.nlm.nih.gov/pubmed/7350291,ID 5,vancomycin,0,7,h,,,,,,,,,,,,,,,59.06358382,mL/min,arith. Mean,,,,CLiv,
5126,Schaad 1980,https://www.ncbi.nlm.nih.gov/pubmed/7350291,ID 6,vancomycin,0,8,h,,,,,,,,,,,,,,,74.3583815,mL/min,arith. Mean,,,,CLiv,
5151,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,I1,Alfentanil,0,45,min,21.1,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5152,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,I2,Alfentanil,0,45,min,14,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5153,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,I3,Alfentanil,0,45,min,19.8,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5154,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,I4,Alfentanil,0,45,min,18.5,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5155,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,I5,Alfentanil,0,45,min,15.9,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5157,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,C1,Alfentanil,0,45,min,12.4,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5158,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,C2,Alfentanil,0,45,min,24.3,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5159,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,C3,Alfentanil,0,45,min,11.3,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5160,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,C4,Alfentanil,0,45,min,18.6,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5161,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,C5,Alfentanil,0,45,min,20.7,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5162,den Hollander 1992,https://www.ncbi.nlm.nih.gov/pubmed/1610996,C6,Alfentanil,0,45,min,22.7,mg*min/L,individual,,,,AUC_tau,,,,,,,,,,,,,,,
5163,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID1,Alfentanil,0,360,min,0.005882353,mg*min/mL,individual,,,,AUC_tau,,,,,,,,3.4,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5164,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID2,Alfentanil,0,360,min,0.003389831,mg*min/mL,individual,,,,AUC_tau,,,,,,,,5.9,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5165,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID3,Alfentanil,0,360,min,0.002409639,mg*min/mL,individual,,,,AUC_tau,,,,,,,,8.3,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5166,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID4,Alfentanil,0,360,min,0.004347826,mg*min/mL,individual,,,,AUC_tau,,,,,,,,4.6,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5167,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603 ,ID5,Alfentanil,0,360,min,0.005405405,mg*min/mL,individual,,,,AUC_tau,,,,,,,,3.7,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5168,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID6,Alfentanil,0,360,min,0.004166667,mg*min/mL,individual,,,,AUC_tau,,,,,,,,4.8,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5169,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID7,Alfentanil,0,360,min,0.004545455,mg*min/mL,individual,,,,AUC_tau,,,,,,,,4.4,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5170,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID8,Alfentanil,0,360,min,0.007407407,mg*min/mL,individual,,,,AUC_tau,,,,,,,,2.7,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5171,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,mean child,Alfentanil,0,360,min,0.004255319,mg*min/mL,arith. Mean,,,,AUC_tau,,,,,,,,4.7,mL/min/kg,arith. Mean,0.6,mL/min/kg,arith. SD,CLiv,AUCinf imputed based on reported Dose/AUC
5172,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID9,Alfentanil,0,360,min,0.002777778,mg*min/mL,individual,,,,AUC_tau,,,,,,,,7.2,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5173,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID10,Alfentanil,0,360,min,0.005128205,mg*min/mL,individual,,,,AUC_tau,,,,,,,,3.9,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5174,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID11,Alfentanil,0,360,min,0.007407407,mg*min/mL,individual,,,,AUC_tau,,,,,,,,2.7,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5175,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID12,Alfentanil,0,360,min,0.005128205,mg*min/mL,individual,,,,AUC_tau,,,,,,,,3.9,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5176,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,ID13,Alfentanil,0,360,min,0.006060606,mg*min/mL,individual,,,,AUC_tau,,,,,,,,3.3,mL/min/kg,individual,,,,,AUCinf imputed based on reported Dose/AUC
5177,Meistelman 1987,https://www.ncbi.nlm.nih.gov/pubmed/3099603,mean adult,Alfentanil,0,360,min,0.004761905,mg*min/mL,arith. Mean,,,,AUC_tau,,,,,,,,4.2,mL/min/kg,arith. Mean,1.7,mL/min/kg,arith. SD,CLiv,AUCinf imputed based on reported Dose/AUC
5178,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID1,Alfentanil,0,360,min,5543,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5179,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID2,Alfentanil,0,360,min,4609,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5180,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID3,Alfentanil,0,360,min,5753,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5181,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID4,Alfentanil,0,360,min,8086,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5182,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID5,Alfentanil,0,360,min,6923,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5183,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID6,Alfentanil,0,360,min,6736,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5184,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID7,Alfentanil,0,360,min,6089,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5185,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID8,Alfentanil,0,360,min,5702,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5186,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID9,Alfentanil,0,360,min,6972,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5187,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID10,Alfentanil,0,360,min,9343,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5188,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID11,Alfentanil,0,360,min,4837,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5189,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID12,Alfentanil,0,360,min,5492,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5190,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID13,Alfentanil,0,360,min,9100,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5191,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID14,Alfentanil,0,360,min,14704,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5192,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID15,Alfentanil,0,360,min,11003,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5193,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID16,Alfentanil,0,360,min,17707,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5194,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID17,Alfentanil,0,360,min,140909,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5195,Goresky 1987,https://www.ncbi.nlm.nih.gov/pubmed/3118743,ID18,Alfentanil,0,360,min,21587,ng*min/mL,individual,,,,AUC_inf,,,,,,,,,,,,,,,
5127,Bovill 1984,https://www.ncbi.nlm.nih.gov/pubmed/6238552,mean,Sufentanil,0,8,h,,,,,,,,,,,,,,,12.66,mL/min/kg,arith. Mean,0.78,mL/kg/min,arith. SEM,CLiv,Table 3
5128,Willsie 2015,https://www.ncbi.nlm.nih.gov/pubmed/25544247,mean,Sufentanil,0,1440,min,273.8,pg*h/mL,arith. Mean,61.1,pg*h/mL,arith. SD,AUC_inf,,,,,,,,,,,,,,CLiv,
5129,Davis 1987,https://www.ncbi.nlm.nih.gov/pubmed/2950809,mean,Sufentanil,0,120,min,0.000545455,mg*min/mL,arith. Mean,,,,AUC_tau,,,,,,,,27.5,mL/min/kg,arith. Mean,9.3,mL/kg/min,arith. Mean,CLiv,"Table 3, last samples taken 120 OR until the initiation of cardiopulmonary bypass, AUCinf imputed based on reported Dose/CL"
5130,Davis 1987,https://www.ncbi.nlm.nih.gov/pubmed/2950809,mean,Sufentanil,0,120,min,0.000828729,mg*min/mL,individual,,,,AUC_tau,,,,,,,,18.1,mL/min/kg,arith. Mean,10.7,mL/kg/min,arith. Mean,CLiv,"Table 3 ,AUCinf imputed based on reported Dose/CL"
5131,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID1,Sufentanil,0,360,min,0.00010838,mg*min/mL,individual,,,,AUC_tau,,,,,,,,17.9,mL/min/kg,individual,,,,CLiv,"t_end is time to reach limit of quanititation after dose, AUCinf imputed based on reported Dose/CL"
5132,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID2,Sufentanil,0,60,min,0.0000463,mg*min/mL,individual,,,,AUC_tau,,,,,,,,40.6,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5133,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID3,Sufentanil,0,240,min,0.0000892,mg*min/mL,individual,,,,AUC_tau,,,,,,,,39.7,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5134,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID4,Sufentanil,0,240,min,0.0000826,mg*min/mL,individual,,,,AUC_tau,,,,,,,,34,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5135,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID5,Sufentanil,0,300,min,0.0000663,mg*min/mL,individual,,,,AUC_tau,,,,,,,,29.7,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5136,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID6,Sufentanil,0,120,min,0.0000673,mg*min/mL,individual,,,,AUC_tau,,,,,,,,29.7,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5137,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID7,Sufentanil,0,420,min,0.000134872,mg*min/mL,individual,,,,AUC_tau,,,,,,,,19.5,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5138,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID8,Sufentanil,0,240,min,0.0000699,mg*min/mL,individual,,,,AUC_tau,,,,,,,,44.9,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5139,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID9,Sufentanil,0,120,min,0.0000436,mg*min/mL,individual,,,,AUC_tau,,,,,,,,44.7,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5140,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID10,Sufentanil,0,240,min,0.0000853,mg*min/mL,individual,,,,AUC_tau,,,,,,,,36.1,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5141,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID11,Sufentanil,0,420,min,0.000135498,mg*min/mL,individual,,,,AUC_tau,,,,,,,,23.1,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5142,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID12,Sufentanil,0,240,min,0.0000755,mg*min/mL,individual,,,,AUC_tau,,,,,,,,26.5,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5143,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID13,Sufentanil,0,420,min,0.000161538,mg*min/mL,individual,,,,AUC_tau,,,,,,,,18.2,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5144,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID14,Sufentanil,0,420,min,0.000151832,mg*min/mL,individual,,,,AUC_tau,,,,,,,,19.1,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5145,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID15,Sufentanil,0,180,min,0.000127542,mg*min/mL,individual,,,,AUC_tau,,,,,,,,23.6,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5146,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID16,Sufentanil,0,240,min,0.0000571,mg*min/mL,individual,,,,AUC_tau,,,,,,,,25.9,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5147,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID17,Sufentanil,0,180,min,0.0000617,mg*min/mL,individual,,,,AUC_tau,,,,,,,,32.9,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5148,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID18,Sufentanil,0,180,min,0.000035,mg*min/mL,individual,,,,AUC_tau,,,,,,,,28,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5149,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID19,Sufentanil,0,240,min,0.0000736,mg*min/mL,individual,,,,AUC_tau,,,,,,,,40.1,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5150,Guay 1991,https://www.ncbi.nlm.nih.gov/pubmed/1531117,ID20,Sufentanil,0,180,min,0.0000565,mg*min/mL,individual,,,,AUC_tau,,,,,,,,35.2,mL/min/kg,individual,,,,CLiv,AUCinf imputed based on reported Dose/CL
5224,Friesen 2004,https://www.ncbi.nlm.nih.gov/pubmed/15076638,7-16.8y,Montelukast,0,12,h,4387.2,ng*h/mL,geo. mean,3855.4,ng*h/mL,95%CI,AUC_inf,,,,,,,,,,,,,,,
5225,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID1,Montelukast,0,24,h,30336.98,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5226,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID2,Montelukast,0,24,h,29350.14,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5227,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID3,Montelukast,0,24,h,19481.8,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5228,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID4,Montelukast,0,24,h,15271.04,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5229,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID5,Montelukast,0,24,h,14152.63,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5230,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID6,Montelukast,0,24,h,19490.31,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5231,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID7,Montelukast,0,24,h,17384.8,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5232,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID8,Montelukast,0,24,h,16069.03,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5233,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID9,Montelukast,0,24,h,14555.88,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5234,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID10,Montelukast,0,24,h,12845.36,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5235,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID11,Montelukast,0,24,h,10016.44,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5236,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID12,Montelukast,0,24,h,10024.69,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5237,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID13,Montelukast,0,24,h,8774.445,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5238,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID14,Montelukast,0,24,h,6998.658,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5239,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID15,Montelukast,0,24,h,5419.723,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5240,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID16,Montelukast,0,24,h,5024.989,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5241,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID17,Montelukast,0,24,h,3709.209,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5242,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID18,Montelukast,0,24,h,9835.066,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5243,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID19,Montelukast,0,24,h,6941.125,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5244,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID20,Montelukast,0,24,h,10369.89,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5245,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID21,Montelukast,0,24,h,9843.322,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5246,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID22,Montelukast,0,24,h,6488.084,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5247,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID23,Montelukast,0,24,h,3791.252,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5248,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID24,Montelukast,0,24,h,3462.049,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5249,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID25,Montelukast,0,24,h,6167.911,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5250,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID26,Montelukast,0,24,h,11833.5,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5251,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID27,Montelukast,0,24,h,10986.76,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5252,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID28,Montelukast,0,24,h,10394.92,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5253,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID29,Montelukast,0,24,h,8289.154,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5254,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID30,Montelukast,0,24,h,10534.24,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5255,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID31,Montelukast,0,24,h,4612.969,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5256,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID32,Montelukast,0,24,h,3897.288,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5257,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID33,Montelukast,0,24,h,15879.4,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5258,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID34,Montelukast,0,24,h,13116.26,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5259,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID35,Montelukast,0,24,h,5155.535,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5260,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID36,Montelukast,0,24,h,18848.16,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5261,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID37,Montelukast,0,24,h,7334.827,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5262,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID38,Montelukast,0,24,h,5690.103,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5263,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID39,Montelukast,0,24,h,6167.137,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5264,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID40,Montelukast,0,24,h,11060.03,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5265,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID41,Montelukast,0,24,h,15221.25,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5266,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID42,Montelukast,0,24,h,8642.352,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5267,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID43,Montelukast,0,24,h,7392.36,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5268,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID44,Montelukast,0,24,h,5945.002,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5269,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID45,Montelukast,0,24,h,14374.25,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5270,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID46,Montelukast,0,24,h,11940.31,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5271,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID47,Montelukast,0,24,h,11414,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5272,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID48,Montelukast,0,24,h,10558.23,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5273,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID49,Montelukast,0,24,h,12013.84,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5274,Kearns 2008,https://www.ncbi.nlm.nih.gov/pubmed/18296556,ID50,Montelukast,0,24,h,9250.706,ng*h/mL,individual,,,,,,,,,,,,,,,,,,,
5288,Knorr 2000,https://www.ncbi.nlm.nih.gov/pubmed/10984399,2mg PO CT,Montelukast,0,24,h,575,ng*h/mL,geo. mean,109,ng*h/mL,geo. SD,AUC_inf,92,ng/mL,arith. mean,15,ng/mL,arith. SD,Cmax,,,,,,,,Paramters are listed in table 2 PMID https://www.ncbi.nlm.nih.gov/pubmed/10434229
5289,Knorr 2000,https://www.ncbi.nlm.nih.gov/pubmed/10984399,5mg PO CT,Montelukast,0,24,h,1417,ng*h/mL,geo. mean,313,ng*h/mL,geo. SD,AUC_inf,232,ng/mL,arith. mean,50,ng/mL,arith. SD,Cmax,,,,,,,,Paramters are listed in table 2 PMID https://www.ncbi.nlm.nih.gov/pubmed/10434229
5290,Knorr 2000,https://www.ncbi.nlm.nih.gov/pubmed/10984399,10mg PO CT,Montelukast,0,24,h,2938,ng*h/mL,geo. mean,583,ng*h/mL,geo. SD,AUC_inf,1.9,ng/mL,arith. mean,83,ng/mL,arith. SD,Cmax,,,,,,,,Paramters are listed in table 2 PMID https://www.ncbi.nlm.nih.gov/pubmed/10434229
5291,Knorr 2000,https://www.ncbi.nlm.nih.gov/pubmed/10984399,10mg FCT,Montelukast,0,24,h,2448,ng*h/mL,geo. mean,779,ng*h/mL,geo. SD,AUC_inf,4.4,ng/mL,arith. mean,110,ng/mL,arith. SD,Cmax,,,,,,,,Paramters are listed in table 2 PMID https://www.ncbi.nlm.nih.gov/pubmed/10434229
5292,Zhao 1997,https://www.ncbi.nlm.nih.gov/pubmed/9429741,MD 10mg FCT,Montelukast,0,24,h,3624,ng*h/mL,geo. mean,1258,ng*h/mL,geo. SD,AUC_inf,541.5,ng/mL,geom.mean,172.6,ng/mL,arith. SD,Cmax,,,,,,,,
5293,Fey 2014,https://www.ncbi.nlm.nih.gov/pubmed/25250173,4mg PO granules (Sandoz),Montelukast,0,36,h,1083,ng*h/mL,arith. Mean,293.88,ng*h/mL,arith. SD,AUC_tend,178.04,ng/mL,arith. mean,41.58,ng/mL,arith. SD,Cmax,,,,,,,,
5294,Fey 2014,https://www.ncbi.nlm.nih.gov/pubmed/25250173,4mg PO granules (Singular),Montelukast,0,36,h,1112.84,ng*h/mL,arith. Mean,309.13,ng*h/mL,arith. SD,AUC_tend,196.04,ng/mL,arith. mean,53.25,ng/mL,arith. SD,Cmax,,,,,,,,
5401,Friesen 2004,https://www.ncbi.nlm.nih.gov/pubmed/15076638,min,Montelukast,0,12,h,,,,,,,,,,,,,,,,,,,,,,
5402,Friesen 2004,https://www.ncbi.nlm.nih.gov/pubmed/15076638,max,Montelukast,0,12,h,,,,,,,,,,,,,,,,,,,,,,
5403,Friesen 2004,https://www.ncbi.nlm.nih.gov/pubmed/15076638,Mean ,Montelukast,0,12,h,4387.2,ng*h/mL,geo. mean,1485.1,ng*h/mL,geo.SD,AUC_inf,,,,,,,,,,,,,,,
5404,Knorr 2001,https://www.ncbi.nlm.nih.gov/pubmed/11402629,2-5y,Montelukast,0,24,h,2721,ng*h/mL,geo. mean,164,ng*h/mL,geo.SD,AUC_inf,,,,,,,,,,,,,,,
5405,Knorr 1999,https://www.ncbi.nlm.nih.gov/pubmed/10434229,9-14y GT45kg,Montelukast,0,24,h,3528,ng*h/mL,geo. mean,1883,ng*h/mL,geo.SD,AUC_inf,526,ng/mL,arith. mean,413,ng/mL,arith. SD,Cmax,,,,,,,,
5406,Knorr 1999,https://www.ncbi.nlm.nih.gov/pubmed/10434229,6-8y ,Montelukast,0,24,h,2929,ng*h/mL,geo. mean,994,ng*h/mL,geo.SD,AUC_inf,495,ng/mL,arith. mean,129,ng/mL,arith. SD,Cmax,,,,,,,,
5407,Knorr 1999,https://www.ncbi.nlm.nih.gov/pubmed/10434229,9-14 SE45kg,Montelukast,0,24,h,2928,ng*h/mL,geo. mean,904,ng*h/mL,geo.SD,AUC_inf,444,ng/mL,arith. mean,37,ng/mL,arith. SD,Cmax,,,,,,,,
5408,Knorr 2006,https://www.ncbi.nlm.nih.gov/pubmed/16707408,3-6m,Montelukast,0,24,h,3644.3,ng*h/mL,geo. mean,481.5,ng*h/mL,SEM,AUC_inf,561.1,ng/mL,geom.mean,78,ng/mL,SEM,Cmax,18.3,mL/min,geom. Mean,2.4,mL/min,SEM,CL/F,
5409,Miyoga 2004,https://www.ncbi.nlm.nih.gov/pubmed/15102869,6-12m,Montelukast,0,24,h,2470.9,ng*h/mL,geo. mean,499.3,ng*h/mL,SEM,AUC_inf,583.5,ng/mL,geom.mean,85,ng/mL,SEM,Cmax,19.2,mL/min,geom. Mean,2.8,mL/min,SEM,CL/F,
5410,Miyoga 2004,https://www.ncbi.nlm.nih.gov/pubmed/15102869,12-24m,Montelukast,0,24,h,3629.2,ng*h/mL,geo. mean,243.1,ng*h/mL,SEM,AUC_inf,582.3,ng/mL,geom.mean,47,ng/mL,SEM,Cmax,18.4,mL/min,geom. Mean,1.2,mL/min,SEM,CL/F,
5411,Cheng 1996,https://www.ncbi.nlm.nih.gov/pubmed/8692739,3mg IV male,Montelukast,0,24,h,,,,,,,,,,,,,,,50.4,mL/min,harmonic mean,12.1,mL/min,Jacknife SD,CLiv,
5412,Cheng 1996,https://www.ncbi.nlm.nih.gov/pubmed/8692739,9mg IV male,Montelukast,0,24,h,,,,,,,,,,,,,,,46,mL/min,harmonic mean,4.2,mL/min,Jacknife SD,CLiv,
5413,Cheng 1996,https://www.ncbi.nlm.nih.gov/pubmed/8692739,18mg IV male,Montelukast,0,24,h,,,,,,,,,,,,,,,40.2,mL/min,harmonic mean,6.4,mL/min,Jacknife SD,CLiv,
5414,Cheng 1996,https://www.ncbi.nlm.nih.gov/pubmed/8692739,9mg IV Female,Montelukast,0,24,h,,,,,,,,,,,,,,,47.6,mL/min,harmonic mean,16,mL/min,Jacknife SD,CLiv,
5415,Cheng 1996,https://www.ncbi.nlm.nih.gov/pubmed/8692739,10mg PO Female,Montelukast,0,24,h,2270,ng*h/mL,Harmonic mean,919,ng*h/mL,Jacknife SD,AUC_tau,350,ng/mL,Harmonic mean,161,ng/mL,Jacknife SD,Cmax,,,,,,,,
5416,Cheng 1996,https://www.ncbi.nlm.nih.gov/pubmed/8692739,10mg PO male,Montelukast,0,24,h,2441,ng*h/mL,Harmonic mean,441,ng*h/mL,Jacknife SD,AUC_tau,385,ng/mL,Harmonic mean,85,ng/mL,Jacknife SD,Cmax,,,,,,,,
5452,Taverne 1992,https://pubmed.ncbi.nlm.nih.gov/1387351/,mean,Sufentanil,0,5.64,h,1.5,µg*h/L,arith. Mean,0.4,µg*h/L,arith. SD,AUC_tend,,,,,,,,,,,,,,,
